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T
he nucleus, nucleolus and cytoplasm of eukaryotic cells contain many types of 
small RNA molecules containing less than 400 nucleotides. Among these are the 
small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and the small cyto­
plasmic RNAs (scRNAs). These stable RNA molecules are associated with specific 
proteins in ribonucleoprotein particles (RNPs) that play important roles in various 
cellular processes such as the splicing of pre-messenger RNA (snRNPs) and ribo­
some biogenesis (snoRNPs).
The Ro RNPs, belonging to the group of the scRNPs, consist of several proteins, 
including Ro60 and La, and the small cytoplasmic Y RNAs. In this chapter an over­
view of the current knowledge on the structure and function of the Ro RNPs is pre­
sented.
Historical background
In  1961 A nderson and  co-w orkers described  p re ­
cip itating  au toan tibod ies against the antigens 
called SjD and  SjT in  sera from  patien ts suf­
fering from  the au to im m une  disorder Sjögren’s 
syndrom e (SS) (1). Several years later Clark et 
al. identified  two antigens, designated  Ro and  
La, p rec ip ita ted  by sera from  pa tien ts w ith sys­
tem ic lupus ery them atosus (SLE) (2). In 1975, 
A lspaugh and  Tan repo rted  the detec tion  of two 
novel au toan tibod ies by m eans of im m unodif­
fusion in  patien ts w ith SS. Therefore they called 
the antigens Sjögren’s syndrom e-A  and  -B (SS-A 
an d  SS-B) (3). It was n o t un til 1979 th a t com pari­
son  of all d a ta  revealed th a t SjD corresponds to 
the Ro (SS-A) an tigen  and  SjT to the La (SS-B) 
an tigen  (4). Adding to the complexity, the Ro 
(SS-A) antigen com prises two different pro teins 
w ith  m olecular m asses of 60 kDa and  52 kDa (5, 
6). For reasons of clarity the designations Ro60 
(for SjD, Ro or SS-A), La (for SjT, La or SS-B) and
Ro52 (for 52 kDa Ro/SS-A) will be used  th rough­
out this thesis.
The use of the anti-Ro60 an d  anti-La au to im ­
m u n e  sera led in  1981 to the discovery th a t bo th  
Ro60 and  La w ere associated  w ith  a subclass 
of sm all RNA m olecules, te rm ed  Y RNAs. The 
resulting RNA-protein particles w ere nam ed  Ro 
ribonucleopro te in  com plexes (Ro RNPs) (7, 8).
Structure of the Ro RNPs
The RNA component of the Ro RNPs: Y RNAs
In h u m an  cells the RNA co m p o n en t of a Ro RNP 
consists of one of the four Y RNAs designated  
hY1, hY3, hY4 and  hY5 (8). Originally also hY2 
RNA was identified, bu t this RNA was show n to 
be a degradation  p ro d u c t of the hY1 RNA m ol­
ecule (9). The hY RNAs are transcribed  by RNA 
polym erase III (8). All four hY RNAs have been
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Figure 1. The secondary structures of the four human Y RNAs.
The secondary structures have been proposed by Van Gelder et al. (22) based upon experimental data obtained by chemical and 
enzymatic RNA probing studies, as well as phylogenetic data. For the hY1 RNA molecule the names of the various stem and loop 
structures are indicated.
sequenced  (9-11) and  have lengths o f 112 (hY1), 
101 (hY3), 93 (hY4) an d  84 (hY5) nucleotides, 
a lthough  som e heterogeneity  in  their 3’-ends 
has been  observed. The Y RNAs posses a triphos­
ph a te  at their 5’-end  and  do n o t con ta in  m od i­
fied nucleo tides (8, 10). Like all RNA polym erase 
III transcripts, the hY RNAs con ta in  an  oligo- 
urid ine stretch  a t their 3’-end, w hich is, in  con ­
trast to o ther RNA polym erase III transcripts, 
n o t rem oved by 3’-end  processing. A lthough the 
hY RNAs are synthesized from  single copy genes 
th a t are clustered  on  chrom osom e 7q36 (9, 12, 
13), the h u m an  genom e contains m ultip le hY 
RNA pseudogenes (14, 15). The p ropensity  of hY 
sequences to generate pseudogenes by an  RNA- 
m ed ia ted  process know n as re troposition  sug­
gests th a t the sm aller hY RNA genes orig inated  
as re troposons from  the larger hY RNAs (15).
C haracterization  of the Y RNAs from  several 
organism s dem onstra ted  tha t the n u m b er of Y 
RNAs associated  w ith  Ro RNPs varies betw een 
cell types an d  species (11, 16, 17). The nu m b er of 
different Y RNAs p resen t in  the cell varies from 
four in  h um ans an d  Xenopus laevis, to two in  
iguana and  mice, an d  to only one in  Caenorhab- 
ditis elegans (ceY RNA) (8, 18-21). The Y RNAs 
are highly conserved in  evolution (17) and  the 
conservation  is m ore obvious at the secondary  
structure level th an  on the p rim ary  sequence 
level. All Y RNAs can  be folded into secondary  
structures contain ing  a pyrim idine-rich  in ternal 
loop and  a long stem  form ed by base-pairing  of 
the 5’ an d  3’ ends (21-23) (see Figure 1). W ithin 
the stem  is a highly conserved region contain ing  
a single bulged cytidine (C9; Figure 1). Experi­
m en ta l evidence tha t the stem  and  loop exist has 
b een  provided by chem ical and  enzym atic m o d i­
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fication  experim ents (22-24) and  by oligonucleo­
tide-d irected  RNase H cleavage (25). Moreover, 
also phylogenetic structure  analyses su p p o rt the 
p red ic ted  Y RNA secondary  structures (19, 26).
The protein components of the Ro RNPs 
Ro60
The Ro60 au toan tigen  con tains an  RNA-binding 
m o tif (RNP m otif) in  the N -term inal region, and  
exists in  at least two isoform s as a result o f alter­
native splicing (Ro60a and  Ro60ß; see Figure 2) 
(27, 28). Ro60 b inds directly an d  in d ep en d e n t of 
the La p ro te in  to the hY RNAs (29). The binding 
site of Ro60 on  the hY RNA m olecules has b een  
m ap p ed  to the cen tral p a rt o f the conserved stem  
structu re  using a ribonuclease p ro tec tion  assay 
(30) (see Figures 1 and  4). The bulged cytidine at 
position  9 is im p o rtan t for Ro60 binding, since 
deletion  of this residue elim inated  the associa­
tion  of Ro60 w ith  hY RNAs (29). The bulged C9 
residue has b een  show n to be involved in  the 
w idening of the m ajor groove of the RNA helix, 
allowing a b e tte r access for the Ro60 p ro tein  
(24).
La
The h u m an  La p ro te in  is an  RNA chaperone of 47 
kDa contain ing  three RNP m otifs in  its prim ary  
sequence ((31); Figure 3). In  analogy to Ro60, La 
in teracts directly an d  independen tly  w ith  the hY 
RNAs (29). The La b inding site on  the hY RNAs 
is the 3’ oligouridine stretch  com m on to all RNA 
polym erase III transcrip ts (29, 32, 33). As sta ted  
above the hY RNAs do n o t loose their 3’ oligouri­
d ine stre tch  after RNA polym erase III tran scrip t­
ion  and, therefore, La is though t to rep resen t a 
stable com ponen t of the h u m an  Ro RNPs (8, 34) 
(see Figures 1 an d  4). In contrast, the  xY RNAs of 
X. laevis are p rocessed  a t their 3’-end  and  as a 
result loose the La b ind ing  site (18). Also the ceY 
RNA from  C. elegans does n o t con ta in  a 3’-end 
oligouridine stretch, w hich m ight preclude b in d ­
ing of the C. elegans La hom ologue (21, 35). Thus, 
w hereas Ro60 is associated  w ith  the Y RNA spe­
cies from  every organism  stud ied  so far, this does 
n o t seem  to be the case for the La protein .
Ro52
The detec tion  of anti-Ro52 antibodies in  anti-Ro 
positive sera o f pa tien ts w ith  SS and  SLE, and
RNP motif Zn-finger
Ro60a
538
1
Ro60ß
525
Figure 2. Structure of the Ro60a and Ro60ß proteins.
The Ro60 autoantigen contains an RNA-binding motif (RNP 
motif) in the N-terminal region, and exists in at least two iso­
forms as a result of alternative splicing (Ro60a and Ro60ß) 
(27, 28). The Ro60a and Ro60ß differ only at the C-terminus 
(encoded by an alternative 3' exon; indicated in black). The pre­
dicted molecular masses (Mr) and the pI's of the two variants, are 
for Ro60a (MW 60.6 kDa; pI 8.27) and Ro60b (MW 59.3 kDa; pI 
8.72). Furthermore, both Ro60 proteins contain a potential zinc- 
finger motif, although no function is known for this motif in the 
Ro60 proteins.
s ■ ■  ■  I
40!
WAM ^
PKR
Figure 3. Structure of the human La protein.
The human La protein contains several structural motifs inclu­
ding three RNP motifs (implicated in RNA binding) indicated by 
RNP-1, RNP-2 and RNP-3 (31). Three PEST regions (rich in the 
amino acids P, E, S and T) that are susceptible to proteolytic clea­
vage (36), are indicated by arrows. A sequence element homol­
ogous to the double-stranded RNA-dependent protein kinase 
PKR is indicated by PKR. Furthermore, a putative ATP binding site 
(Walker A motif; indicated by WAM) is present (31, 37). Finally, a 
functional nuclear localization signal (indicated by NLS) is pres­
ent in the C-terminal part of La (38).
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the capability of anti-Ro52 patient sera to pre­
cipitate both Ro60 and the hY RNAs from a HeLa 
cell extract suggested that Ro52 is a bona fide 
Ro RNP protein (5, 39, 40). The observation that 
binding of Ro52 to hY1 RNA required the pres­
ence of Ro60 suggested that the association of 
Ro52 with Ro RNPs is m ediated by protein-pro­
tein interactions between Ro60 and Ro52 (29, 
41). However, these results were challenged by 
other reports in  which the authors were unable 
to detect the presence of Ro52 in  Ro RNP par­
ticles (42-44). Considering the conflicting data, 
it remains unclear whether or not Ro52 is asso­
ciated with the Ro RNPs. The relevance of the 
putative hY RNA-Ro52 association is not obvious 
since no functions have been ascribed to Ro52 
in vivo. A clue might come from the observation 
that the amino acid sequence of Ro52 contains 
a zinc finger-like domain, which is referred to 
as RING finger-B box domain, a leucine zipper 
m otif and a coiled-coil dom ain (6, 45). The 
presence of these protein motifs suggests that 
Ro52 interacts with nucleic acids and/or other 
proteins. In vitro studies have indeed revealed 
that Ro52 is capable of binding DNA (46, 47), 
other proteins, e.g. UnpEL, a de-ubiquitinating 
enzyme (48), and to homodimerize (49).
Calreticulin
The association of another putative Ro RNP pro­
tein, the calcium-binding molecular chaperone 
calreticulin (50, 51), is also a subject of contro­
versy. In analogy to Ro60 and La, also calreticu- 
lin was shown to bind specifically to hY RNAs in 
vitro, thereby possibly facilitating the binding of 
Ro60 to the hY RNAs (52). However, Pruijn et al. 
were unable to reproduce this result (53). In the 
same study, calreticulin was found to interact 
with Ro52 in  the yeast two-hybrid system (52).
The development of antibodies to calreticulin in 
mice im m unized with Ro60 and Ro52 has been 
suggested to be an additional observation sup­
porting the in vivo association of calreticulin 
with Ro RNPs (54). However, it is more likely that 
this points to cross-reactivity of the anti-Ro60 
antibodies with calreticulin. This is corroborated 
by the observation that mice im m unized with 
Ro60 also developed antibodies cross-reactive 
with several unrelated proteins including the 
U1-70 kDa protein and several Sm proteins (55). 
Chromatographic purifications of Ro RNPs from 
hum an cells did not unambigously prove the 
association of calreticulin with Ro RNPs; whereas 
Lieu et al. did observe a co-fractionation of cal­
reticulin with Ro RNPs (56), Lu et al. found the 
opposite (57). Thus, in  analogy to Ro52 also the 
association of calreticulin with Ro RNPs is still a 
m atter of debate.
hnRNP I & hnRNP K
Recently several proteins (with molecular masses 
between 53 and 80 kDa) were identified using 
in vitro reconstitution experiments with biotiny- 
lated hY RNAs and a HeLa cell extract as a source 
of proteins (58) (see Figure 4). Subsequent work 
by the same group identified two of these pro­
teins, that specifically associated with hY1 and 
hY3 RNA, but not with hY4 or hY5 RNA, as 
the heterogeneous nuclear ribonucleoproteins 
hnRNP I (also known as polypyrimidine-tract 
binding protein; PTB) and hnRNP K (59). Both 
hnRNP I and K need the pyrimidine-rich inter­
nal Loop 2 and an intact La-binding site for effi­
cient association with the hY1 RNA molecule 
(59). Only the interaction of hnRNP I with the 
Ro RNPs could be corroborated by the co-pre­
cipitation of hY1 and hY3 RNAs from a HeLa 
cell extract using a monoclonal antibody against
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Figure 4. Hypothetical structural model of a hY1 RNP.
A schematic representation of a hY1 RNP particle showing the 
binding sites of the ''core'' proteins Ro60 and La. The Stem 2 
binding factor (ST2BF), a factor needed for the nuclear export of 
the hY1 RNA molecule (66), probably associates transiently with 
the hY1 RNA prior to nuclear export (indicated by a line). Fabini 
and co-workers have identified several proteins associated with 
the hY1 RNA using a reconstitution assay with biotinylated hY1 
RNA (58, 59). Several of these proteins need the pyrimidine-rich 
Loop 2 for association (hnRNP K, hnRNP I, a 68 kDa-protein and 
a 80 kDa-protein), although the precise binding sites on the hY1 
RNA have not been determined. In the same study also a protein 
with a molecular mass of 65 kDa was identified (58). This protein 
needs in addition to Loop 2 also Loop 4 and Stem 4 for asso­
ciation. Ro52 has been proposed to associate with the Ro RNPs 
via a protein-protein interaction with Ro60 (29, 41). The associa­
tion of calreticulin (CaR) with the hY1 RNP has not been proven 
unambigously (indicated by a line and question-mark).
hnRNP I (59). Both hnRNP I and K are nucleo- 
cytoplasmic shuttling proteins that belong to a 
group of multifunctional RNA-binding proteins 
(60-62). They regulate various processes ranging 
from transcription and pre-mRNA processing in 
the nucleus to cytoplasmic mRNA translation 
and turnover (63-65). Although m uch is known 
about the cellular functions of hnRNP I and K, 
the function(s) of both proteins in the context of 
Ro RNPs is still elusive.
RoBPI
Using a modified three-hybrid assay consisting 
of hum an Ro60 co-expressed with hY5 RNA in 
yeast as a ‘bait’ RNP, Bouffard et al. identified Ro 
RNP-binding protein I (RoBPI) (67, 68). RoBPI 
associated only with the Ro60-hY5 RNP com ­
plex, whereas no association with the other 
Ro60-hY RNPs, Ro60 alone or hY5 RNA alone was 
observed (68). Antibodies raised against RoBPI 
failed, however, to co-precipitate hY5 RNPs from 
a HeLa cell extract. RoBPI, a pyrimidine-tract 
binding factor, is identical to the hum an pre- 
mRNA splicing-factor PUF60 (69) and to a repres­
sor of activated RNA polymerase II transcription 
(70). Despite these studies on RoBPI the func­
tional implications of the Ro60-hY5 RNA-RoBPI 
interaction are not known.
Stem 2 binding factor
Stem 2 binding factor (ST2BF) was identified as a 
factor necessary for the efficient nuclear export 
of hY1 RNA (66, 71). The identity of ST2BF is 
not known yet, and it is likely that this protein 
is also involved in the nuclear export of other 
RNA molecules. Most likely, this protein only 
transiently associates with the hY RNAs, prior to 
export from the nucleus (66).
Function of the Ro RNPs
Since the discovery of the Ro RNPs over 20 years 
ago, a large body of experimental data has been 
obtained. Early studies on the composition of the 
Ro RNPs revealed the existence of several sub­
populations of Ro RNPs (34, 42, 72). In humans, 
the num ber of different hY RNAs accounts for at
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least four different subpopulations. This hetero­
geneity is increased by the variety of proteins 
capable of binding to Y RNAs (see above), thus 
forming several subsets of Ro RNPs. However, 
the function(s) of these particles is still enig­
matic. X. laevis oocyte injection and cell enucle­
ation studies have established that the Y RNAs, 
and as a consequence also the Ro RNPs, accu­
mulate in the cytoplasm (18, 30, 40, 73), although 
recent evidence suggests that hY5 RNPs are 
mainly localized in the nucleus (74). The cyto­
plasmic accum ulation of hY1, hY3 and hY4 RNPs 
suggests that these particles function in the cyto­
plasm, in contrast to the hY5 RNPs that most 
likely have a nuclear function.
Despite the fact that for the Ro RNPs no func­
tion has been reported yet, for the two core 
proteins of the Ro RNPs, Ro60 and La, several 
functions have been proposed. For example, the 
La protein has been shown to be involved in 
RNP m aturation, internal-ribosome-entry-site- 
m ediated translation, mRNA stabilization and 
RNA polymerase III transcription (reviewed in 
(31, 75)). La binds to the 3’ oligo(U) tracts of pri­
mary RNA polymerase III transcripts (76) and 
to certain RNA polymerase II transcribed RNAs, 
e.g. U3 RNA (77). La has been proposed to act as 
an RNA chaperone, which might be consistent 
with all of the functions m entioned above (78). 
Much less is known about the biological activi­
ties of Ro60. In X  laevisRo60 has been implicated 
in the quality control pathway for 5S ribosomal 
RNA synthesis (79), and the regulation of trans­
lation of the ribosomal L4 protein (80). Further­
more, Ro60 has been shown to be involved in 
the nuclear export process ofY RNAs, as dem on­
strated in a X  laevis oocyte system (71). Interest­
ingly, an ortholog of Ro60 was recently identified 
in the radiation-resistant eubacterium  Deino-
coccus radiodurans, and this protein was shown 
to play a role in the resistance of this organism 
to UV irradiation (81). Ro60 might also act as an 
RNA chaperone, since knocking-out the rop-1 
gene (encoding the C. elegans Ro60 ortholog) in 
C. elegans led to a significant decrease in ceY 
RNA levels (82, 83).
Outline of this thesis
The goals of the work described in  this thesis 
were: A) to investigate the Ro60 protein in more 
detail (e.g. post-translational modifications) and 
B) to identify novel Ro RNP-associated proteins.
A) Detailed analysis o f the human Ro60 protein
A large body of evidence has been obtained for 
the phosphorylation of the La protein (84-88), 
but data on the post-translational modification 
of the Ro60 protein are still scarce (89, 90). In 
Chapter 2 we set out to investigate in detail 
the phosphorylation of the hum an Ro60 protein 
using the powerful m ethod of nanoelectrospray 
mass spectrometry (Nano ES-MS) to map the 
phosphorylation site(s). We show that Ro60 is 
weakly phosphorylated in vivo, and m apped 
the major phosphorylated residue to serine-265. 
(De)phosphorylation of serine-265 does not 
affect incorporation of Ro60 into Ro RNPs but 
influences the subcellular distribution of Ro60 
in hum an and monkey cells.
B) Identification o f novel Ro RNP-associated proteins
The molecular mass of the Ro RNPs was, based 
on gel filtration data, estimated to be between 
150 and 600 kDa, which is larger than would 
be expected from the molecular masses of the 
known protein and RNA com ponents (34, 42,
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58). These results suggested that there might be 
other, yet unidentified, proteins that associate 
with Ro RNPs. In the past other researchers have 
used several m ethods to identify novel Ro RNP- 
associated proteins. The application of the yeast 
two-hybrid system using Ro60 as ‘bait’ resulted 
in  the identification of pp75 (91). Despite the 
fact that pp75 appeared to interact with Ro60 in 
hum an cells, pp75 did not (detectably) associ­
ate with hY RNAs. Using a modified yeast three- 
hybrid system designated RNP interaction trap 
assay (RITA), in which Ro60 complexed to hY5 
RNA was used as ‘bait’, Bouffard et al. identified 
RoBPI (67, 68). RoBPI associated with hY5 RNA 
complexed to Ro60 in yeast cells, whereas evi­
dence for this RoBPI-hY5 RNA-Ro60 association 
in  hum an cells was not convincing (see above 
and (68)). Fabini and co-workers used an in 
vitro reconstitution approach in which biotiny- 
lated hY RNAs were added to a HeLa cell extract, 
followed by the extraction of hY RNA-binding 
proteins by neutravidin beads. They identified 
several proteins, including hnRNP I and K, that 
associated specifically with hY1 and hY3 RNA, 
but only weakly or not at all with hY4 and hY5 
RNA (58, 59).
To identify novel Ro RNP-associated proteins a 
different experimental strategy was developed 
based upon large-scale im m unoprecipitations 
(see Figure 5) using the monoclonal antibodies 
(mAbs) 2G10 (anti-Ro60) and SW5 (anti-La). 
Previous work indicated that both mAbs were 
suited for im m unoprecipitation assays, since 
they were able to imm unoprecipitate native Ro 
RNP complexes from HeLa cell extracts (92, 93). 
We looked specifically for proteins co-precipi­
tated with both Ro60 and La, since this increased 
the likelihood of identifying a novel Ro RNP- 
associated protein, instead of identifying a Ro60-
or La-associated protein. This m ethod was used 
in Chapters 3 to 5 of this thesis.
Application of this m ethod in Chapter 3 resulted 
in the identification of nucleolin as a novel spe-
immunoprecipitation
anti-Ro60; anti-La; mock
I
isolation co-precipitated proteins
elution with 1M NaCl
I
fractionation of proteins
(2D-IEF) SDS-PAGE; staining
I
excision protein of interest
present in both anti-Ro60 and anti-La
I
analysis by mass spectrometry
I
protein identity
novel protein known protein
I
done protein
validate association
immunoprécipitation; in vitro pull-down
Figure 5. Experimental strategy to identify Ro RNP-associ- 
ated proteins.
Protein A-agarose beads coated with anti-Ro60 mAb 2G10 
(anti-Ro60) or anti-La mAb SW5 (anti-La) via a rabbit anti-mouse 
IgG bridge, were incubated with a HeLa S100 extract (from 
1109 cells). After washing of the beads co-precipitated material 
was eluted by 1 M NaCl. Eluted proteins are resolved by 12% 
SDS-PAGE or 2D-IEF/SDS-PAGE and stained with Coomassie Bril­
liant Blue. Bands of interest (e.g. bands present in both the 
anti-Ro60 and anti-La precipitates) are excised, destained, and 
subsequently digested with trypsin and processed for Q-TOF- 
mass spectrometry according to Raymackers et al. (94). Peptide 
sequences obtained by mass spectrometry are used to identify 
the co-precipitated proteins using the NCBI non-redundant pro­
tein database. In case of a novel protein, the peptide sequences 
are used to search the EST database and to assemble the full- 
length protein sequence. The association of the identified pro­
teins with Ro60 and La is subsequently validated via various 
assays including immunoprecipitation analysis and in vitro pull­
down assays.
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cific protein subunit of hY1 and hY3 RNPs, but 
not of hY4 and hY5 RNPs. Using an in vitro hY 
RNA-binding assay we established that the inter­
nal pyrimidine-rich loop of hY1 and hY3 RNA 
is essential for the association of nucleolin. The 
binding is critically dependent on the presence 
of all four RNP motifs of nucleolin, but not of 
the C-terminal RGG-box. In Chapter 4 we identi­
fied a novel protein-protein interaction between 
La and a m em ber of the DEAH-box RNA heli- 
case family, DDX15. The La-binding dom ain of 
DDX15 was m apped to a region overlapping the 
DEAH-box. Furthermore, DDX15 was shown to 
localize to both nucleoli and nuclear speckles in
hum an cells. Chapter 5 describes the identifi­
cation of a novel FYVE-domain protein, nam ed 
early endosom e antigen 2 (EEA2), by virtue of 
its direct interaction with the anti-La mAb SW5. 
We show that EEA2 functionally interacts with 
the small GTPases rab4 and rab5 and is involved 
in the internalization and recycling of transfer­
rin from early endosomes. The surprising inter­
action of SW5 with EEA2 was further analyzed in 
Chapter 6. We show that the cross-reactive epi­
tope is located in coiled-coil region 3 of EEA2. 
Finally, in  Chapter 7 a general discussion of the 
results described in this thesis and future pros­
pects of Ro RNP research are presented.
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T
he human Ro60 (SS-A) autoantigen is an RNA-binding protein, and a core compo­
nent of the Ro ribonucleoprotein complexes. We investigated the phosphorylation 
of Ro60 in Jurkat (lymphocytic) and HeLa (epithelial) cells. By [32P]orthophosphate 
labeling in vivo we showed that Ro60 is weakly phosphorylated in Jurkat cells. Two­
dimensional isoelectric focussing/SDS-PAGE of Jurkat cell extracts revealed two 
major isoelectric isoforms of Ro60, which however were not due to differences in 
the phosphorylation state. Using nanoelectrospray mass spectrometry of immuno- 
purified Ro60 protein from HeLa cells we identified serine-265 as a phosphorylated 
residue. The analysis of substitution mutants of serine-265 revealed that the phos­
phorylation state affects the subcellular distribution of Ro60. Whereas the wild­
type Ro60 protein and a non-phosphorylated alanine-265 mutant accumulated to 
higher levels in the nucleus than in the cytoplasm, a mutant containing an aspar­
tate at position 265 (mimicking a phosphorylated residue) displayed higher con­
centrations in the cytoplasm of HEp-2 and COS-1 cells as demonstrated by confocal 
microscopy. The association of Ro60 with Ro ribonucleoprotein complexes was not 
affected by substitution of serine-265.
Introduction
Sera from patients suffering from systemic rheu­
matic diseases, e.g. systemic lupus erythem ato­
sus (SLE) and Sjögren’s syndrome (SS), frequently 
contain antibodies against the Ro/SS-A auto­
antigen (95). Anti-Ro/SS-A antibodies recognize 
either a 52 kDa protein (Ro52) or a 60 kDa pro­
tein (Ro60) (5). The Ro60 protein is a core com ­
ponent of the small cytoplasmic RNA-protein 
complexes, called Ro ribonucleoprotein parti­
cles (Ro RNPs). In hum an cells, Ro RNPs consist 
of one of four hY RNA molecules, associated 
with several proteins, including the Ro60 and 
the La/SS-B protein (96). Several cDNAs encod­
ing the hum an Ro60 and orthologs from mouse, 
Xenopus laevis, Caenorhabditis elegans and 
Deinococcus radiodurans have been charac­
terized (18, 27-29, 81, 82, 97) and show a m od­
erate degree of amino acid sequence homology. 
The Ro60 autoantigen contains an RNA-binding 
motif in  the N-terminal region, and exists in  at 
least two isoforms as a result of alternative splic­
ing (Ro60a and Ro60ß) (27, 28).
The subcellular localization of the Ro/SS-A 
autoantigens is controversial, with different 
laboratories reporting different localizations, 
although immunofluorescence data obtained 
with anti-Ro60 monoclonal antibodies show a 
fine speckled pattern  in the nucleus and a 
more homogeneous cytoplasmic staining (92, 
96). These differences m ay reflect differences in 
cell types studied and/or culturing conditions. 
The latter possibility is substantiated by the rapid
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relocalization of the Ro/SS-A autoantigen to the 
cytoplasm after UV-irradiation of hum an kera- 
tinocytes (98). The cellular functions of Ro60 
have not been characterized in hum ans, but in 
X. laevis oocytes the Ro60 protein has been sug­
gested to function in  a quality control pathway 
for 5S rRNA, as it was associated with aberrant 
5S rRNAs (79, 99). Furthermore, Ro60 has been 
shown to be involved in the nuclear export pro­
cess of Y RNAs, as dem onstrated in a X  laevis 
oocyte system (71). In C. elegans, the Ro60 ortho­
log ROP-1 has been postulated to function as a 
stabilizing factor for the C. elegans Y RNA during 
biogenesis, as the level of the ceY RNA drasti­
cally decreased in ROP-1 knock-out strains (83). 
Moreover, strains defective in  ROP-1 show an 
accum ulation of m utant 5S rRNAs (83), and do 
not readily form dauer larvae under stress condi­
tions (100). Recently, the surprising identification 
of a Ro60 ortholog, Rsr, in the radiation-resis­
tant eubacterium D. radiodurans, suggested that 
Ro60 might be involved in  the recovery of cells 
from damage induced by ionizing radiation 
(81).
A large body of evidence has been obtained 
for the phosphorylation of the La/SS-B protein 
(84-88), but data on the post-translational m odi­
fication of the Ro60 protein are still scarce (89, 
90).
In this study we investigated in detail the phos­
phorylation of the hum an Ro60 protein using 
the powerful m ethod of nanoelectrospray mass 
spectrom etry (Nano ES-MS) to map the 
phosphorylation site(s). We show that Ro60 is 
weakly phosphorylated in vivo, and m apped 
the major phosphorylated residue to serine-265. 
(De)phosphorylation of serine-265 does not 
affect incorporation of Ro60 into Ro RNPs. Inte­
restingly, the (de)phosphorylation of this residue
influences the subcellular distribution of Ro60 
in hum an and monkey cells.
Results and discussion
Human Ro60 is phosphorylated in vivo
To investigate the phosphorylation state of 
hum an Ro60 in cultured cells, immunoprecipita- 
tions were perform ed using extracts from Jurkat 
(lymphocytic) cells metabolically labeled with 
[32P]orthophosphate and two different m ono­
clonal antibodies against Ro60 (1D8 and 2G10). 
Both antibodies are reactive with native Ro60, 
but recognize different, spatially separated epi­
topes on the protein (92). Using these mAbs 
thus diminished the chance that phosphoryla­
tion influences the isolation of Ro60. The results 
reproducibly showed that Ro60 is phosphory­
lated in vivo, although the level of phosphory­
lation is probably low, because long exposures 
were required (Figure 1A) and as a consequence 
several background bands appeared. A low level 
of phosphorylation of Ro60 has previously also 
been observed in  HEp-2 cells (90) and HeLa 
cells (91), suggesting that this is a more general 
phenom enon, not restricted to Jurkat cells. 
The mAb 1D8 precipitated a larger am ount of 
[32P]orthophosphate-labeled protein than 2G10 
(Figure 1A, lanes 2 and 3). This is probably due to 
a difference in  the am ount of antibody. Immu- 
noblotting using a polyclonal anti-Ro60 antibody 
confirmed that the position of the specifically 
precipitated phosphorylated polypeptides coin­
cided with that of Ro60 (data not shown).
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Two-dimensional isoelectric focussing/SDS- 
polyacrylamide gelelectrophoresis (2D IEF/ 
SDS-PAGE) reveals two major isoelectric 
isoforms of Ro60
Since phosphorylation of proteins alters their 
isoelectric points, Ro60 was analyzed by two­
dimensional IEF/SDS-PAGE. A total cell extract 
from Jurkat cells was subjected to 2D IEF/SDS- 
PAGE, followed by immunoblotting and detec­
tion of Ro60 by the monoclonal antibody 1D8 
(92). The hum an Ro60 protein was separated into 
two major isoelectric isoforms with pI values 
between 6.5 and 8.5 (Figure 1B). Since the Ro60 
protein was focussed over a relatively large pI 
range, we checked the separation of other pro­
teins on the same blot by Ponceau S staining 
(Figure 1C). This did not reveal any separation 
irregularities and clearly shows that proteins in 
the same pI range of Ro60 are focussed into dis­
crete spots. Cell extracts from other cell types 
including MR65 cells (hum an lung cancer cell 
line) and HeLa (hum an epithelial cell line) ana­
lyzed by the same procedure as above, gave simi­
lar results as observed for the Jurkat cells (not 
shown). To investigate whether the appearance 
of isoelectric isoforms could be attributed to 
phosphorylation, the Ro60 protein was isolated 
from HeLa cell extracts using mAb 2G10. Incu­
bation of the 2G10-immunoprecipitate with 
calf intestine alkaline phosphatase followed by 
2D IEF/SDS-PAGE and im m unoblotting using 
a polyclonal anti-Ro60 serum  did not lead to 
detectable differences with the untreated sample 
(not shown). This suggests that the isoelectric 
isoforms observed in  Figure 1B cannot be attrib­
uted to phosphorylation. Most likely, the major 
isoforms represent the Ro60a and the Ro60ß 
proteins (27, 28). The Ro60a and Ro60ß are alter-
anti-Ro60
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Figure 1. Ro60 is weakly phosphorylated in vivo  and sepa­
rates into two major isoelectric isoforms in two-dimensional 
IEF/SDS-PAGE
(A) Immunopurification of Ro60 from [32P]orthophosphate- 
labeled Jurkat cell extracts.Protein A-agarose beads were coated 
with the monoclonal anti-Ro60 antibodies 1D8 (lane 2) or 2G10 
(lane 3) via a rabbit-anti mouse bridge, or rabbit anti-mouse 
IgG alone (lane 1) as a control. The coated beads were incu­
bated with the [32P]orthophosphate labeled Jurkat cell extract. 
After extensive washing, precipitated proteins were solubilized 
in SDS-sample buffer and analyzed by SDS-PAGE. The gel was 
subsequently subjected to autoradiography. Lane 1, rabbit-anti- 
mouse IgG (mock); lane 2, anti-Ro60 (1D8); lane 3, anti-Ro60 
(2G10). (B) Two-dimensional IEF/SDS-PAGE analysis of Ro60 pro­
tein from total Jurkat cell extract. A total cell extract from Jurkat 
cells was fractionated by isoelectric focussing using a non-linear 
gradient from pH 3.0 to pH 10.0, followed by SDS-PAGE in the 
second dimension.The Ro60 protein (indicated by an arrow) was 
visualized by immunoblotting using the mAbs 2G10 and 1D8. 
On the left, a non-isoelectrically focussed Jurkat cell extract was 
run in parallel during SDS-PAGE (indicated by XT). (C) Total pro­
tein content of the western blot in B, visualized by Ponceau S 
staining of the membrane. The position of Ro60 is indicated by
an arrow
Phosphorylation of human Ro60 23
natively spliced variants, differing in  the usage 
of the last exon. The predicted molecular masses 
(Mr) and the pI’s of the two variants are for 
Ro60a (MW 60.6 kDa; pI 8.27) and Ro60ß (MW 
59.3 kDa; pI 8.72). However, we cannot rule out 
the possibility that the smearing of the two major 
isoforms, that has been observed before (45, 
101), obscures the detection of low-abundant 
isoforms caused by phosphorylation.
Analysis of the Ro60 protein by nanoelectro­
spray mass spectrometry identifies serine-265 
as the major phosphorylation site
Since we failed to identify isoelectric isoforms 
of Ro60 due to phosphorylation by 2D IEF/SDS- 
PAGE, we used a more sensitive m ethod to ana­
lyze the phosphorylation of Ro60. To identify 
the phosphorylated residue(s) of native Ro60 
isolated from HeLa cells, proteolytic digests of 
the protein were analyzed by nanoelectrospray 
tandem  mass spectrometry. Ro60 was isolated 
from a HeLa cell extract by im m unoprecipita­
tion with mAb 2G10 and separated from poten­
tial contam inants by SDS-PAGE. The Ro60 band 
was excised from the gel and digested with 
either trypsin or Lys-C protease. Peptides were 
extracted from the gel and analyzed by nano­
electrospray mass spectrometry. Phosphopep- 
tides were identified using parent ion scanning, 
which allows the specific detection of a class 
of molecules that produce a ‘reporter’ ion upon
collision with argon atoms in  the collision cell 
of the mass spectrometer. In the case of phos- 
phopeptides, the reporter ion is PO3- (m/z 79). 
Using this approach, several phosphopeptides 
were detected, but it was not possible to obtain 
sequence inform ation on these peptides by pro­
duct ion scans in  the positive ion mode, which 
was probably due to low ionization efficiency. 
However, when the observed masses of the 
identified phosphopeptides were com pared to 
the calculated phosphopeptide masses of Ro60, 
there were only a few calculated peptides that 
m atched the observed masses. Since there was 
only a single serine present in  these overlapping 
peptides (serine-265), and no other calculated 
phosphopeptide masses of Ro60 m atched the 
observed masses, we conclude that serine-265 
is the phosphorylation site. Figure 2 displays 
a CLUSTAL W alignment of hum an Ro60, show­
ing the relatively high degree of conservation of 
the residues surrounding serine-265 in human, 
mouse, X  laevis and C. elegans. Although the 
sequence containing serine-265 does not corre­
spond to a known consensus site for a protein 
kinase, serine-265 has a high phosphorylation 
prediction score of 0.992, using the NetPhos 2.0 
Prediction m ethod ((102); http://www.cbs.dtu.dk/ 
services/NetPhos). It has been suggested previously 
that Ro60 in  HEp-2 cells is phosphorylated on 
tyrosine residues (89), although the data did not 
unambigously show this and the phosphorylated
*
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Figure 2. Partial protein sequence alignment of human Ro60 and orthologs from mouse, X .la e v is  and C. elegans
The CLUSTAL W algorithm (113) was used to create an amino acid sequence alignment of human Ro60 (28) and the corresponding 
orthologs from mouse (97), X.laevis (18), and C.elegans (82).The GenBank Accession Numbers for the corresponding cDNA sequences 
are: J04137 (human), U66843 (mouse), L15434 (X. laevis) and U21487 (C. elegans). Black shading marks the most highly conserved 
amino acids. Gray shading marks conservation of similar amino acids. An asterisk indicates the position of serine-265.
human 
mouse 
X. la e v i s  
C. e leg a n s
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residue(s) was/were not m apped (89). Our analy­
ses did not reveal any phosphopeptides contain­
ing tyrosine residues. This suggests that either 
the level of tyrosine phosphorylation is very low 
in HeLa cells, or alternatively that there are dif­
ferent phosphorylation sites in HeLa and HEp-2 
cells.
Phosphorylation of serine-265 does not affect 
incorporation of Ro60 into Ro RNPs
The RNA binding activity of RNA binding pro­
teins can be regulated by phosphorylation, as 
has been shown for instance for the RNA binding 
protein Sam68 (103, 104). Ro60 has been shown 
to bind directly to Y RNAs in Ro RNP complexes 
(24, 28, 41). To investigate if the binding of Ro60 
to the Y RNAs is regulated by the phosphoryla­
tion of serine-265 we perform ed transient trans­
fection assays in COS-1 cells, usingVSV-G-tagged 
versions of Ro60 and two amino acid substitu­
tion mutants, followed by im m unoprecipitation 
of the tagged proteins and analysis of the co-pre- 
cipitatedY RNAs. In the substitution m utants ser­
ine-265 was either replaced by an alanine (Ro60 
S265A) or by an aspartic acid (Ro60 S265D). 
Replacement by an aspartic acid is generally 
believed to mimic a constitutively phosphory­
lated residue. As shown in Figure 3A, all three 
proteins were expressed to similar levels in  COS-1 
cells. Extracts of the transfected cells were used 
for im m unoprecipitation using an anti-VSV-G- 
tag mAb coupled to protein A-agarose beads. As 
a positive control immunoprecipitations were 
perform ed with the anti-Ro60 mAb 2G10. Subse­
quently, co-precipitated Y RNAs were visualized 
by northern  blot hybridization using specific 
probes for the four Y RNAs (Y1, Y3, Y4 and Y5, 
Figure 3B). All three versions of Ro60 were asso­
ciated with Y RNAs in transfected cell extracts to
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Figure 3. Association of VSV-G-tagged Ro60 proteins with Y 
RNAs in transiently transfected COS-1 cells
COS-1 cells were transfected with constructs encoding VSV-G- 
tagged Ro60 wild-type, Ro60 S265A, Ro60 S265D, and an empty 
vector (mock). Cell extracts were prepared 24 h after transfec­
tion. (A) Expression of VSV-G-tagged proteins was analyzed by 
immunoblotting using a monoclonal anti-VSV-G-tag antibody.
(B) Northern blot analysis of Y RNAs co-precipitated with VSV-G- 
tagged proteins.The cell extracts were subjected to immunopre- 
cipitation with monoclonal anti-VSV-G-tag (a-VSV) or anti-Ro60 
(a-Ro60) antibodies. RNA isolated from the total cell extract 
(input) and from the immunoprecipitates was analyzed by 
northern blot hybridization using antisense hY RNAs as probes. 
The positions of Y1, Y3, Y4 and Y5 are indicated.
similar levels (Figure 3B, lanes 3, 6 and 9), sug­
gesting that phosphorylation of serine-265 does 
not affect the association of Ro60 with Ro RNPs.
(De)phosphorylation of serine-265 modulates 
the subcellular localization of Ro60
It has been shown before that hum an Ro60, 
although lacking an obvious nuclear localiza­
tion signal (NLS), is transported into the nucleus 
in an energy-dependent m anner (73). Neverthe­
less, in logarithmically growing cultured cells 
Ro60 is known to reside in  both nucleus and 
cytoplasm (40, 96, 105). We tested the possibility 
that phosphorylation of serine-265 affects the
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Figure 4. Subcellular localization of GFP-tagged phosphorylation site mutants in HEp-2 and COS-1 cells
HEp-2 cells (panels A - D) or COS-1 cells (panels E - H) were transfected with GFP-expression constructs. After overnight incubation 
the cells were fixed and analyzed by confocal fluorescence microscopy for expression of recombinant proteins. Panels: A, E: GFP-alone; 
B, F: GFP-Ro60 WT; C, G: GFP-Ro60 S265A; D, H: GFP-Ro60 S265D. The bar indicates 10 ^m.
subcellular distribution of Ro60 in a transient 
transfection experiment with GFP-tagged Ro60 
and the substitution mutants. The expression 
of these fusion proteins was analyzed in  HEp-2 
and COS-1 cells by confocal fluorescence m icro­
scopy. GFP-alone, which was used as a control 
showed a uniform distribution with no clear 
accum ulation in any particular cellular com part­
m ent or organelle (Figures 4A and 4E). In agree­
m ent with previous studies, the wild-type Ro60 
protein was located both in  the nucleus and 
cytoplasm in both cell types (Figures 4B and 4F), 
although higher concentrations were observed 
in the nucleus (40, 96, 105). Whereas Ro60 S265A 
showed a wild-type localization (Figures 4C 
and 4G), Ro60 S265D displayed reproducibly a 
stronger cytoplasmic and weaker nuclear stain­
ing (Figures 4D and 4H) in com parison to the 
wild-type and S265A proteins. This strongly sug­
gests that the subcellular distribution of Ro60 is 
m odulated by phosphorylation at serine-265.
Possible functional implications of the 
regulation of the subcellular localization of 
Ro60 by phosphorylation of serine-265
Our study is the first detailed analysis of the phos­
phorylation state of Ro60. Phosphorylation of 
serine-265 appears to modulate the subcellular 
localization of Ro60 in hum an and monkey cells. 
Phosphorylation of serine-265, by a yet unknown 
protein serine kinase, leads to a reduced accu­
m ulation of Ro60 in  the nucleus. Addressing 
the questions which kinase phosphorylates Ro60 
and how it is activated/deactivated should shed 
more light on the functional aspects of the phos­
phorylation of serine-265 of Ro60. Simons et 
al. showed that Ro60 is involved in  the nuclear 
export process of hY1 RNA molecules in  X  laevis 
oocytes (71). It thus is possible that phosphoryla­
tion of serine-265 modulates this export process. 
Alternatively, the phosphorylation state of ser­
ine-265 could modulate protein-protein interac­
tions. For instance, phosphorylation of the SR 
protein ASF/SF2 affects the interaction with sev­
eral protein partners including the U1-70K pro­
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tein (106). Recently, an association of Ro60 with 
the cytoplasmic phosphoprotein pp75 has been 
described (91). Phosphorylation of serine-265 
might m odulate such an interaction.
Materials and methods
Cell culture
Hum an HEp-2 cells and African green m onkey COS-1 
cells were cultured in Dulbecco’s modified Eagle’s 
medium  (DMEM) containing 10% heat-inactivated fetal 
calf serum. Jurkat cells were grown in RPMI (Gibco- 
BRL) m edium  supplem ented with 10% heat-inacti­
vated fetal calf serum and 1 mM sodium-pyruvate. All 
cells were cultured at 37°C in the presence of 5% CO2.
In vivo labeling o f Jurkat cells
Jurkat cells were labeled for 20 h with 
[32P]orthophosphate (1 mCi per 20 ml of culture 
medium) in phosphate-free RPMI supplem ented with 
5% dialyzed fetal calf serum. Cells were washed with 
PBS, and extracts were prepared by lysis in lysis-buffer 
containing 25 mM Tris-HCl (pH 7.5), 100 mM KCl,
1 mM dithioerythritol (DTE), 2 mM EDTA, 0.5 mM 
PMSF and 0.5% (v/v) NP-40. Insoluble m aterial was 
removed by centrifugation at 12000 x g for 15 min.
Immunoprecipitation
Protein A-agarose beads were coated with the anti-Ro60 
m onoclonal antibodies (mAb) 2G10 or 1D8 (92), the 
anti-VSV-G-tag mAb (Roche), or rabbit anti-m ouse IgG 
as a control antibody by overnight incubation at 4°C 
in IPP500 (10 mM Tris-HCl (pH 8.0), 500 mM NaCl, 
0.05% NP-40). The coated beads were incubated with 
the (32P-labeled) cell extract in IPP150 (10 mM Tris-HCl 
(pH 8.0), 150 mM NaCl, 0.05% NP-40), for 2 h at 4°C. 
After extensive washing, precipitated proteins were 
solubilized in SDS-sample buffer and analyzed by SDS-
PAGE. The gel was subsequently stained with Coo- 
massie Brilliant Blue, or subjected to autoradiography 
for the detection of 32P-labeled proteins. Alternatively, 
co-precipitated RNAs were isolated using phenol/ 
chloroform extraction and ethanol precipitation. Sub­
sequently, RNAs were detected using northern  blot 
hybridization.
Dephosphorylation of immunoprecipitated Ro60
Soluble calf intestinal alkaline phosphatase (AP Roche) 
was added to imm unoprecipitated Ro60 (bound to pro­
tein A-agarose beads), and the mixture was incubated 
at 37°C for 2 h. After removal of AP by extensive wash­
ing, proteins were eluted in 2D-sample buffer and ana­
lyzed by IEF/SDS-PAGE.
In-gel digestion
Proteins fractionated by 10% SDS-PAGE were stained 
with Coomassie Brilliant Blue and the band corre­
sponding to Ro60 was excised from the gel. After reduc­
tion and alkylation of the protein, it was digested with 
trypsin or Lys-C protease as previously described (107, 
108). The resulting peptides were extracted and dried 
under vacuum.
Nano ES-MS and sample desalting
The peptide mixture was reconstituted in 10 ml of 
5% formic acid solution and applied to a 0.5% formic 
acid equilibrated m icrocolumn (Poros oligoR3 sorbent, 
Perseptive Biosystems, Farmingham, MA). After the 
column was washed, peptides were eluted in a step­
wise fashion (with 20% m ethanol, 50% m ethanol, and 
50% m ethanol/5%  ammonia) directly into the spray­
ing needle of the nanoelectrospray ion source, as pre­
viously described (109). Each fraction was analyzed 
individually. All mass spectrometric experiments were 
carried out on a triple quadrupole mass spectrom eter 
(API III, Perkin-Elmer Sciex, Ontario, Canada) equipped 
with a nanoelectrospray ion source with a flow rate of
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20-40 nL/m in (110). For Q1 scans, the stepwidth was 
0.1 amu and the dwell time 1 msec at unit resolution. 
For parent and daughter scans, the stepwidth was 0.2 
amu, the dwelltime 3 msec, and the resolution was set 
to allow transmission of 3-4 amu.
Two-dimensional gel electrophoresis with 
immunoblotting
Two-dimensional gel electrophoresis was performed 
by isoelectric focussing in the first dimension (111) and 
10% SDS-PAGE in the second dimension. Pharmalyte 
(Amersham Pharmacia Biotech) ampholytes with pH 
ranges from 3.0-10.0, 5.0-8.0 and 6.5-9 were used for IEF 
gels in a ratio of 2:3:3. After two-dimensional gel electro­
phoresis, the proteins were transferred to nitrocellulose 
and reversibly stained with Ponceau S. Subsequently, 
the Ro60 protein was visualized by imm unoblotting 
using the m ouse anti-Ro60 m onoclonal antibodies 
2G10 and 1D8 and peroxidase-conjugated rabbit anti­
m ouse antibodies.
Transfection constructs
To create a transfection plasmid encoding a GFP-Ro60 
fusion protein, the hum an Ro60 cDNA (29) was 
fused in-frame to a GFP-encoding sequence and 
cloned into the pCI-neo vector (Promega, Leiden, The 
Netherlands). Alternatively, the N-terminal VSV-G-tag 
(MEIYTDIEMNRLGK) was introduced in Ro60 cDNA 
constructs via PCR using the following primers: Ro-1 
(5 ’- GAATTC G C CAC C a t g g a g a t t t a t a c a g a c a t a g -  
A G A T G A A C C G A C T T G G A A A G  CGCGGCCG CATGGA- 
GGAATCTGTAAACCAAATG-3’) and Ro-2 (5-CTCGAG- 
TTAAATCATATCTAATGTGAAATTTCG-3’) using a full- 
length Ro60 cDNA as template. Indicated in bold are 
the introduced EcoRI, Noti and XhoI site, respectively. 
The VSV-G tag encoding sequence is indicated in small 
caps. The PCR product was digested with EcoRI/XhoI 
and cloned in the corresponding sites of the pcDNA3 
vector (Invitrogen). Constructs for the serine-265 point
m utants S265A and S265D were m ade using the Quick­
Change Site Directed Mutagenesis kit (Stratagene). 
The integrity of all constructs was confirmed by DNA 
sequencing. Subsequently, the m utant cDNAs were 
cloned into the GFP-vector or the VSV-G-tag vector for 
transfection. As controls, either the GFP alone con­
struct or the pcDNA3 vector were used in transfection 
experiments.
Transfection o f HEp-2 cells
Logarithmically growing HEp-2 cells were transfected 
with the GFP-Ro60 fusion protein transfection plas­
mids, or the GFP alone construct as a control, by means 
of electroporation. Per transfection, 5-106 cells were 
electroporated with 10 |xg of plasmid DNA in 0.8 ml 
of medium  at 276 V and a capacity of 950 |xF using a 
Gene Pulser II (BioRad). After transfection, cells were 
resuspended in 10 ml of culture m edium  and grown on 
coverslips. Cells were fixed with paraformaldehyde and 
analyzed by confocal fluorescence microscopy 24 h 
after transfection. Alternatively, COS-1 cells were trans­
fected with the same constructs for confocal fluore­
scence analysis (for transfection details see below).
Transfection and extract preparation o f COS-1 cells
COS-1 cells were transiently transfected with the VSV- G- 
tagged Ro60 expression constructs. Briefly, COS-1 cells 
were grown to 80% confluency in culture m edium  (see 
above). Cells were trypsinized and resuspended in ice- 
cold PBS. Approximately 5-106 cells were transfected 
with 20 |xg of plasmid DNA in a total volume of 400 |xl 
PBS. Electroporation was perform ed at 300 V and a 
capacity of 125 |xF with a Gene Pulser II (Bio-Rad). 
Subsequently, the cells were seeded in 75 cm2 culture 
flasks and cultured overnight. Cell extracts were pre­
pared by sonication with a Branson microtip (three 
times 10 sec, 4°C) in lysis-buffer (see above). Cell debris 
was removed by centrifugation (12000 x g, 15 min, 4°C)
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and the supernatant was used for imm unoblot analysis 
and imm unoprecipitation.
Immunoblot analysis o f transfected cells
Extracts from transfected COS-1 cells were fractionated 
by SDS-PAGE and blotted onto a nitrocellulose m em ­
brane. After blocking the m em branes in wash buffer 
(5% non-fat dried milk, 0.1% NP-40, PBS) for 1 h at 
room temperature, m em branes were incubated with 
m onoclonal anti-VSV-G-tag antibody (Roche) diluted 
1:500 in wash buffer for 1 h at room temperature. After 
washing, bound antibodies were detected by incu­
bation with horseradish peroxidase-conjugated goat 
anti-m ouse IgG (Dako Immunoglobulins), followed by 
chemiluminescence.
Northern blot hybridization
RNA was size-fractionated on 10% denaturing poly­
acrylamide-8 M urea gels and electroblotted onto 
Hybond-N m em branes at 3 V/cm in 0.025 M phosphate,
pH 6.5, for 2 h. After UV crosslinking, hybridizations 
were perform ed overnight at 65°C in 6 x SSC, 5 x Den- 
hardt’s solution containing 100 |xg/ml sheared, dena­
tured herring sperm DNA with a mixture of 32P-labeled 
anti-sense RNA transcripts of the four hY RNAs.
In vitro transcription
Transcription of anti-sense hY1, hY3, hY4 and hY5 RNA 
was perform ed as described (112). To obtain anti-sense 
RNAs, pTZ19-hY1, hY3, hY4 and hY5 constructs were 
linearized with EcoRI and used as a tem plate for in 
vitro transcription using T7 RNA polymerase.
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R
o RNPs are evolutionarily conserved small cytoplasmic RNA-protein complexes 
with an unknown function. In human cells, Ro RNPs consist of one of the four 
hY RNAs and two 'core' proteins: Ro60 and La. Recently, the association of hnRNP I 
and hnRNP K with particles containing hY1 and hY3 RNAs has been described. The 
association of three other proteins, namely calreticulin, Ro52 and RoBPI, with (sub­
sets of) the Ro RNPs is still controversial. To gain more insight into the composition 
and function of the Ro RNPs we have immunopurified these particles from HeLa 
cell extracts using monoclonal antibodies against Ro60 and La. Using this approach 
we have identified the RNA-binding protein nucleolin as a novel subunit of Ro RNP 
particles containing hY1 or hY3 RNA, but not hY4 and hY5 RNA. Using an in vitro 
hY RNA-binding assay we established that the internal pyrimidine-rich loop of hY1 
and hY3 RNA is essential for the association of nucleolin. The binding is critically 
dependent on the presence of all four RNP motifs of nucleolin, but not of the C-ter­
minal RGG-box. We postulate that nucleolin functions in the biogenesis and/or traf­
ficking of hY1 and hY3 RNPs through the nucleolus and subsequent transport to 
the cytoplasm.
Introduction
The small ribonucleoprotein (RNP) complexes 
known as the Ro RNPs are com posed of one of 
the small cytoplasmic Y RNAs (transcribed by 
RNA polymerase III) associated with a num ber 
of proteins. The num ber of different Y RNAs 
present in the cell varies from four in humans 
(hY1-hY5 RNA, hY2 RNA is a degradation prod­
uct of hY1) to only one in Caenorhabditis elegans 
(ceY RNA) (8, 21). The Y RNAs are highly con­
served in evolution (17) and the conservation is 
more obvious at the secondary structure level 
than on the primary sequence level. All Y RNAs 
can be folded into a structure containing a long 
stem formed by base-pairing of the 5’ and 3’ 
ends (21-23). A highly conserved bulged helix 
in  the stem contains the binding site for the
60-kDa protein Ro60 (24, 29, 30), whereas the 
oligo(U) stretch at the 3’ end of the Y RNA 
molecules, which is retained after RNA poly­
merase III transcription, contains the binding 
site for the 47-kDa phosphoprotein La (32-34). 
Recently, several additional hY1 and hY3 RNA- 
binding proteins, among which the heteroge­
neous nuclear ribonucleoproteins (hnRNP) I and 
K, have been identified (58, 59). The proposed 
associations of the calcium-binding protein cal­
reticulin and of the 52-kDa protein Ro52 with 
the Ro RNPs are still controversial (5, 29, 41-43, 
52). The recently described association of RoBPI 
with hY5 RNA, which was detected via a yeast 
three-hybrid assay, has not been dem onstrated 
in m am m alian cells yet (67, 68).
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Since the discovery of the Ro RNPs over 20 years 
ago, a large body of experimental data has been 
obtained. However, the function(s) of these par­
ticles is still enigmatic. For the two core proteins 
of the Ro RNPs, Ro60 and La, several functions 
have been proposed. For example, the La pro­
tein has been shown to be involved in  RNP m at­
uration, internal-ribosome-entry-site-mediated 
translation, mRNA stabilization and RNA poly­
merase III transcription (reviewed in  (31, 75)). La 
binds to the 3’ oligo(U) tracts of primary RNA 
polymerase III transcripts (76) and to certain 
RNA polymerase II transcribed RNAs, e.g. U3 
RNA (77). La has also been proposed to act as an 
RNA chaperone, which might be consistent with 
all of the functions m entioned above (78). Much 
less is known about the biological activities of 
Ro60. In Xenopus laevis Ro60 was implicated in 
the quality control pathway for 5S ribosomal 
RNA synthesis (79), and the regulation of trans­
lation of the ribosomal L4 protein (80). Further­
more, Ro60 has been shown to be involved in 
the nuclear export process ofY RNAs, as dem on­
strated in a X  laevis oocyte system (71). Interest­
ingly, an ortholog of Ro60 was recently identified 
in the radiation-resistant eubacterium  Deino- 
coccus radiodurans, and this protein was shown 
to play a role in  the resistance of this organism 
to UV irradiation (81). Ro60 might also act as an 
RNA chaperone, since knocking-out the rop-1 
gene (encoding the C. elegans Ro60 ortholog) in 
C. elegans led to a significant decrease in ceY 
RNA levels (83).
X. laevis oocyte injection and cell enucleation 
studies have established that the Y RNAs, and 
as a consequence also the Ro RNPs, strongly 
accumulate in the cytoplasm (18, 30, 40, 73), 
although recent evidence suggests that hY5 RNPs 
are mainly localized in the nucleus (74). The
molecular mass of the Ro RNPs was, based on gel 
filtration data, estim ated to be between 200 and 
550 kDa, which is larger than would be expected 
from the molecular masses of the known protein 
and RNA com ponents (34, 42, 58). These results 
suggest that there may be other, yet unidenti­
fied, proteins that associate with Ro RNPs. To 
shed more light on this issue we performed 
large-scale immunoprecipitations on HeLa cell 
extracts using monoclonal antibodies (mAbs) 
against Ro60 and La, followed by isolation and 
characterization of the co-precipitated proteins 
by mass spectrometry. Using this approach we 
were able to identify nucleolin as a novel bona 
fide Ro RNP-associated protein. We present data 
that nucleolin binds to the hY1 and hY3 RNPs 
both in vivo and in vitro.
Results
Nucleolin is co-precipitated with La and Ro60 
from a HeLa S100 extract
To identify proteins that either directly or indi­
rectly (via an association with Ro RNPs) interact 
with both Ro60 and La we perform ed prepar­
ative im m unoprecipitations from HeLa S100 
extracts with mAbs 2G10 (anti-Ro60) and SW5 
(anti-La). Since both mAbs were coupled to the 
protein A-agarose beads using a rabbit anti­
mouse antibody bridge, the immobilized latter 
antibody was used as a negative control. Co-pre­
cipitated proteins were eluted by raising the salt 
concentration to 1 M NaCl and were fractionated 
by SDS-PAGE. Both 2G10 and SW5 have been 
shown to be able to precipitate the hY RNAs from 
HeLa extracts (92, 93), and are therefore suited 
for immunoaffinity selections of complexes con­
taining these proteins. Because our goal was to
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identify novel Ro RNP associated proteins, we 
searched for bands present in both the anti-Ro60 
and the anti-La precipitates, but absent in 
the control precipitate. Using the anti-La mAb 
m any polypeptides, in  addition to the expected 
Ro60 and La proteins, could be isolated by this 
approach. In contrast, the anti-Ro60 precipita­
tion yielded in  addition to the Ro60 protein itself 
and the La protein (Figure 1, lane 3), only a few 
other proteins. The band indicated with p100 
was chosen for further characterization because 
it was clearly detectable in the anti-La precipitate 
and also, albeit more weakly, in the anti-Ro60 
precipitate (Figure 1, lanes 3 and 4). To identify 
p100, we excised the band from the gel con­
taining the anti-La precipitate, subjected it to 
trypsin digestion and analyzed the resulting pep­
tides by mass spectrometry. The peptide masses 
obtained for p100 by MALDI-TOF mass spec­
trom etry m atched with the predicted masses 
of hum an nucleolin (data not shown). This 
was confirmed by the results of tandem  Q-TOF 
mass spectrometry which resulted in a peptide 
sequence (NDLAVVDVR) that is completely iden­
tical to a tryptic peptide of hum an nucleolin. No 
other proteins were identified in  this sample.
To confirm the association of nucleolin with 
Ro60 and La containing complexes, we used a 
rabbit antiserum  raised against hum an nucle- 
olin (114). Western blots containing anti-Ro60 
and anti-La imm unoprecipitates were probed 
with the nucleolin-specific antiserum. Figure 
2A shows that nucleolin indeed is precipitated 
by both the anti-La and the anti-Ro60 mAbs 
(lanes 2 and 3), but not by the control m ono­
clonal antibody against the U2B’’-protein (mAb 
4G3; lane 4). As observed before (Figure 1), the 
anti-Ro60 precipitation was less efficient than 
the anti-La precipitation, which is probably due
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Figure 1. Monoclonal antibodies SW5 and 2G10 co-precipi­
tate a 100-kDa protein
Protein A-agarose beads coated with anti-Ro60 mAb 2G10 
(anti-Ro60) and anti-La mAb SW5 (anti-La) via a rabbit anti­
mouse IgG bridge, were incubated with a HeLa S100 extract 
(from 1109 cells) and after washing of the beads co-precipitated 
material was eluted in the presence of 1 M NaCl and analyzed 
by SDS-PAGE. Proteins were visualized by Coomassie Brilliant 
Blue staining.The more efficient elution of Ro60 from the anti-La 
resin and of La from the anti-Ro60 resin was expected because 
this elution procedure does not efficiently disrupt the antibody- 
antigen and antibody-protein A-agarose interactions. Neverthe­
less, some of the antibody polypeptide chains were observed in 
the eluates. Lane 1, molecular weight markers (kDa); lane 2, con­
trol precipitation (rabbit anti-mouse IgG); lane 3, 2G10 immuno­
precipitation; lane 4, SW5 immunoprecipitation. Arrows indicate 
the positions of Ro60, La and p100 (the staining of p100 in lane 
3 was very weak and is hardly visible on this reproduction of 
the gel) and asterisks mark immunoglobulin heavy and light 
chains.
to antibody titer differences. Because Ro60, La 
and nucleolin all contain RNA binding domains 
and are known to bind to RNA directly, the asso­
ciations between Ro60 and nucleolin and/or La 
and nucleolin might be m ediated by a com mon
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Figure 2. Nucleolin co-precipitates with Ro60 and La in an 
RNA-dependent manner
Protein A-agarose beads coated with the anti-La mAb SW5, 
anti-Ro60 mAb 2G10 or the anti-U2B'' mAb 4G3, were incubated 
with a HeLa S100 extract (from 5106 cells) preincubated in the 
absence (- m.n.; lanes 1-3) or presence (+ m.n.; lanes 4-6) of 
micrococcal nuclease. Bound nucleolin was analyzed by immu- 
noblotting using an anti-nucleolin rabbit serum. Lane 1, 1% 
input; lanes 2 and 5, anti-La immunoprecipitate; lanes 3 and 6, 
anti-Ro60 immunoprecipitate; lanes 4 and 7, control anti-U2B'' 
immunoprecipitate (A). Protein A-agarose beads coated with 
the anti-nucleolin rabbit serum or the anti-hPop4 rabbit serum 
were incubated with HeLa S100 extract (from 5106 cells) in the 
absence (- m.n.) or presence (+ m.n.) of micrococcal nuclease. 
Co-precipitated proteins were eluted from the antibody-coated 
protein A-agarose beads by 1M NaCl and concentrated by ace­
tone precipitation to avoid aberrant migration of Ro60 and La 
due to the presence of IgG from the anti-nucleolin antiserum. 
Subsequently, bound Ro60 and La were analyzed by immu­
noblotting using either the anti-Ro60 mAb 2G10 (B) or the 
anti-La mAb SW5 (C). Lane 1, 1% input; lanes 2 and 4, anti- 
nucleolin immunoprecipitate; lanes 3 and 5, control anti-hPop4 
immunoprecipitate.
RNA molecule. To investigate this possibility, the 
HeLa S100 extracts were treated with micrococ- 
cal nuclease prior to the immunoprecipitations. 
This procedure efficiently degraded RNA mole­
cules present in the extract, including the Ro RNP 
associated hY RNAs, as m onitored by northern 
blot hybridization (data not shown). The micro­
coccal nuclease treatm ent completely abolished 
the interactions of both Ro60 and La with nucle- 
olin, strongly suggesting that these interactions 
were indeed m ediated by an RNA molecule 
(Figure 2A, lanes 5 and 6). To further substanti­
ate the interactions of nucleolin w ith Ro60 and 
La containing complexes, we perform ed immu- 
noprecipitations using the anti-nucleolin rabbit 
serum and HeLa S100 extracts. Western blots 
containing the anti-nucleolin immunoprecip- 
itates were probed with the anti-Ro60 mAb 
2G10 (Figure 2B) and the anti-La mAb SW5 
(Figure 2C). Both Ro60 and La co-immunopre- 
cipitated with nucleolin in an RNA-dependent 
m anner (Figure 2B and 2C; compare lanes 2 and
4). A control rabbit antiserum  (raised against 
the hum an hPop4 protein, a protein subunit of 
the RNAse P and RNAse MRP ribonucleoprotein 
complexes; (115)) did not detectably co-precipi­
tate Ro60 or La (Figure 2B and 2C, lanes 3 and
5).
Nucleolin co-fractionates with a subset of the 
Ro RNPs during gel filtration of a HeLa S100 
extract
Since nucleolin co-precipitated with Ro60 and 
La in an RNA-dependent manner, we hypothe­
sized that the RNA moiety mediating this inter­
action might be hY RNA, the only type of RNA 
that is known to be bound by both Ro60 and La. 
To investigate this we fractionated a HeLa S100 
extract (See Materials and methods) by gel filtra-
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tion on a Superdex 200 HR column. The major­
ity of Ro60 eluted in fractions corresponding to 
molecular masses between 158 kDa and 670 kDa 
(Figure 3B, fractions 15 - 22), whereas the La pro­
tein was detected in almost all fractions (Figure 
3B). The highest concentrations of La were found 
in  the peak fractions of Ro60 and the hY RNAs 
(fractions 17 - 22), indicative of the presence of 
Ro RNP complexes in  these fractions. Figure 3D 
shows that the hY1, hY3 and possibly also the hY4 
RNPs were eluting in higher molecular weight 
fractions than the hY5 RNPs, which is in  agree­
m ent with previously published data (34, 42, 58). 
Nucleolin eluted in  fractions 13 to 21, partially 
overlapping with the Ro RNP containing frac­
tions, in  particular those containing hY1, hY3 
and possibly also hY4 RNA (Figure 3C). Varying
the concentration of the HeLa S100 extract, and 
the concentration m ethod of the fractions did 
not influence the elution pattern  of the proteins 
and RNAs analyzed. These data are consistent 
with the hypothesis that hY RNAs mediate the 
association of nucleolin with Ro60 and La.
Nucleolin interacts with native hY RNAs
To investigate whether and, if so, which hY RNAs 
are associated with nucleolin in vivo, a HeLa 
S100 extract was subjected to im m unoprecip­
itation using the anti-Ro60 and anti-La mAbs 
and the anti-nucleolin rabbit serum. As a speci­
ficity control, an antiserum  against the hum an 
U3 snoRNP-specific protein, hU3-55K, was used 
(116). RNAs were isolated from the immuno- 
precipitates and probed by northern  blot hybri-
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Figure 3. Gel filtration analysis of Ro RNP components
A HeLa S100 extract (from 5107 cells was fractionated by Superdex 200 HR 10/30 gel filtration chromatography as described in 
Materials and methods. The positions of marker proteins (thyroglobulin [670 kDa], gamma globulin [158 kDa], ovalbumin [44 kDa]) 
are indicated in the elution profile (monitored by the absorbance at 280 nm) (A). Column fractions were analyzed by immunoblotting 
with antibodies against Ro60 and La (B), and nucleolin (C), and by northern blot hybridization for the presence of the hY RNAs (D). 
The positions of the various proteins and hY RNAs are indicated on the right of panels B-D.
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dization with 32P-labeled antisense hY RNAs, and 
antisense hU3 RNA, or antisense hMRP RNA (the 
RNA com ponent of RNase MRP) as controls. As 
shown in Figure 4A, efficient co-precipitation 
of hY1 and hY3 and/or hY4 RNA by the anti- 
nucleolin serum  was observed. In contrast, the 
norm al rabbit serum and the anti-hU3-55K
B
■ hYI
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hY4
• hY5
—  hY3
—  hY4
—  hU3
—  hMRP
Figure 4. Anti-nucleolin rabbit serum co-precipitates hY1 
and hY3 RNA from a HeLa extract
Protein A-agarose beads were coated with anti-Ro60 mAb 2G10, 
anti-La mAb SW5, rabbit anti-nucleolin antibody, rabbit anti- 
hU3-55K antibody or normal rabbit serum (NRS) and incubated 
with HeLa S100 extracts (from 5106 cells; See Materials and 
methods). After extensive washing the co-precipitating RNAs 
were isolated and analyzed by northern blot hybridization using 
antisense 32P-labeled hY RNA probes. All blots were exposed for 
similar periods. (A). The positions of the various RNAs are indi­
cated on the right. Lane 1, 10% input; lane 2, anti-Ro60 immu- 
noprecipitate; lane 3, anti-La immunoprecipitate; lane 4, control 
immunoprecipitate; lane 5, anti-nucleolin immunoprecipitate; 
lane 6 anti-hU3-55K immunoprecipitate. The same blot was rep­
robed sequentially using only an hY3 RNA probe (B), using only 
an hY4 RNA probe (C), using only an hU3 RNA probe (D), and 
using only an hMRP RNA probe (E).
rabbit serum did not detectably co-precipitate 
hY RNAs (Figure 4A, lanes 4 - 6). As expected, the 
anti-La and anti-Ro60 antibodies efficiently pre­
cipitated all four hY RNAs (Figure 4A, lanes 2 
and 3). The resolution of the gel system did 
not allow a clear distinction between hY3 and 
hY4 RNA. Therefore, the same northern blot was 
reprobed under high-stringency conditions (to 
prevent cross-hybridization between hY RNAs) 
using single hY3 and hY4 RNA probes (Figures 4B 
and 4C) instead of a mixture of hY RNA probes. 
The results of these experiments showed that 
hY3 RNA, but not hY4 RNA was co-precipitated 
with nucleolin (Figure 4B and 4C, lane 5). The 
anti-hU3-55K rabbit serum  efficiently precipi­
tated hU3 RNA (116), whereas it did not detect- 
ably precipitate the hY RNAs nor the hMRP 
RNA (Figure 4A-E, lane 6). Both the anti-La mAb 
(Figure 4D, lane 3) and the anti-nucleolin rabbit 
serum (Figure 4D, lane 5) co-precipitated small 
am ounts of (pre)-U3 RNA, in agreement with 
previous data (77, 117). Probing the same north­
ern blot with antisense hMRP RNA (115), showed 
that hMRP RNA was not detectably co-precipi­
tated with any of the antibodies used (Figure 4E). 
These results dem onstrate that in HeLa cell 
extracts hY1 and hY3 RNA are associated with 
nucleolin and suggest that the co-precipitation 
of nucleolin with the Ro60 and La proteins is 
most likely due to the sim ultaneous interaction 
of these proteins with hY1 and hY3 RNA mole­
cules. In agreement with this, immunoprecipita- 
tions using the Ro RNP containing fractions of 
the gel filtration experiment and mAbs against 
Ro60, La and nucleolin revealed that nucleolin 
co-precipitated the hY1 and hY3 RNAs, whereas 
Ro60 and La co-precipitated all four hY RNAs 
(data not shown).
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Figure 5. Nucleolin associates with hY1 and hY3, but not hY4 
and hY5 RNA in vitro
Wild-type nucleolin fused to GST was incubated with glutathi­
one beads, followed by incubation with 32P-labeled hY RNAs 
as indicated. Human sel-tRNA was used as a negative control. 
After extensive washing bound RNAs were extracted, size-frac­
tionated by denaturing polyacrylamide gel electrophoresis and 
visualized by autoradiography. Lanes 1 to 5, 5% input; lanes 6 to 
10, precipitated RNAs.
Nucleolin interacts with hY1 and hY3, but not 
with hY4 and hY5 RNA in vitro
To study the interaction of nucleolin with hY 
RNAs in more detail, we developed an in vitro 
RNA binding assay using a recom binant GST- 
fusion protein of full-length ham ster nucleolin 
and in vitro transcribed 32P-labeled hY RNAs. 
Incubation of radiolabeled hY RNAs with GST- 
tagged nucleolin was followed by the selection 
of nucleolin and associated RNA using im m o­
bilized glutathione. Subsequent analysis of the 
RNAs dem onstrated that GST-nucleolin bound 
specifically to hY1 and hY3 RNA (Figure 5). As 
observed for the HeLa cell extracts, nucleolin 
did not bind to either hY4 or hY5 RNAs (lanes 8 
and 9) or a control RNA, selenocysteinyl-tRNA 
(lane 10).
Loop 2b of hY1 RNA is essential for the in vitro 
binding of nucleolin
The data described above indicate that nucleolin 
binds directly to hY1 and hY3 RNA. To map the 
binding site of nucleolin on hY1 RNA we ana­
lyzed the binding of nucleolin with a panel of in 
vitro transcribed hY1 RNA m utants in the in vitro 
binding assay. Most of these m utants are deletion 
m utants in  which one of the structural domains 
is deleted (Figure 6A). In m utant hY1L2bs the 
nucleotides of the pyrimidine stretch in  Loop 2b 
were substituted by other nucleotides, i.e. C-res- 
idues were replaced by U’s and vice versa, thus 
m aintaining the pyrimidine stretch to reduce the 
possibility that other alterations (folding) would 
occur as well. The results of the GST-pull-down 
experiments with the GST-tagged full-length 
ham ster nucleolin identified a region within the 
central loop of hY1 RNA as being indispensable 
for the interaction with nucleolin (Figure 6B). 
The hY1AL2b m utant lacking nucleotides 71-87 
(Loop 2b, Figure 6A) was not detectably bound 
by recom binant nucleolin, in contrast to all other 
m utants which were bound with efficiencies 
similar to that of wild-type hY1 RNA (Figure 6B). 
The lack of binding of nucleolin to hY1AL2b and 
the efficient binding to hY1L2bs suggest that 
an oligopyrimidine stretch in a single-stranded 
region is required for binding of nucleolin to hY1 
RNA.
All four RNA binding domains of nucleolin are 
needed for the in vitro interaction with hY1 
and hY3 RNA
To map the region of nucleolin that is mediating 
the binding to hY1 and hY3 RNA we used a series 
of deletion m utants of ham ster nucleolin, which 
were either expressed as GST-fusion proteins 
or as (His)6-tagged proteins (Figure 7A). Based 
upon the presence of sequence motifs nucleolin 
can be divided into three domains; the N-ter- 
minal dom ain lacking known sequence motifs 
(except for a nuclear localization signal), the cen­
tral dom ain containing four RNP motifs (118),
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Figure 6. The central Loop 2b of hY1 RNA is essential for the association with nucleolin in vitro
Secondary structure of hY1 RNA (22) and deletion mutants. Mutant hY1AS1L1 lacks Stem 1 and Loop 1; mutant hY1AL1S2 lacks Loop 
1 and Stem 2; mutant hY1AS3L3 lacks Stem 3 and Loop 3; mutant hY1AS4L4 lacks Stem 4 and Loop 4; and mutant hY1AL2b lacks Loop 
2b. In mutant hY1L2bs the nucleotides of the pyrimidine stretch in Loop 2b were substituted by other nucleotides, i.e. C-residues were 
replaced by U's and vice versa. (A) Wild-type GST-tagged nucleolin was incubated with glutathione beads, followed by incubation 
with 32P-labeled RNAs as indicated. After extensive washing bound RNAs were extracted, size-fractionated by denaturing polyacryl­
amide gel electrophoresis and visualized by autoradiography. Lanes 1 to 7, 5% input; lane 8, control precipitation with hY1wt RNA: no 
GST-nucleolin added; lanes 9 to 15, precipitated RNAs (B).
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Figure 7. Mapping of the region of nucleolin involved in the 
association with hY1 and hY3 RNA
Schematic structure of the recombinant nucleolin mutants. 
Except for GST-wt and GST-nterm all proteins were produced 
with a histidine-tag rather than GST at their N-terminus. The 
N-terminal part of nucleolin, denoted by nterm (light grey box) 
is bordered at the C-terminal side by the nuclear localization 
signal (NLS; black box); RNP motifs are numbered 1-4 (dark grey 
boxes) and the RGG domain is indicated with rgg (middle grey 
box). (A) Recombinant nucleolin mutants were pre-bound to 
either glutathione beads (for GST-wt and GST-nterm) or nickel- 
agarose beads (for the histidine-tagged mutants) and incubated 
with 32P-labeled hY1 RNA (B) or hY3 RNA (C). After extensive 
washing bound RNAs were extracted, size-fractionated by dena­
turing polyacrylamide gel electrophoresis and visualized by 
autoradiography.The weak signal for mutant R234G (lane 7) was 
not reproducibly observed. Lane 1, 5% input; lane 2, control (glu­
tathione beads only); lanes 3 to 10, precipitated RNA.
and the C-terminal dom ain containing RGG 
boxes (118, 119). In each m utant one or more 
of these motifs were deleted. All recom binant 
proteins were purified to near homogeneity as 
revealed by Coomassie Brilliant Blue staining of 
a SDS-PAGE gel containing the purified proteins 
(data not shown). Using the in vitro pull-down 
assay we tested the ability of these nucleolin 
m utants to bind to in vitro transcribed hY1 RNA 
(Figure 7B) and hY3 RNA (Figure 7C). All four 
RNP motifs of nucleolin appeared to be required 
for the binding to hY1 and hY3 RNA, whereas 
deletion of the RGG dom ain or the complete 
N-terminal part (including the nuclear local­
ization signal) of nucleolin did not affect hY1 
and hY3 RNA-binding (Figures 7B and 7C). The 
m utants containing only the N -terminal or RGG 
domains did not detectably associate with hY 
RNAs. Since equimolar am ounts of recom binant 
proteins were added in the assay, these results 
suggested that under these experimental condi­
tions the binding-efficiency of the (His)6-tagged 
m utant (R1234) to hY1 and hY3 RNA was som e­
what lower than that observed with the GST- 
tagged protein (GST-wt; Figure 7B, C: compare 
lanes 3 and 5). Alternatively, the affinity of R1234 
for hY1 and hY3 RNA might be lower than that 
of the wild-type protein. Taken together, our in 
vitro results suggest that nucleolin interacts via 
its four RNA binding domains with the ‘upper’ 
part of hY1 RNA and that the internal, pyrimi­
dine-rich Loop 2b plays an im portant role in this 
association.
Discussion
Although the Ro RNPs have been extensively 
studied over the last two decades their mole-
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cular architecture, the identity of their protein 
com ponents and their function(s) rem ain in part 
obscure. Early studies on the com position of the 
Ro RNPs revealed the existence of several sub­
populations of Ro RNPs (34, 42, 72). In humans, 
the num ber of different hY RNAs accounts for 
at least four different subpopulations. This het­
erogeneity is increased by the variety of proteins 
capable of binding to Y RNAs. Most, if not all 
Y RNAs are complexed with the ‘core’ proteins 
Ro60 and La (8, 30, 40), whereas additional pro­
teins may bind to subsets of these RNPs. For 
example, the association of hnRNP I with hY1 
and hY3 RNA has been clearly dem onstrated (59). 
In contrast, the association of Ro52 (5, 29, 41-43), 
calreticulin (52), RoBPI (67, 68) and hnRNP K 
(59) with hY RNAs has still not been unam bigu­
ously proven. However, using the immunoaffi- 
nity purification m ethod described in  this paper, 
we were recently able to identify hnRNP I and 
RoBPI in the anti-Ro60 and anti-La precipitates, 
confirming that both proteins indeed associate 
with (subsets) of Ro RNPs (our unpublished 
observations). These data also substantiate the 
suitability of this m ethod to identify Ro RNP 
associated proteins.
In this paper we describe the identification of 
nucleolin as a novel protein subunit of hY1 and 
hY3 RNPs by the same approach. Subsequent 
im m unoprecipitation experiments and gel fil­
tration analysis of a HeLa cell extract provided 
further evidence for the in vivo association of 
nucleolin with hY1 and hY3 RNA. Nucleolin, 
also designated C23, is an abundant nucleolar 
RNA-binding phosphoprotein. It is involved in 
ribosome biogenesis and maturation, and reg­
ulates various processes, e.g. cell proliferation 
and growth, embryogenesis and nucleogenesis 
(reviewed in  (120, 121)). A remarkable feature of
nucleolin is that it shuttles between the nucleolus 
and the cytoplasm (122), thereby possibly target­
ing several ribosomal proteins to the nucleolus 
(119).
In agreement with the data obtained with cell 
extracts, recom binant nucleolin associated with 
hY1 and hY3, but not with hY4 and hY5 RNA, 
in an in vitro RNA-binding assay. This suggested 
that the association of nucleolin with hY1 and 
hY3 RNA is not dependent on other proteins, e.g. 
Ro60 and La, but requires specific structural ele­
m ents in  the target hY RNAs. Indeed the results 
obtained with the hY1 RNA deletion m utants 
showed that the internal pyrimidine-rich Loop 
2b (nucleotides 71 - 86) was essential for the 
efficient association of nucleolin with hY1 RNA. 
A similar internal pyrimidine-rich loop is also 
present in hY3 RNA, whereas it is lacking in hY4 
and hY5 RNA (22), which is consistent with their 
inability to bind to nucleolin. Because the dele­
tion of Loop 2b may affect the overall structure 
of hY1 RNA, the possibility that this interferes 
with nucleolin binding cannot be excluded. 
The efficient association of nucleolin with 
m utant hY1L2bs, in which the pyrimidine stretch 
was maintained, although all C-residues were 
replaced by U’s and vice versa, suggested that 
indeed the pyrimidine-rich internal loop struc­
ture rather than the sequence of Loop 2b is 
essential for nucleolin association. The results 
obtained with the recom binant deletion m utants 
of nucleolin showed that all four RNP motifs, 
but not the RGG box, are required for the bind­
ing to hY1 and hY3 RNA. The two most N-ter- 
minal RNP motifs of nucleolin have been shown 
to be required and sufficient for binding to a 
stem-loop RNA structure containing a consen­
sus (U/G)CCCGA sequence in  the loop, which is 
called the nucleolin-recognition element (NRE)
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(123, 124). The fact that Loop 2b of hY1 RNA 
does not contain an NRE, but still is recognized 
by nucleolin is not unprecedented. Studies on 
the RNA-binding specificity of nucleolin identi­
fied several RNA targets distinct from the NRE 
(117, 125, 126), corroborating the idea that the 
four RNP motifs in nucleolin are able to interact 
w ith several other RNA structures.
Interestingly, also hnRNP I and hnRNP K have 
been reported to require Loop 2b of hY1 RNA 
for binding (59). This suggests that nucleolin, 
hnRNP I and hnRNP K bind to Loop 2b in close 
proximity to each other on the same hY1 RNA 
molecule, or that their binding to the central 
pyrimidine-rich region is mutually exclusive. A 
third possibility is that com binations of the three 
proteins associate with this region on hY1 RNA 
via nucleolin, because it has not been investi­
gated if hnRNP I and hnRNP K directly contact 
Loop 2b (59). The fact that the pyrimidine-rich 
loop of hY1 RNA was shown to be resistant to 
enzymatic and chemical cleavage suggests that 
this loop may adopt a specific tertiary structure 
that serves as an interaction site for these pro­
teins (22). Moreover since the sequence of the 
central region of all four hY RNAs is very diverse, 
this part of the molecule could serve as a critical 
determ inant for the functional specificity of the 
various hY RNPs. Binding of nucleolin to hY1 
and hY3 RNA might thus influence the function­
ing of the corresponding RNPs, discriminating 
them  from hY RNPs lacking nucleolin.
To investigate the stoichiometry of Ro60, La and 
nucleolin in  hY1 and hY3 RNPs, we have per­
formed im m unoprecipitation studies on HeLa 
S100 extracts, using the anti-La mAb SW5, and 
the anti-nucleolin mAb 7G2 (data not shown). 
Using recom binant Ro60, La and nucleolin pro­
teins as a reference, and taking into account the
relative am ounts of hY1 and hY3 RNA in com ­
parison with hY4 and hY5 RNAs in HeLa cells 
(17), we estim ated the ratio Ro60 : La : nucleolin 
associated with hY1 and hY3 RNA at 1 : 1 : 0.5. 
This suggests that approximately fifty percent of 
the hY1 and hY3 RNPs contain a nucleolin mole­
cule, whereas most, if not all, hY1 and hY3 RNPs 
are associated with Ro60 and La (40).
What might be the functional relevance of the 
association of nucleolin with hY1 and hY3 RNPs? 
During or shortly after transcription of the hY 
RNAs by RNA polymerase III in the nucleoplasm, 
the hY RNAs are bound by La, the binding of 
which efficiently retains the hY RNA molecules 
in the nucleus (71, 73). By in situ hybridization 
experiments M atera and co-workers have previ­
ously detected the hY1, hY3 and hY5 RNAs, but 
not hY4 RNA, in the perinucleolar com partm ent 
(PNC) (25). The La-associated newly transcribed 
hY RNAs (excluding hY5 RNA, which remains in 
the nucleus (74)) may first move to and accum u­
late in the PNCs. In the PNCs the La-hY1 and 
La-hY3 RNPs possibly associate with hnRNP I, 
which recently has been reported to interact with 
hY1 and hY3 RNPs (59) and which also has been 
detected in the PNCs (25). Alternatively, hnRNP 
I may be involved in the transport of hY1 and 
hY3 RNA to the PNCs. The presence of these 
RNAs in the PNCs, which are tightly associated 
with the nucleoli, may allow the interaction of 
nucleolar nucleolin with these RNAs. This might 
be a signal for further transport, which may 
proceed either through the nucleoli or directly 
to the nuclear envelope. Nuclear export further 
requires the association of Ro60 and of another 
export factor, which for their binding are depen­
dent on Stem 1 and Stem 2, respectively (66, 71). 
It is unclear at which stage during the nuclear
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transport process the latter factors associate with 
the RNAs. Most likely, this is a relatively late event 
given that both are involved in nuclear export 
and that Ro60 is neither detectable in PNCs nor 
in nucleoli. In view of the nucleocytoplasmic 
shuttling behavior of nucleolin it is tempting to 
speculate that nucleolin remains associated with 
hY1 and hY3 RNAs during their nuclear export. 
In the cytoplasm nucleolin may dissociate from 
these RNAs and return to the nucleolus. The lack 
of association of both hnRNP I and nucleolin 
w ith hY4 RNPs implies that a similar transport 
model as outlined above for hY1 and hY3 RNA 
does not apply to hY4 RNA. Recent data indi­
cate that other RNA polymerase III transcripts 
including U6 small nucleolar RNA (127) and the 
RNA com ponent of RNase P (128) pass through 
the nucleolus during the early phases of their 
life cycles. Of particular interest in this respect 
is the fact that also the RNA com ponent of the 
signal recognition particle (SRP) (129, 130) is 
transiently associated with the nucleolus. Like 
the hY RNAs, SRP RNA is an RNA polymerase 
III product and does not undergo post-tran­
scriptional modifications (8, 10, 131). During the 
intranuclear migration the protein moiety of the 
hY RNPs m ay becom e even more complex due 
to the association of other proteins, like RoBPI 
and hnRNP K (59, 68). Prior to export to the 
cytoplasm the La protein is either released from 
the Y RNPs or modified in such a way that its 
nuclear retention function is turned off (71, 73). 
Taken together, we hypothesize that nucleolin is 
involved in the biogenesis and/or trafficking of 
hY1 and hY3 RNPs to the cytoplasm.
Materials and methods
Sera and antibodies
Monoclonal antibodies 2G10 (anti-Ro60) (92), SW5 
(anti-La) (93), 4G3 (anti-U2B’’) (132) and 7G2 (anti- 
nucleolin, a kind gift of Dr. S. Piñol-Roma, Mount 
Sinai School of Medicine, New York) (133), have been 
described before. Rabbit serum against hPop4 (115) 
was a kind gift of Dr. H. van Eenennaam  (Department 
of Biochemistry, University of Nijmegen, The Nether­
lands). Rabbit serum against hum an nucleolin (114) 
was a kind gift of Dr. H.K. Kleinman (National Institute 
for Dental Research, NIH, Bethesda, Maryland). Rabbit 
serum against the hum an U3-55K protein was a kind 
gift of Dr. S. Grannem an (Department of Biochem­
istry, University of Nijmegen, The Netherlands). For 
the im m unodetection of Ro60 and La an anti-Ro60 
and anti-La positive autoim m une patient serum (O12) 
was used. Peroxidase-conjugated secondary antibod­
ies were from Dako Immunoglobulins (Glostrup, Den­
mark).
Cell extracts
S100 extracts were prepared from HeLa cells purchased 
from Computer Cell Culture Center (Mons, Belgium). 
Briefly, cells were washed twice in isotonic buffer 
(10 mM Tris-HCl pH 7.9, 140 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 1 mM DTE, 20% glycerol), resuspended in
2 volumes of buffer A (25 mM Tris-HCl pH 7.4, 50 mM 
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTE, 20% glyce­
rol) and disrupted by dounce homogenization. Nuclei 
were removed by centrifugation (3,000 x g, 5 min) and 
the supernatant was first centrifuged for 20 m in at
20,000 x g, followed by centrifugation at 100,000 x g for
1 h. The extract was adjusted to 1408 cells per ml using 
buffer A.
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Isolation o f proteins co-precipitating with 2G10 
and SW5
Protein A-agarose beads were coated using a rabbit 
anti-m ouse bridge for 2G10 and SW5, or rabbit anti­
m ouse alone as a control antibody, by overnight rota­
tion at 4°C in IPP500 (10 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 0.05% NP-40). HeLa S100 extract (from 1-109 
cells) was diluted in IPP100 (10 mM Tris-HCl pH 8.0, 
100 mM NaCl, 0.05% NP-40) and incubated with 2G10-, 
or SW5-, or rabbit-anti-m ouse-coated protein A-aga- 
rose beads for 2 h at 4°C. After extensive washing, pro­
teins were eluted in IPP1000 (10 mM Tris-HCl pH 8.0, 
1000 mM NaCl, 0.05% NP-40; 30 min, 4°C), followed by 
acetone precipitation and solubilization in SDS-sam- 
ple buffer. Proteins were resolved by 12% SDS-PAGE 
and stained with Coomassie Brilliant Blue. Bands of 
interest were excised, destained, and subsequently 
digested with trypsin and processed for Q-TOF-mass 
spectrom etry according to Raymackers et al. (94). Pep­
tide sequences obtained by mass spectrom etry were 
used to identify the co-precipitated proteins using the 
NCBI non-redundant protein database.
Immunoprecipitation
Protein A-agarose beads were coated with 2G10, SW5, 
rabbit anti-nucleolin antibody, rabbit anti-hU3-55K 
antibody, rabbit anti-hPop4 antibody or norm al rabbit 
serum, by overnight incubation at 4°C in IPP500. Sub­
sequently, the antibody-coated beads were incubated 
with HeLa S100 extracts (from 5-106 cells) in IPP100 for
2 h at 4°C. Then the beads were extensively washed 
with IPP100 and the co-precipitating RNAs were iso­
lated by phenol/chloroform  extraction and ethanol 
precipitation. Alternatively, co-precipitated proteins 
were solubilized in SDS-sample buffer and processed 
for immunoblotting.
Immunoblotting
Western blots containing HeLa S100 extracts, immu- 
noprecipitated proteins, or column fractions were pre­
pared, blocked in wash buffer (5% non-fat dried milk, 
0.1% NP-40, PBS) for 1 h at room temperature, and 
incubated with antibodies against Ro60 and La (patient 
serum O12; 1:5000), Ro60 (mAb 2G10; 1:10) and nucle­
olin (mAb 7G2; 1:500 or anti-nucleolin rabbit serum; 
1:500), for 1 h at room temperature. After washing, fil­
ters were incubated with HRP-conjugated secondary 
antibodies and bound antibodies were visualized by 
chemiluminescence.
In vitro transcription and northern blot analyses
In vitro transcription of sense and antisense hY RNAs, 
hY1 RNA deletion mutants, antisense hU3 RNA and 
antisense hMRP RNA was perform ed as described (58, 
112, 115). In all cases, the specific activity of the RNA 
probes was similar. For detection of hY RNAs, hU3 RNA 
and hMRP RNA by northern  blot hybridization, RNAs 
were size-fractionated on 10% denaturing polyacryl­
amide-8 M urea gels and electroblotted onto nylon 
m em branes in 0.025 M phosphate, pH 6.5, for 2 h. After 
UV crosslinking, hybridizations were perform ed over­
night at 65°C in 6 x SSC, 5 x Denhardt’s solution con­
taining 100 |xg/ml sheared, denatured herring sperm 
DNA with a mixture of 32P-labeled antisense RNA tran­
scripts of the four hY RNAs, hU3 RNA or hMRP RNA. 
Following extensive washing with 2 x SSC/0.1% SDS, 
the blots were autoradiographed using similar expo­
sure times for all northern blots. For high-stringency 
hybridizations the same procedure was followed except 
that wash steps were perform ed in 0.2 x SSC/0.1% 
SDS.
In vitro h Y  RNA binding assay
Recombinant ham ster nucleolin proteins were con­
structed, expressed and purified as described before 
(134). Purity and concentration of the recom binant
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protein preparations were determined with Bradford 
reagent (Bio-Rad protein assay) and by SDS-PAGE. Equi- 
molar am ounts of recom binant nucleolin (mutant) pro­
teins were bound to glutathione beads (for full-length 
GST-tagged-nucleolin and GST-nterm) or to nickel- 
agarose beads (for His6-tagged-nucleolin m utants) in 
IPP200 (10 mM Tris-HCl pH 8.0, 200 mM NaCl, 0.05% 
NP-40) supplem ented with 3 mM DTE for 1 h at room- 
temperature. Subsequently, the beads were washed 
with the same buffer and incubated with in vitro tran ­
scribed 32P-labeled hY RNAs and m utants of hY1 RNA 
for 2 h at 4°C followed by extensive washing and RNA 
isolation by phenol/chloroform  extraction and ethanol 
precipitation. The RNAs were size-fractionated on 10% 
denaturing polyacrylamide-8 M urea gels and precipi­
tated RNAs were visualized by autoradiography.
Gel filtration
A HeLa S100 extract (5-107 cells in a total volume of 
0.5 ml; see Cell extracts) was loaded on a Superdex 
200 HR 10/30 column (Pharmacia, Roosendaal, The 
Netherlands), calibrated with thyroglobulin (670 kDa), 
bovine gamm a globulin (158 kDa) and chicken oval­
bum in (44 kDa). Chromatography was perform ed at 
a flow-rate of 0.5 m l/m in in 25 mM Tris-HCl pH 7.5, 
50 mM KCl, 1 mM DTE, 1 mM PMSF. Fractions were 
concentrated by acetone precipitation (4 volumes of 
ice-cold acetone, followed by incubation at -70°C for 
1 h; centrifugation at 15,000 x g for 20 min, and solubili­
zation of the protein pellet in SDS-sample buffer). Sub­
sequently, the fractions were fractionated by SDS-PAGE 
and analyzed by im m unoblotting for the presence of 
Ro60, La and nucleolin, and by northern blotting for 
the presence of hY RNAs.
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T
he human La (SS-B) autoantigen is an abundantly expressed RNA chaperone, func­
tioning in various intracellular processes involving RNA. To further explore the 
molecular mechanisms by which La functions in these processes, we performed 
large-scale immunoprecipitations of La from HeLa S100 extracts using the anti-La 
monoclonal antibody SW5. La-associated proteins were subsequently identified by 
sequence analysis. This approach allowed the identification of DDX15 as a protein 
interacting with La. DDX15, the human orthologue of yeast Prp43, is a member of 
the superfamily of DEAH-box RNA helicases, that appeared to bind directly, thus 
independently of other proteins, to La both in vivo and in vitro.The binding region 
of La partly overlaps the DEAH-box domain of DDX15. Immunofluorescence data 
indicated that endogenous DDX15 accumulates in U snRNP containing nuclear 
speckles in HEp-2 cells. Surprisingly DDX15 also accumulates in the nucleoli of 
HEp-2 cells. Regions of DDX15 involved in nuclear, nuclear speckle and nucleolar 
localization are located within the N- and C-terminal regions flanking the DEAH- 
box. RNA co-precipitation experiments indicated that DDX15 is associated with 
spliceosomal U small nuclear RNAs in HeLa cell extracts. The possible functional 
implications of the interaction between La and DDX15 are discussed.
Introduction
Nuclear pre-messenger RNA (mRNA) splicing is 
a process used by eukaryotic cells to remove 
non-coding introns from mRNA precursors. A 
massive ribonucleoprotein complex called the 
spliceosome catalyzes the splicing reaction (135). 
Five small nuclear RNAs (snRNAs), U1, U2, U4, 
U5 and U6, and more than 50 protein factors 
form the spliceosome (for recent reviews see 
(136, 137)). Although the RNA com ponents of 
the spliceosome are thought to form the catalytic 
core, the protein com ponents direct RNA struc­
tural rearrangements in  the spliceosome that are 
critical for catalysis (137). Among these factors 
are a group of spliceosomal proteins that con­
tain DExD/H-box RNA helicase domains (Prp2,
Prp5, Prp16, Prp22, Prp28 and Prp43) and that 
were originally identified in  the yeast Saccharo­
myces cerevisiae. These proteins play an essen­
tial role at various stages of the splicing reaction 
(for reviews see (137, 138)). Of particular interest 
for the present study is the Prp43 protein, acting 
late in  the splicing process at the step of spliceo­
some disassembly (139). The m am m alian ortho- 
logues of Prp43, nam ely mDEAH9 (murine) and 
DBP1 (human) have been characterized previ­
ously (140, 141). Whereas mDEAH9 was shown 
to functionally com plem ent Prp43 in  yeast, data 
on the hum an protein are still scarce.
The hum an La (SS-B) protein is an RNA-bind- 
ing phosphoprotein of 47 kDa, originally iden-
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tified as an autoantigen in patients suffering 
from autoim m une diseases like Sjögren’s syn­
drome and systemic lupus erythematosus (142, 
143). The La protein is ubiquitously expressed 
in m any eukaryotic organisms including S. cere- 
visiae, Drosophila melanogaster and Xenopus 
laevis (144-146). Experiments perform ed in vitro 
have implicated La in a variety of cellular pro­
cesses, e.g. RNA polymerase (Pol) III transcrip­
tion and transcript processing (147-149) and 
internal initiation of translation of poliovirus 
and hepatitis C virus RNA (150-152). Potentially 
related to these functions La has been shown 
to be capable of unwinding DNA-RNA hybrids 
and double-stranded RNA in an ATP-dependent 
m anner (153-155), although recently the dou­
ble-stranded RNA-unwinding activity of La has 
been questioned (156). A role for La in process­
ing of Pol III transcripts has been dem onstrated 
for transfer RNA (tRNA) (157-159). Despite the 
large body of evidence obtained for the various 
processes in  which La plays a role, the in vivo rel­
evance of these activities of La is still unknown. 
The m ost extensively docum ented activity of La 
is its binding to and stabilization of newly syn­
thesized Pol III transcripts. These transcripts are 
the precursors to, amongst others, transfer RNAs, 
5S rRNA, 7S rRNAs, U6 RNA, and the Y RNAs (8, 
77, 78, 158, 160, 161). Recently, yeast La has been 
shown to be involved in  U small nuclear ribo- 
nucleoprotein (snRNP) assembly and to bind to 
precursors of U1, U2, U4, U5 and U6 snRNA (78, 
162). Furthermore, La has been shown to associ­
ate with the hum an telomerase ribonucleopro- 
tein complex and its expression level influences 
telomere homeostasis in vivo (163). In addition, 
certain viral RNAs, such as adenovirus VA RNAs 
and the leader RNA of vesicular stomatitis virus 
have been shown to associate with La (164, 165).
The com m on binding site for the La protein on 
these RNAs is the sequence UUU-OH, which is 
present at the 3’ end of all newly synthesized RNA 
Pol III transcripts (32). In most cases, except for 
the m am m alian Y RNAs, the Euplotes telomer- 
ase RNA (166) and the virally encoded VA RNAs, 
this association is transient due to the removal of 
the 3’-oligouridine stretch during m aturation of 
these RNAs. Recently, La has been proposed to 
act as an RNA chaperone, which might be con­
sistent with all of its reported activities (reviewed 
in (31)).
Human La normally resides in  the nucleoplasm, 
although nucleolar and cytoplasmic localization 
has also been docum ented (reviewed in  (96)). 
In agreement with its nuclear localization, La 
contains a nuclear localization signal (NLS) at 
the C-terminus, and a region responsible for 
nuclear retention (38). The mechanism(s) under­
lying the subcellular distribution of La have 
not been determined, although phosphorylation 
does not seem to play a role (87).
To further explore the cellular function(s) of 
hum an La we have used the mouse anti-La 
monoclonal antibody (mAb) SW5, recognizing 
a conformational epitope in the RNP m otif of 
La (93). Large-scale immunoprecipitations of 
La from HeLa S100 extracts using mAb SW5, 
followed by sequencing of the co-precipitated 
proteins, allowed the identification of a 92-kDa 
polypeptide specifically co-precipitated with La. 
This protein, previously described as DBP1 (141), 
but renam ed DDX15 associates with La both in 
vivo and in vitro. The possible functional impli­
cations of the interaction between La and DDX15 
are discussed.
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Results
DDX15 is co-precipitated with La from a HeLa 
S100 extract
To identify proteins that either directly or indi­
rectly interact with La we perform ed preparative 
im m unoprecipitations from HeLa S100 extracts 
with the anti-La mAb SW5. SW5 has been shown 
to be able to precipitate the majority of La- 
associated RNAs (e.g. the hY RNAs) from HeLa 
extracts (93), and thus is likely suited for immu- 
noaffinity selections of La-associated proteins 
as well. Co-precipitated proteins were eluted by 
raising the salt concentration to 1 M NaCl and 
were fractionated by SDS-PAGE. Because our 
goal was to identify novel La-associated proteins, 
we searched for bands in  the anti-La precipitate 
that were absent in the control precipitate (rabbit 
anti-m ouse IgG). The efficient co-precipitation 
of Ro60, a protein that together with La is a core 
protein of the Ro ribonucleoprotein complexes 
(96), indicated that La-containing macromole- 
cular complexes were selected by this approach 
(Figure 1). As can be seen in Figure 1, lane 3, in 
addition to Ro60 m any polypeptides were iso­
lated by this approach using the anti-La mAb. 
Among the bands chosen for further charac­
terization, the band indicated by p92, clearly 
detectable in  the anti-La precipitate and absent 
in  the control precipitate (Figure 1, lanes 2 and 
3), was characterized and will be presented in 
this paper. To determine the identity of p92, we 
excised the band from the gel, subjected it to 
trypsin digestion and analyzed the resulting pep­
tides by mass spectrometry. The peptide masses 
obtained for p92 by MALDI-TOF mass spec­
trom etry m atched with the predicted masses of 
hum an DEAH-box protein 1 (DBP1, (141)) (data 
not shown). The identity was confirmed by the
results of tandem  Q-TOF mass spectrom etry that 
resulted in five peptide sequences identical to 
tryptic peptides of DBP1 (see Figure 2). However, 
an additional peptide sequence contained an 
isoleucine residue at a position corresponding 
to amino acid (aa) 149 of DBP1 rather than a gly­
cine residue (DBP1: GenBank Accession Number
212 ­
158 — 
116 — 
97­
66 ­
55­
42­
36­
26-
20­
14­
1 2 3
Figure 1. Monoclonal antibody SW5 co-precipitates a 92-kDa 
protein
Protein A-agarose beads coated with anti-La mAb SW5 (anti-La) 
via rabbit anti-mouse IgG antibodies, or coated with rabbit anti­
mouse IgG alone (control), were incubated with a HeLa S100 
extract and co-precipitated material was eluted in the presence 
of 1 M NaCl and analyzed by SDS-PAGE (12% acrylamide). The 
more efficient elution of Ro60 than La from the anti-La resin was 
expected by this elution method, since antibody-antigen and 
antibody-Protein A interactions are not efficiently disrupted by 
1M NaCl. Nevertheless, some of the antibody polypeptide chains 
were observed in the eluates. Proteins were visualized by Coo- 
massie Brilliant Blue staining. Lane 1, molecular weight markers 
(kDa); lane 2, control precipitation (rabbit anti-mouse IgG); lane 
3, SW5 immunoprecipitation. Arrows indicate the positions of 
Ro60, La and p92 and asterisks mark immunoglobulin heavy and 
light chains.
p92
Ro60
La
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^  Figure 2. Protein sequence alignment of DDX15 and 
orthologues from mouse, yeast and C. elegans
The CLUSTAL W algorithm (113) was used to create an amino acid 
sequence alignment of DDX15 and the corresponding ortho­
logues mDEAH9 from mouse (140), Prp43 from yeast (Saccharo­
myces cerevisiae) (139), and Caenorhabditis elegans.Jhe GenBank 
Accession Numbers for the corresponding cDNA sequences are: 
AF279891 (DDX15), AF017153 (mDEAH9), AF005090 (Prp43) and 
U13644 (C elegans). Black shading marks the most highly con­
served amino acids. Gray shading marks conservation of similar 
amino acids.The tryptic peptides obtained by the tandem Q-TOF 
mass spectrometry analysis are depicted above the aligned 
sequences. Asterisks below the alignment indicate the positions 
of the motifs characteristic of the superfamily of DEAH-box RNA 
helicases (167).
Figure 3. DDX15 co-precipitates with La in an RNA-indepen- 
dent manner
Protein A-agarose beads coated with the control anti-Ro60 mAb 
2G10 or the anti-La mAb SW5, were incubated with a HeLa S100 
extract preincubated in the absence (- m.n.) or presence (+ 
m.n.) of micrococcal nuclease. Bound DDX15 was analyzed by 
immunoblotting using an anti-DDX15 rabbit serum. Lane 1, 1% 
input; lanes 2 and 4, anti-Ro60 immunoprecipitate; lanes 3 and 5, 
anti-La immunoprecipitate.
- m.n +m.n
DDX15-
AB001636). No additional proteins were iden­
tified in this sample. Subsequent cloning and 
sequencing of p92 cDNAs from two indepen­
dent hum an cDNA libraries (placenta and ter- 
atocarinoma) dem onstrated that these cDNAs, 
which were identical in  both libraries, contained 
a num ber of differences com pared to the non­
redundant database entry of DBP1 (Acc. No. 
AB001636). At the amino acid level these differ­
ences resulted in several substitutions as well 
as a frame-shift in the C-terminal part of DBP1. 
The sequence of the cDNAs isolated from the 
hum an libraries has been deposited under 
accession num ber AF279891 (GenBank). The 
protein encoded by this sequence was des­
ignated DDX15, for DEAH-box protein 15 for 
reasons docum ented below. Importantly, the 
sequence of the sixth peptide, one residue of 
which did not m atch the DBP1 sequence, was 
identical to the corresponding region of DDX15. 
Like DBP1, DDX15 contains the seven distinct 
and highly conserved motifs characteristic of 
the superfamily of DEAH-box putative RNA heli- 
cases (See Figure 2 and 4A) (167). In addition, 
extensive homology was observed between the
C-terminal region (aa 475 to 767) of DDX15 and 
the yeast members of the DEAH-box RNA heli- 
case family, Prp2, Prp16, Prp22 and Prp43. As 
noted before for DBP1, DDX15 displays a high 
degree of homology to the m ouse DEAH9 pro­
tein, the yeast Prp43 protein and an uncharacte­
rized Caenorhabditis elegans protein. In contrast, 
the N-terminal region of DDX15 (aa 1 to 160; see 
Figure 4A) does not contain significant hom o­
logy to other known DEAH-box RNA helicases. 
An extensive region of alternating positively and 
negatively charged residues (Arg/Lys - Asp/Glu) 
is located between aa 25 and 60 in the N-termi- 
nal part of DDX15.
To confirm the association of DDX15 with La 
containing complexes, we used a rabbit anti­
serum raised against hum an DDX15. Western 
blots containing anti-La imm unoprecipitates 
were probed with the DDX15-specific antiserum. 
Figure 3 shows that DDX15 is indeed co-precipi­
tated by the anti-La mAb (lane 3), but not by the 
control anti-Ro60 antibody (lane 2). Because La 
and DDX15 both contain RNA binding domains 
and La is known to bind to RNA directly (31), 
it was possible that the association between La
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Figure 4. The La-binding site on DDX15 maps to a region between amino acids 153 and 286
(A) Purity of recombinant GST-La and GST proteins used in the GST pull-down assay. Samples of GST-La and GST were fractionated 
by SDS-PAGE, and subsequently the gel was stained using Coomassie Brilliant Blue. Lane 1, molecular weight marker (in kDa); lane 2, 
GST protein; lane 3, GST-La protein. (B) Schematic structure of DDX15 truncation mutants. DDX15-specific regions are in middle grey, 
whereas the highly conserved DEAH-box domain is in black marked by DEAH.The region of DDX15 that is conserved among the yeast 
DEAH-box proteins Prp2, Prp16, Prp22 and Prp43 is in light grey. Numbers under the structures indicate the corresponding amino acid 
positions in DDX15. (C) Pull-down assay of in vitro translated DDX15 and deletion mutants of DDX15. Glutathione beads coated with 
GST-La or GST alone were incubated with in vitro translated 35S-methionine-labeled DDX15 and mutants thereof, and precipitated 
proteins were analyzed by gel electrophoresis and autoradiography. Lanes 1-9, 5% input; lanes 10-18, GST-La pull-down; lanes 19-27, 
GST pull-down (control).
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and DDX15 was m ediated by the binding to a 
com m on RNA molecule. To investigate this pos­
sibility, the HeLa S100 extracts were treated with 
micrococcal nuclease prior to the immunopre- 
cipitations, which resulted in efficient degrada­
tion of RNA molecules present in  the extract, 
including the Ro RNP associated hY RNAs, as 
m onitored by northern  blot hybridization (data 
not shown). The micrococcal nuclease treatm ent 
did not affect the association between La and 
DDX15, strongly suggesting that the interaction 
is direct and not dependent on nucleic acids 
(Figure 3, lane 5). To further substantiate the 
interaction of La with DDX15, we performed 
im m unoprecipitations using an anti-DDX15 
antiserum  and HeLa S100 extracts. Western blots 
containing the anti-DDX15 imm unoprecipitates 
were probed with the mAb SW5 (anti-La). In 
agreement with the results in Figure 3, La co- 
im m unoprecipitated with DDX15 in an RNA- 
independent m anner (data not shown).
La binds directly to DDX15 in vitro
To study the interaction between La and DDX15 
in more detail we used a recom binant GST-La 
fusion protein and in vitro translated 35S-methio- 
nine-labeled DDX15 protein in a GST pull­
down assay. In addition to the GST-La fusion 
protein (Figure 4A, lane 3) GST was used as a 
control (Figure 4A, lane 2). Incubation of in vitro 
translated wild-type DDX15 with GST-La pre­
absorbed to immobilized glutathione revealed 
that DDX15 associated with GST-La (Figure 4C, 
lane 10), even under relatively stringent condi­
tions (300 mM KCl). No binding was observed 
using the GST-protein alone, indicating that the 
binding was m ediated by the La moiety of the 
GST-La fusion protein (Figure 4C, lane 19). The 
analysis of a panel of deletion m utants of DDX15
(Figure 4B) in this assay allowed the mapping 
of the La-binding site on DDX15. The results 
showed that La interacts with the region between 
aa 153 and 286 on the DDX15 protein, since dele­
tion of this region abolished the association of 
La and DDX15 completely (Figure 4C). Deletion 
of the N-terminal 152 and/or C-terminal parts of 
DDX15 up to aa 477 (mutants AC689, AC583 and 
AC477) had no effect on the association between 
La and DDX15 (Figure 4C).
DDX15 accumulates in both nuclear speckles 
and nucleoli of HEp-2 cells
DDX15 and its orthologues have not been exten­
sively studied, unlike several other members of 
the DEAH-box RNA helicase family (139-141). In 
order to gain more insight into the subcellular 
localization of this protein, we visualized endo­
genous DDX15 in HEp-2 cells using the anti- 
DDX15 specific antiserum. As shown in Figures 
5A/B DDX15 was found both in nuclear speck­
les and in  the nucleoli. No detectable staining of 
the cells was observed with the corresponding 
pre-im m une serum (data not shown). To shed 
more light on the identity of the nucleoplasmic 
speckles stained by anti-DDX15, we performed 
co-localization experiments with monoclonal 
antibodies against the Sm-proteins (Figure 5C-E)
(168) and the U2 snRNP specific B’’ protein 
(Figures 5F-H), which are known to localize to 
nuclear speckles that are enriched in splicing fac­
tors (132). The nucleoplasmic staining patterns 
(obtained by confocal microscopy) of the anti- 
DDX15 antibodies and the anti-Sm and anti- 
U2B’’ mAbs were coincident, as indicated by the 
yellow staining in the merged images (Figure 5E 
and H). These results dem onstrate that DDX15, 
the Sm-proteins and U2B’’ co-localize in nuclear 
speckles. As m entioned above, also nucleolar
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staining was observed with anti-DDX15 anti­
bodies (Figure 5A). The nucleolar accumulation 
of DDX15 was confirmed by the co-localization 
of DDX15 with the nucleolar protein fibrillarin
(169) (Figures 5I-K). Taken together, these im m u­
nofluorescence data show that DDX15 accum u­
lates in U snRNP containing nuclear speckles as 
well as in nucleoli of HEp-2 cells.
Figure 5. Endogenous DDX15 accumulates in nuclear speck­
les and nucleoli of HEp-2 cells
(A) HEp-2 cells were fixed and incubated with anti-DDX15 anti­
bodies. Bound antibodies were visualized by indirect epifluores- 
cence microscopy. (B) Corresponding phase-contrast image; bar 
indicates 10 jam. (C,F,I) HEp-2 cells stained with anti-DDX15 anti­
bodies, followed by visualization with FITC-conjugated second­
ary antibodies and confocal fluorescence microscopy (green). 
(D) HEp-2 cells incubated with mAb Y12 (anti-Sm) and visualized 
by Texas Red-conjugated secondary antibodies (red).(E) Merged 
image of C and D,showing co-localization of DDX15 and Sm-pro- 
teins in nuclear speckles (yellow). (G) HEp-2 cells incubated with 
mAb 4G3 (anti-U2B") visualized by Texas Red-conjugated sec­
ondary antibodies (red). (H) Merged image of F and G, showing 
co-localization of DDX15 and U2B'' in nuclear speckles (yellow). 
(J) HEp-2 cells incubated with mAb 72B9 (anti-fibrillarin) visu­
alized by Texas Red-conjugated secondary antibodies (red). (K) 
Merged image of I and J, showing co-localization of DDX15 and 
fibrillarin in nucleoli (yellow). The images shown in panels C-K 
were generated by confocal microscopy. A colour version of this 
image is available on page 133.
Figure 6. Subcellular localization of VSV-G-tagged DDX15 
and DDX15-mutants in HEp-2 cells
(A-J) HEp-2 cells were transiently transfected with constructs 
encoding the VSV-G-tagged wild-type DDX15 (A), AN63 (C), 
AN153 (E), AC689 (G), and AC583 (I). 24 h after transfection, cells 
were fixed and incubated with a mouse anti-VSV-G-tag anti­
body, which was visualized with a FITC-conjugated rabbit anti­
mouse antibody. (B, D, F, H, J) corresponding phase-contrast 
images; bar represents 10 am. All images in this figure were 
generated by epifluorescence microscopy.
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DDX15 contains multiple localization signals 
in both the N-terminal and the C-terminal part 
of the protein
To further characterize the DDX15 protein we 
constructed a series of N-terminally VSV-G- 
tagged DDX15 m utants and analyzed their 
subcellular localization by indirect im m unoflu­
orescence microscopy using transiently trans­
fected cells expressing these m utants. As shown 
in Figure 6A/B, the wild-type VSV-G-tagged 
DDX15 localized to speckles in  the nucleoplasm 
and to nucleoli, as observed for the endogenous 
DDX15 protein (see Figure 5). This result shows 
that the N-terminal VSV-G-tag did not influence 
the intracellular distribution of DDX15. A dele­
tion m utant of DDX15 lacking the N-terminal 62 
aa (AN63) showed a subcellular distribution sim­
ilar to the wild-type protein (Figure 6C/D) except 
for the absence from the nucleoli. This suggests 
that the region between aa 1 and 62 is essential for 
the nucleolar accum ulation of DDX15. A further 
truncation from the N-terminal side abrogated 
nuclear entry, because m utant AN153 localized 
primarily to the cytoplasm (Figure 6E/F), sug­
gesting that the region between aa 63 and 152 is 
required for the nuclear localization of DDX15. 
Interestingly, deletion of C-terminal parts of 
DDX15, m utants AC689 and AC583, led to a 
homogeneous nucleoplasmic distribution with 
no or hardly any nucleolar staining (Figures 
6G/H and 6I/J). The lack of accum ulation in 
nucleoplasmic speckles and nucleoli observed 
with these m utants suggests that the region 
between aa 690 to 795 is required for targeting 
DDX15 to nuclear speckles. Nucleolar accum u­
lation of DDX15 apparently depends on two 
regions of this protein, namely aa 1 to 62 and aa 
690 to 795.
Spliceosomal U snRNAs co-precipitate with 
DDX15 from a HeLa extract
Previous studies on DEAH-box proteins (e.g. 
Prp16, Prp22, and Prp43) in yeast revealed that 
these proteins are involved in some aspects of 
RNA metabolism, particularly pre-mRNA splic­
ing (reviewed in  (170)). This prom pted us to 
investigate if DDX15 associates with cellular 
RNAs. DDX15 was im m unoprecipitated from 
Jurkat cell extracts using rabbit anti-DDX15 
serum SN562 and co-precipitated RNAs were 
size-fractionated and visualized by silver stain­
ing. Since it is possible that La and DDX15 
(in part) associate as a complex with the same 
RNAs, we also included the anti-La mAb SW5 
in these experiments, as well as a monoclonal 
anti-Sm antibody (Y12) as a control. The results 
in Figure 7 (lanes 4 and 5) show that the anti- 
DDX15 antibodies co-precipitated several RNAs. 
Comparison of the pattern  of these RNAs with 
those co-precipitated by mAb Y12 (Figure 7, 
lane 3), which has previously been shown to 
precipitate U snRNP particles (168), strongly 
suggested that these represent U snRNAs. The 
identity of the U snRNAs was confirmed by 
northern blot hybridization analysis (not shown). 
The association of DDX15 with the U snRNAs 
was not detectable w hen the imm unoprecipita- 
tions were perform ed at 200 mM or higher NaCl 
concentrations, indicative of a relatively weak 
interaction (data not shown). Some co-precipi­
tation of the small ribosomal 5.8S and 5S RNAs 
was reproducibly observed. Comparison of the 
RNAs co-precipitated with DDX15 (lane 5) with 
those co-precipitated with La (lane 2) revealed 
hardly any overlap, although weak signals at the 
U1, U4 and U6 positions were observed in the La 
lane.
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Discussion
Using the anti-La mAb SW5 to identify La-inter­
acting proteins, we identified hum an DDX15, a 
m em ber of the superfamily of DEAH-box pu ta­
tive RNA helicases (167). Proteins of this super­
family are thought to unwind double-stranded 
RNA molecules in an energy-dependent fashion 
through the hydrolysis of NTP (generally ATP). 
In addition, some DExD/H helicases may be 
involved in disrupting or rearranging RNA-pro- 
tein interactions (171, 172). The putative RNA 
helicases, also called ‘unwindases’, function in 
a variety of cellular processes involving RNA, 
including ribosome biogenesis, pre-mRNA edit­
ing and splicing, transcription, RNA export and 
RNA degradation (for reviews see (137, 138, 
170)). The cDNA sequence of DDX15 appeared 
to be very similar to the previously identified 
DBP1 cDNA (141). Because only a single cDNA 
sequence for DDX15 was isolated from two inde­
pendent cDNA libraries (placenta and teratocar- 
cinoma), the possibility exists that the differences
T  Figure 7. Anti-DDX15 antibodies co-precipitate U snRNAs
A Jurkat cell extract was subjected to immunoprecipitation 
using mAbs SW5 (anti-La) and Y12 (anti-Sm), the polyclonal 
rabbit serum SN562 raised against DDX15 (immune), and the 
corresponding pre-immune serum. Co-precipitated RNAs were 
isolated and analyzed by denaturing polyacrylamide gel elec­
trophoresis and subsequent silver staining. The input lane con­
tains RNAs isolated from the complete cell extract (10% of the 
amount used in the immunoprecipitations). The positions of 
U1-U6 snRNAs and of the most prominent RNAs in the input lane 
are indicated. Lane 1, 10% input RNAs; lane 2, anti-La immuno­
precipitation (SW5); lane 3, anti-Sm immunoprecipitation (Y12); 
lane 4,pre-immune serum from rabbit SN562; lane 5, anti-DDX15 
immunoprecipitation (immune serum SN562).
I  Figure 8. Schematic structure of DDX15
DDX15-specific regions are in light grey, whereas the highly con­
served DEAH-box domain is marked in black (DEAH).The region 
of DDX15 that is conserved among the yeast DEAH-box pro­
teins Prp16, Prp2, Prp22 and Prp43 is in middle grey. The region 
required for nuclear localization is indicated by Nu (dark grey) 
the region bound by La is marked by La and a bar above the 
scheme. Regions involved in nucleolar localization are indicated 
by No (bar above scheme), whereas the region involved in the 
localization of DDX15 to nuclear speckles is indicated by Sp (bar 
above scheme). Numbers below the structure indicate the cor­
responding amino acid positions in DDX15.
Sp/No
I / \
689 767 795
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between the DDX15 and DBP1 cDNAs are due 
to sequencing errors in  the database entry for 
DBP1. This is further supported by the fact that 
the sequence of all tryptic peptides of this pro­
tein isolated from HeLa cells and analyzed by 
mass spectrom etry corresponded to the DDX15 
sequence, whereas one peptide did not fully 
m atch the DBP1 sequence.
Specificity of DDX15
The m odular structure of DDX15, consisting of a 
helicase core (DEAH-box) and the N- and C-ter­
minal extensions is com m on for the family of 
DExD/H proteins (Figure 8 and (170)). It has been 
proposed that the regions flanking the DexD/ 
H-box dom ain of DExD/H-box family m em ­
bers, which are unique for each of these pro­
teins, may determ ine their specificity (138, 173). 
For instance, the N-terminal dom ain of Prp16 
is required for its specific association with the 
spliceosome (173). However, in some cases the 
DExD/H-box dom ain itself may also determine 
specificity, because eIF4A, a prototype DEAD-box 
RNA helicase, consists essentially of a helicase 
core w ithout extensions, but still is a highly spe­
cific enzyme (174). This hypothesis is strength­
ened by the fact that the regions responsible 
for the interactions between the hum an DEAD- 
box RNA helicases p68 and hDbp5 with fibrilla­
rin and CAN/Nup159p, respectively, are located 
within the DEAD-box region of the two proteins 
(175, 176). Similarly, our in vitro binding studies 
using GST-La and 35S-labeled DDX15 indicate 
that residues exposed at the surface of the heli­
case core of DDX15 (between aa 153 and 285; 
Figure 8) mediate the interaction with La. Deter­
m ination of the identity of several other proteins 
co-precipitated with La did not identify other 
DExD/H-box RNA helicases, strongly suggest­
ing that this interaction is specific for the heli­
case core of DDX15 (M.F. and G.P., unpublished 
data). A deletion analysis of La did not allow the 
determ ination of the region bound by DDX15 
(all m utations abrogated the interaction), sug­
gesting that various regions of La are im portant 
for this interaction (data not shown).
Subcellular localization of DDX15
The N-terminal and C-terminal extensions of 
DDX15 seem to play a role in the subcellular 
localization of DDX15. Using the anti-DDX15 
rabbit serum we showed that endogenous DDX15 
localizes to nuclear speckles and, surprisingly, to 
nucleoli of HEp-2 cells (Figure 5). The subcel­
lular localization of DDX15 to nuclear speckles 
and co-localization with the splicing factor U2B’’ 
and the Sm-proteins are in agreement with the 
fact that the yeast orthologue Prp43 has been 
reported to be involved in spliceosome disas­
sembly (139). The observation that DDX15 also 
accumulates in  nucleoli suggests that, besides 
functioning in splicing, DDX15 is also involved 
in other processes (see below). Data from the 
literature on the localization of DDX15 and its 
homologues is very limited. The nucleolar accu­
m ulation of DDX15 was recently corroborated by 
the proteomic analysis of purified hum an nucle­
oli, in which DDX15 was identified as a nucleolar 
protein (177). Whereas several DExD-box RNA 
helicases were identified, no other m em bers of 
the DExH-box RNA helicase family were identi­
fied in  this analysis of nucleolar proteins (177). 
Imam ura and co-workers reported that a GFP- 
tagged version of DBP1 localized to the nucleus 
of HeLa cells (141). However, they did not observe 
the nuclear speckles and nucleolar accum ula­
tion we report in this paper. The mouse ortho­
logue of DDX15, mDEAH9 was shown to localize
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to nuclear speckles, but was not observed in  the 
nucleoli (140). The discrepancies between our 
results and the results obtained with DBP1 and 
mDEAH9 might be explained by sequence dif­
ferences between the three proteins. First, the 
sequence of DBP1 contains a frame-shift, result­
ing in an alternative C-terminal end in com par­
ison with DDX15; second, whereas the murine 
and hum an proteins are almost identical over 
the whole protein sequence, mDEAH9 does have 
a shorter C-terminal part com pared to DDX15 
(see Figure 2). Based on these observations we 
suggest that the C-terminal part is im portant for 
the subnuclear localization of DDX15. This is cor­
roborated by the results from the deletion ana­
lysis of DDX15. In agreement with the nuclear 
localization of DDX15, we identified a region 
required for its entry into the nucleus between 
aa 63 to 153 (see Figure 8). A deletion of aa 690 to 
795 abolished its association with nuclear speck­
les, substantiating the im portance of this region 
for its subnuclear localization. Other DExD/H 
family members, like hPrp16 and HRH1 also 
have been reported to accumulate in  speckles. 
The localization of hPrp16 and HRH1 to nuclear 
speckles is m ediated by their RS-domains (178, 
179), which is not discernable in the DDX15 
sequence. Detailed analysis of the region span­
ning aa 690 to 795 is therefore needed to iden­
tify the amino acids involved in the targeting of 
DDX15 to nuclear speckles. The nucleolar accu­
m ulation of DDX15 appeared to require two, spa­
tially separated regions of the protein (Figure 8). 
Deletion of aa 1 to 62 in the N-terminal part 
abolished nucleolar accumulation, whereas the 
association with nuclear speckles remained unaf­
fected. The sequence of this region is characte­
rized by the presence of a stretch of alternating 
basic and acidic residues between aa 25 and 60.
This repeat can be subdivided into two parts 
based upon the presence of mainly aspartic acids 
(aa 25 to 48) or glutamic acids (aa 49 to 60). 
Arg - Asp repeats have been previously impli­
cated in  RNA-binding (180) and regions rich 
in basic residues have been shown to mediate 
nucleolar accum ulation (181). Further experi­
m ents are required to determ ine whether these 
charged regions are involved in the nucleolar 
localization of DDX15. Deletion of aa 690 to 795 
in the C-terminal part of DDX15 also abolished 
nucleolar accum ulation of DDX15. The lack of 
nucleolar localization of mDEAH9, the murine 
homologue of DDX15 (140) suggests that aa 756 
to 795 of DDX15 play a crucial role in its nucleo­
lar localization. In sum, all data on the local­
ization of DDX15 m utants support the notion 
that N-terminal and C-terminal extensions of 
DEAH-box proteins confer specificity to these 
proteins. It should be noted however, that also 
the DEAH-box dom ain itself is determining part 
of the specificity of DDX15, namely the associa­
tion of La with a part of the DEAH-box region.
Functional aspects of DDX15 and the 
interaction between La and DDX15
Both the localization of endogenous DDX15 to 
nuclear speckles and the co-precipitation of 
spliceosomal U RNAs from a HeLa cell extract 
suggest that DDX15 might play a role in pre- 
mRNA splicing. This hypothesis is in agreement 
with the observations that the yeast orthologue 
of DDX15, Prp43, is involved in a late step in pre- 
mRNA splicing, namely spliceosome disassem­
bly (139). Also the m urine orthologue, mDEAH9, 
contains a similar activity, since it could func­
tionally replace Prp43 in yeast (140). DDX15 rep­
resents the first example of a hum an DEAH-box 
protein that localizes to both nuclear speckles
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and nucleoli in  mam m alian cells. This suggests 
that besides a function in pre-mRNA splicing, 
DDX15 also plays a role in other processes. 
In yeast several DEAH-box proteins, including 
Dhr1p and Dhr2p localized to nucleoli, where 
they function in  pre-rRNA processing (182). In 
analogy, the nucleolar pool of DDX15 might 
function in  pre-rRNA processing.
What then could be the functional relevance of 
the DDX15-La interaction? In yeast, the La ortho­
logue, Lhp1p, has been shown to be involved in 
the biogenesis of the U1, U2, U4, U5, and U6 
snRNPs (77, 78, 162). La is the first protein to 
bind to newly transcribed RNA polymerase III 
transcripts, including U6 snRNA. A fraction of 
the La protein molecules is known to reside 
in  the nucleolus (96), and several RNA poly­
merase III transcripts like U6 snRNA (127), pre- 
tRNAs (183), SRP RNA (130, 184), 5S rRNA (185), 
RNAse P (128) and RNAse MRP RNA (186) are 
(transiently) localized to this com partm ent as 
well. Therefore it has been suggested that La 
accompanies these RNAs to the nucleolus (75). It 
is tempting to speculate that La recruits DDX15 
to these RNAs in the nucleolus, where DDX15 
might be required for further processing of these 
RNAs and for their assembly into RNPs. Proof for 
such a concerted action of La and DDX15 might 
be provided by yeast strains lacking both Lhp1p 
and the yeast DDX15 protein, Prp43.
Materials and methods
Sera and antibodies
Monoclonal antibodies 2G10 (anti-Ro60) (92), SW5 
(anti-La) (93), 4G3 (anti-U2B’’) (132), 72B9 (anti-fibrilla- 
rin) (187) and Y12 (anti-Sm) (168) have been described
before. Anti-VSV-G-tag antibody was purchased from 
Roche Diagnostics, Almere, The Netherlands. A rabbit 
polyclonal antiserum  against DDX15 was obtained by 
immunizing rabbit SN562 with two synthetic peptides 
from DDX15 (aa 113 to 128 and 735 to 749) conjugated 
to keyhole limpet hemocyanin. This serum  was not 
reactive in immunoblotting, but reacted with native 
DDX15 and was used for im m unoprecipitation assays. 
Rabbit serum against hum an Prp43/DDX15 for use in 
imm unoblotting was a kind gift of Dr. C.L. Will (Max 
Planck Institute for Biophysical Chemistry, Göttingen, 
Germany). Peroxidase-conjugated, Texas Red-conju­
gated and FITC-conjugated secondary antibodies were 
from Dako Immunoglobulins (Glostrup, Denmark).
Cell extracts
S100 extracts were prepared from HeLa cells purchased 
from Computer Cell Culture Center (Mons, Belgium). 
Briefly, cells were washed twice in isotonic buffer 
(10 mM Tris-HCl pH 7.9, 140 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 1 mM DTE, 20% glycerol), resuspended in
2 volumes of buffer A (25 mM Tris-HCl pH 7.4, 50 mM 
KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTE, 20% glyc­
erol) and disrupted by dounce homogenization. Nuclei 
were removed by centrifugation (3,000 x g, 5 min) and 
the supernatant was first centrifuged for 20 m in at
20,000 x g, followed by centrifugation at 100,000 x g for
1 h.
Extracts from Jurkat cells were prepared after harvest­
ing (800 x g, 5 min) and washing of the cells with 
ice-cold PBS. Cells were lysed in lysis-buffer (25 mM 
Tris-HCl, pH 7.5, 100 mM KCl, 1 mM DTE, 2 mM EDTA, 
0.5 mM PMSF, 1% NP-40). After 15 m in insoluble m ate­
rial was removed by centrifugation (16,000 x g, 15 min) 
and the extract was stored at -70°C.
Isolation o f proteins co-precipitating with SW5
Protein A-agarose beads were coated with SW5 using a 
rabbit anti-m ouse bridge, or rabbit anti-m ouse alone
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as a control antibody, by overnight end-over-end rota­
tion at 4°C in IPP500 (10 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 0.05% NP-40). HeLa S100 extract (from 1-109 cells) 
was diluted in IPP100 (10 mM Tris-HCl pH 8.0, 100 mM 
NaCl, 0.05% NP-40) and incubated with SW5-, or rab­
bit-anti-m ouse-coated protein A-agarose beads for 2 h 
at 4°C. After extensive washing with IPP100, proteins 
were eluted in IPP1000 (10 mM Tris-HCl pH 8.0, 1000 mM 
NaCl, 0.05% NP-40; 30 min, 4°C), followed by acetone 
precipitation and solubilization in SDS-sample buffer. 
Proteins were resolved by 12% SDS-PAGE and stained 
with Coomassie Brilliant Blue. Bands of interest were 
excised, destained, and subsequently digested with 
trypsin and processed for Q-TOF-mass spectrometry 
according to Raymackers et al. (94). Peptide sequences 
obtained by mass spectrom etry were used to identify 
the co-precipitated proteins using the NCBI n o n ­
redundant protein database.
Immunoprecipitation
Protein A-agarose beads were coated with 2G10, SW5, 
Y12, anti-DDX15 rabbit serum or the corresponding 
pre-im m une serum, by overnight incubation at 4°C in 
IPP500. Subsequently, the antibody-coated beads were 
incubated with either HeLa S100 extracts or Jurkat 
extracts (for RNA isolation) in IPP150 for 2 h at 4°C. 
Then the beads were extensively washed with IPP150 
and the co-precipitating RNAs were isolated by phenol/ 
chloroform extraction and ethanol precipitation. The 
co-precipitated RNAs were separated by denaturing 
polyacrylamide gel electrophoresis and visualized by 
silver staining according to the protocol by Blum et al. 
(188). Alternatively, co-precipitated proteins were solu­
bilized in SDS-sample buffer and processed for immu- 
noblotting.
Immunoblotting
Western blots containing HeLa S100 extracts or immu- 
noprecipitated proteins were prepared, blocked in
wash buffer (5% non-fat dried milk, 0.1% NP-40, PBS) 
for 1 h at room temperature, and incubated with anti­
bodies against DDX15 (anti-Prp43; 1:500), for 1 h at 
room temperature. After washing, filters were incu­
bated with HRP-conjugated secondary antibodies and 
bound antibodies were visualized by chemilumines- 
cence.
Constructs and recombinant protein expression
For in vitro transcription/translation and transfection 
analyses an N-terminally VSV-G-tagged DDX15 protein 
construct was generated. The N-terminal VSV-G-tag 
(MEIYTDIEMNRLGK) was introduced via PCR using 
the following primers: DDX15-1 (5’-GCGAATTCGC- 
C A C C a tg g a g a t t ta ta c a g a c a ta g a g a tg a a c c g a c t tg g a a -  
a g C G C G G C C G C A T G T C C A A G C G G C A C C G G T T G - 3 ’) 
and DDX15-2 (5’-GCCTCGAGTCAGTACTGTGAATA- 
TTCCTTGGATTG-3’) using DNA from a hum an pla­
cental cDNA library as template. Indicated in bold are 
the introduced EcoRI, Noti and XhoI site, respectively 
The VSV-G-tag encoding sequence is indicated in small 
caps. The PCR product was digested with EcoRI/XhoI 
and cloned in the corresponding sites of the pcDNA3 
vector (Invitrogen). Deletion m utants of DDX15 were 
generated using a PCR-based approach by amplifying 
the desired regions of DDX15 using gene-specific prim ­
ers and the full-length DDX15 cDNA as template. The 
following m utants were made: AN63 (aa 63 to 795), 
AN153 (aa 153 to 795), AN286 (aa 286 to 795), AC689 
(aa 1 to 689), AC583 (aa 1 to 583), AC477 (aa 1 to 477), 
63-477 (aa 63 to 477) and 153-477 (aa 153 to 477). 
The integrity of all constructs was confirmed by DNA 
sequencing. A GST-La fusion-protein construct was 
generated by inserting the full-length hum an La cDNA 
(142) in-frame to a GST-encoding sequence from the 
pGEX-4 vector (Pharmacia, Roosendaal, The Nether­
lands). GST-La and GST were expressed and purified 
according to protocols supplied by the manufacturer 
(Pharmacia, Roosendaal, The Netherlands).
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Transfection and indirect immunofluorescence of 
HEp-2 cells
HEp-2 cells were grown in Dulbecco’s modified Eagle’s 
m edium  (DMEM) containing 10% heat-inactivated 
fetal calf serum and penicillin and streptomycin at 
37°C in the presence of 5% CO2. Logarithmically grow­
ing HEp-2 cells were transfected with the VSV-G-tagged 
DDX15 protein transfection plasmids by m eans of elec­
troporation. Per transfection, 5-106 cells were electro­
porated with 10 |xg of plasmid DNA in 0.8 ml of m edium 
at 276V and a capacity of 950 |xF using a Gene Pulser II 
(BioRad). After transfection, cells were resuspended in 
10 ml of culture m edium  and grown on coverslips 
for 24 h. Subsequently, the HEp-2 cells were fixed in 
100% m ethanol (-20°C, 5 min), rehydrated in PBS, and 
incubated with anti-VSV-G-tag antibody diluted 1:1000 
in PBS. Cells were washed three times in PBS and 
incubated with FITC-conjugated rabbit anti-mouse 
immunoglobulins.
Co-localization experiments
For co-localization experiments, HEp-2 cells grown on 
coverslips were fixed and incubated with anti-DDX15 
rabbit serum (diluted 1:100 in PBS), followed by wash­
ing and incubation with secondary FITC-conjugated 
swine anti-rabbit antibody. Subsequently, the cells were 
incubated with either anti-Sm (mAb Y12), or anti-U2B’’ 
(mAb 4G3), or anti-fibrillarin (mAb 72B9) diluted 1:10 
in PBS, followed by washing and incubation with Texas 
Red-conjugated sheep anti-m ouse antibody. The cells 
were analyzed by confocal fluorescence microscopy.
In vitro translation and immunoprecipitation
In vitro translated 35S-methionine-labeled wild-type 
DDX15 protein and m utants thereof were synthesized 
using the TNT T7 Quick Coupled Reticulocyte Lysate 
System (Promega) as described by the manufacturer, 
using the VSV-G-tagged DDX15 (mutant) proteins in 
the pcDNA3 vector as templates. For imm unoprecipi-
tation analysis, glutathione beads were incubated with 
equimolar am ounts of recom binant GST (control) or 
recom binant GST-La in PDB300 (20 mM HEPES, pH 7.5, 
300 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.05% NP-40, 
5 mM DTE, 0.02% BSA) for 1 h at room temperature. 
After extensive washing with PDB300, 35S-methionine- 
labeled DDX15 proteins were incubated with the GST- 
or GST-La-coated beads in PDB300 for 1 h at 4°C. After 
extensive washing, bound protein was eluted in SDS- 
sample buffer, separated by SDS-PAGE and visualized 
by autoradiography.
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W e describe the characterization of early endosome associated antigen 2 (EEA2), an 80 kDa protein cross-reacting with a monoclonal antibody against the human La autoantigen. EEA2 contains three coiled-coil domains, two leucine zipper motifs, a 
RUN domain and a FYVE-finger domain. EEA2 was shown to be a peripheral mem­
brane protein, which colocalized with internalized transferrin and EEA1 on early 
endosomes. Membrane association required the presence of the FYVE domain and 
was perturbed by the PI3-kinase inhibitor wortmannin. Expression of a dominant 
negative EEA2 mutant reduced internalization, and recycling of transferrin from 
early endosomes, suggesting that it may be functionally linked to the small GTPases 
rab4 and rab5. In agreement with this, we found that EEA2 specifically binds to the 
GTP-form of both rab4 and rab5 and colocalized with the two GTPases. We conclude 
that EEA2 may coordinate the activities of rab4 and rab5, regulating membrane 
dynamics in the early endosomal system.
Introduction
All eukaryotic cells internalize cell surface pro­
teins and material from their environm ent by 
(receptor mediated) endocytosis (reviewed in
(189)). The pathway is also used for the recy­
cling of proteins used in the secretory pathway
(190). Ligands are bound to receptors at the 
cell surface. The complex then enters clathrin- 
coated pits that pinch-off the plasma m em ­
brane to form clathrin-coated vesicles. These 
rapidly loose their coat and subsequently fuse 
and deliver their cargo to early endosomes (EEs). 
The mildly acidic pH in the lum en of EEs causes 
dissociation of m any ligand-receptor complexes 
and assists in sorting cargo molecules to different 
intracellular com partments. Ligands are often 
targeted to late endosomes/lysosomes for deg­
radation, while m ost receptors are transported 
via recycling endosomes (REs) back to the cell 
surface for re-utilization. Although the pathways
of endocytosis are relatively well understood at 
the descriptive level, our knowledge of the m ole­
cular principles that regulate vesicular transport 
through EEs is still in its infancy.
The limiting m em brane of EEs is enriched in 
phosphatidyl inositol 3-phosphate (PI(3)P), while 
late endosomes and multivesicular bodies con­
tain PI(3)P on the m em brane of their internal 
vesicles (191, 192). This phosphorylated inositol 
binds to peripheral m em brane proteins contain­
ing a FYVE dom ain and may serve as docking 
site on EEs (193-195). The FYVE-finger consists 
of eight conserved cysteines at defined dis­
tances (C-X2-C-X12-C-X2-C-X4-C-X2-C-X16-C-X2-C) 
and folds into a so-called ‘cross-braced’ topo­
logy in  coordination with two Zn2+ ions (196, 
197). In addition, it contains a R(R/K)HHCRXCG 
m otif encompassing the third and fourth cys-
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teine (198). Several FYVE-finger proteins, inclu­
ding EEA1 (199) and rabenosyn-5 (200), have 
been shown to be im portant for the orderly flow 
of m em brane through EEs in m am m alian cells. 
Importantly, both EEA1 and rabenosyn-5 are 
effector molecules of the small GTPase rab5 that 
is associated with coated vesicles and EEs, and 
required for homotypic EE fusion and hetero­
typic fusion of coated vesicles with EEs. Rab5 is 
essential for the binding of EEA1 to EEs, and it 
is thought that the combinatorial association of 
EEA1 with both PI(3)P and rab5 causes its highly 
restricted intracellular location to EEs (193, 199). 
Because EEA1 functionally associates with the 
endosomal SNARE protein syntaxin 13 in an 
oligomeric protein complex (201), it is thought 
that rab5 in  its GTP-bound form recruits cyto­
plasmic effector proteins and m em brane-bound 
SNAREs to form a m icrodom ain on EEs involved 
in tethering and fusion (202). Rabenosyn-5 is 
involved in biosynthetic transport of cathepsin D 
to lysosomes and linked to an unknown SNARE 
complex through an interaction with the syntaxin 
binding protein hVps45p (200). Other FYVE- 
finger proteins are known to be involved in  signal 
transduction pathways at the cell surface and 
possibly EEs. For instance SARA is required for 
the recruitm ent of the effector molecules Smad2 
and Smad3 to the activated TGFß receptor on 
the cell surface and intracellular structures (203). 
Furthermore Smad2 binds to the FYVE domain 
protein Hrs, that together with SARA stimulates 
activin receptor m ediated signaling (204).
The La protein is an evolutionarily conserved 
RNA-binding phosphoprotein, originally identi­
fied as an autoantigen in  patients suffering from 
the autoim m une diseases Sjögren’s syndrome 
and systemic lupus erythematosus (31, 142).
La normally resides in  the nucleus, although 
nucleolar and cytoplasmic staining has also been 
docum ented (reviewed in (96)). La has been 
implicated in RNA polymerase III transcription 
and internal initiation of translation of certain 
viral RNAs. Its best docum ented activity is the 
binding to and stabilization of newly synthesized 
RNA polymerase III transcripts and La has been 
proposed to act as an RNA chaperone (31). To 
further explore the function of La we have used 
the monoclonal antibody (mAb) SW5, which rec­
ognizes a conformational epitope in the RNP 
dom ain of La (93). We here describe the charac­
terization of a protein that unexpectedly cross­
reacted with SW5. This protein, term ed EEA2, is 
a novel FYVE-finger dom ain protein that is func­
tionally associated with EEs and m ay serve as a 
novel effector of rab5 and rab4.
Results
Identification and cloning of EEA2
To identify proteins interacting with La we per­
formed preparative im m unoprecipitations from 
HeLa S100 extracts with the mAb SW5. One of the 
co-precipitated proteins had an apparent mole­
cular weight of about 80 kDa (see Figure 1 and 
Material and m ethods section for more details) 
and we nam ed this protein EEA2 for reasons 
docum ented below. To identify the protein, we 
excised the 80 kDa band, incubated it with tryp­
sin and subjected the digest to tandem  Q-TOF 
mass spectrometry. As shown in Figure 2A, 
this yielded several peptide sequences, none of 
which, however, allowed us to identify the pro­
tein. This suggested that EEA2 is a novel protein. 
BLAST searches yielded 6 hum an ESTs (acces­
sion numbers: AI652188, AW978202, BE000558,
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AA324714, AW957168 and AA608559) each 
encoding a num ber of the peptides. Based on 
these ESTs we assembled a contig comprising 
sequences encoding the identified peptides. A 
poly-A signal (AATAAA) was found near the 
3’-end, but the 5’ end was not complete since
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Figure 1. Monoclonal antibody SW5 co-immunoprecipitates 
a 80 kDa protein
Protein A-agarose beads coated with anti-La monoclonal anti­
body SW5 (anti-La) or rabbit anti-mouse IgG (control), were 
incubated with a HeLa S100 extract followed by extensive wash­
ing, elution of the co-precipitated proteins by 1 M NaCl, and 
separation of the co-precipitated proteins by SDS-PAGE (12% 
acrylamide). Proteins were visualized by Coomassie Brilliant Blue 
staining. Several polypeptides were specifically isolated from the 
extract by SW5 in addition to the expected La and Ro60 proteins 
(indicated with arrows). The efficient co-precipitation of Ro60, a 
protein that together with La is stably associated with Ro ribo- 
nucleoprotein complexes, indicated that La-containing macro- 
molecular complexes were selected by this approach. Lane 1, 
molecular weight markers (kDa); lane 2 control precipitation 
(rabbit anti-mouse IgG); lane 3, SW5 immunoprecipitation. 
Arrows indicate the positions of Ro60, La and EEA2 and asterisks 
mark immunoglobulin heavy and light chains.
EEA2
Ro60
La
the sequence encoding peptide AGLGGGDS 
(Figure 2A) was present in the contig upstream of 
the first in-frame m ethionine codon. Moreover, 
all ESTs of this region started with a Noti site, and 
Noti digestion had been perform ed to generate 
the clones encoding these ESTs. We screened the 
hum an genome database with this contig and 
obtained the complete 5’ end of the EEA2 coding 
sequence (accession number: AC023559). This 
sequence has a high GC-content (78%) in the 5’ 
region that m ay have precluded its synthesis by 
5’ RACE analysis (not shown). Based on these 
sequence data we generated a full length clone 
from a hum an placenta cDNA library and a 
genomic fragment isolated by PCR from HeLa cell 
DNA. The integrity of the 5’ region of the EEA2 
coding sequence was confirmed by a recent EST 
database entry (accession num ber BE745186) 
comprising nucleotides 17-700. The full length 
2.63 kb EEA2 clone contains an open reading 
frame of 2124 nucleotides, which encodes a poly­
peptide of 708 amino acids with a calculated 
molecular mass of 79.8 kDa (Figure 2A; GenBank 
accession num ber AF312367). Sequence analy­
sis predicts that EEA2 is a hydrophilic protein 
containing three regions that adopt a mainly 
a-helical conform ation with heptad  repeats 
characteristic of coiled-coil domains (CC1-CC3) 
(205). Leucine zippers are present at amino acid 
positions 213-234 and 318-339, the second of 
which (LZ2) overlaps with the most N-terminal 
coiled-coil dom ain (CC1). EEA2 contains a RUN 
dom ain in  the N-terminal region (aa 139-271), 
thus encompassing LZ1, and a FYVE domain 
close to the C-terminus (aa 634-701) (Figure 2B). 
The RUN dom ain is a recently identified protein 
sequence of unknown function, which occurs in 
several proteins that interact with rab and rap 
GTPases (206). EEA2 has limited homology to
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EEA1 (<20%) which is most pronounced within 
the FYVE dom ain (207).
Rabbit antisera against EEA2 recognize a 
80 kDa protein
We raised EEA2 antibodies against peptides cor­
responding to aa 93-107 and aa 302-316 (SN569 
and SN570). The sera from both rabbits specifi­
cally detected a 80 kDa protein on western blots 
of HeLa cell extracts, that did not react with the 
pre-im m une sera, as shown in Figure 3A. Impor­
tantly, the electrophoretic mobility of in vitro- 
translated EEA2 is indistinguishable from that of 
the 80 kDa HeLa protein detected by the anti­
sera, while SN569 and SN570 also recognized in 
vitro translated EEA2 (not shown). To establish
A
Figure 2. Sequence and domain structure of 
EEA2
Deduced amino acid sequence of EEA2. Peptide 
sequences obtained by mass spectrometry are 
depicted in italics above the amino acid sequence. 
Leucine zipper motifs are boxed in grey, the RUN 
motif is in italics, predicted coiled-coil domains 
are in bold, and the FYVE-finger domain is in bold 
italics (A). Schematic structure of EEA2. Coiled- 
coil domains are indicated with CC1, CC2 and 
CC3, the FYVE-finger domain with FYVE, the leu­
cine zippers with LZ1 and LZ2, and the RUN motif 
by RUN (B).
1 MADREGGCAAGRGRELEPELEPGPGPGSALEPGEEFEIVDRSQLPGPGD
AGLGGGDS
51 RSATRPRAAEGWSAPILTLARRATGNLSASCGSALRAAGLGGGDSGDGT
VLLQSALSLGR
101 ARAASKCQMMEERANLMHMMKLSIKVLLQSALSLGRSLDAÖFAFLQQFFV
151 VMEHCLKHGLKVKKSFIGQNKSFFGPLELVEKLCPEASDIATSVRNLPE
KLADYLK LID NK
201 KTAVGRGRAWL YLALMQKKLADYLKVLIDNKHLLSEFYEPEALMMEEEGM
2 51 VIVGLLVGLNVLDANLCLKGEDL DS QVGVIDFSLYLKDVQDLDGGKEHER
ITDVLDQKNYVEELNR LQEELSAATDR
301 I TD VLDQKNYVEELNRHLSCTVGDLQTKIDGLEKTNSKLQEE L S AATDRI
N E L IR  E IT K  LETYK
351 CSLQEEQQQLREQNELIRERSEKSVEITKQDTKVELETYKQTRQGLDEMY
TEMEIAMK D TLV
4 01 SDVWKQLKEEKKVRLELEKELELQIEMKTEMEIAMKLLEKDTHEKQDTLV
ALR LEEVK N AE SSLQQKNEAITSFEGK
451 ALRQQLEEVKAINLQMFHKAQNAESSLQQKNEAI t SFEGKTNQVMSSMÏQ
5 01  MEERLCfiSERARQGAEERTTSCSRSWAVRIGALQLQLSQLHEQCSSLEIE
LQQVEGLKK QDEKAELQ 
551 LKSEKEQRQALQRELQHEKNTSSLLRMELQQVEGLKKELRELQDEKAELQ
K
6 0 1 KICEEQEQALQEMGLHLSQSKLKMEDIKEVNQALiTGHAWLiCDDEAr/iCiÇ
651 CEKEFSISRRKHHCRNCGHIFCNTCSSNELALPSYPKPVRVCDSCHTLIL
7 01 ßRC SS TAS
B RUN CCI CC2
139-271 299-370 385-479
CC3 FYVE 
524-633 634-701
LZ1 LZ2
213-234 318-339
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whether the rabbit antibodies crossreacted with 
the protein co-precipitated with SW5, we probed 
western blots of SW5 im m unoprecipitates with 
antiserum  SN569. As shown in Figure 3B, EEA2 
was detected in  these imm unoprecipitates, but 
not in  the control imm unoprecipitates. Thus the 
cloned sequence encodes full length EEA2. Pre­
treatm ent of the samples with either micrococ- 
cal nuclease or DNAse I did not influence the 
efficiency of imm unoprecipitation, suggesting 
that the interaction is not dependent on nucleic 
acids (not shown).
noprecipitated EEA2 independent of La. Immu- 
noprecipitations that were done in  the presence 
of bacterially expressed recom binant hum an La 
yielded identical results (not shown). In contrast, 
SW3, another monoclonal antibody against La, 
did not share the ability of SW5 to im m uno­
precipitate in vitro translated EEA2 (Figure 3C), 
even though its binding characteristics to La are 
similar to those of SW5 (93). We conclude that 
EEA2 is a 80 kDa polypeptide that is directly tar­
geted by the anti-La monoclonal antibody SW5.
Our strategy to isolate La-binding proteins relied 
on the ability of immobilized SW5 to recognize 
La. Therefore it was also possible that the iso­
lation of EEA2 was due to a direct interaction 
with SW5. To address this question, we prepared 
35S-labeled EEA2 by in vitro transcription-trans­
lation and subjected it to im m unoprecipitation 
with SW5. As shown in Figure 3C, SW5 immu-
SN569 SN570
B
T C SW5
EEA2
EEA2 binds to membranes via its FYVE domain
To assess the intracellular distribution of EEA2 
we first fractionated HEp-2 cell lysates by differ­
ential centrifugation. The distribution of EEA2 
among nuclear, mitochondrial, microsomal and 
cytosolic fractions was analyzed by im m unoblot­
ting using the rabbit anti-EEA2 serum. As shown 
in Figure 4, we found the majority of EEA2 in the 
cytosolic fraction, whereas a significant am ount 
was present in the microsomal fraction as well. 
Since EEA2 is likely to associate with m embranes 
in a reversible manner, it is possible that some 
of it dissociated from m em branes during frac­
tionation as was observed before for other pro­
teins lacking a m em brane anchor (199, 208). The 
nuclear and mitochondrial fractions contained 
little if any EEA2.
Figure 3. Rabbit sera against EEA2 recognize a 80 kDa protein
HeLa S100 extracts were analyzed by western blotting using 
EEA2 antibodies (I) SN569 and SN570 or the corresponding pre­
immune sera (PI) (A).La was immunoprecipitated with SW5 from 
HeLa S100 extracts, or an unrelated monoclonal antibody (C) 
and EEA2 was analyzed on western blots with SN569 of immu­
noprecipitates, or total cell lysate (T) (B). Immunoprecipitation 
of in vitro translated 35S-labeled-EEA2 with SW3, SW5, or no anti­
body (-). In lane I the in vitro translation product was loaded. 
Immune complexes were resolved by SDS-PAGE and analyzed 
by autoradiography (C).
Cy Nu Mi Me
EEA2
Figure 4. EEA2 co-fractionates with microsomes and cytosol
HEp-2 cell lysates were fractionated by differential centrifu­
gation as described in Materials and methods. Cytosolic (Cy), 
nuclear (Nu), mitochondrial (Mi) and microsomal (Me) fractions 
were analyzed by western blotting with anti-EEA2 serum.
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To further explore the m em brane-association 
of EEA2, we analyzed its distribution by con- 
focal immunofluorescence microscopy. Because 
our antibodies did not allow reliable detection 
of endogenous EEA2, we transfected HeLa cells 
with a construct encoding the full length pro­
tein that was N-terminally tagged with the VSV-G 
epitope tag (209). As shown in Figure 5A, EEA2 
was associated with discrete punctae scattered 
throughout the cytoplasm which are reminiscent 
of endocytic organelles. The same localization 
was found with a construct in which the epitope 
tag was fused to the C-terminus (not shown), 
docum enting that the tag did not affect the sub­
cellular distribution of EEA2. In cells expressing 
high levels of EEA2, the protein distributed into 
the cytoplasm, suggesting that m em brane b ind­
ing is saturable.
To investigate whether the FYVE dom ain of EEA2 
is involved in its association with the cytoplas­
mic organelles, we transiently expressed the 
VSV-G-tagged N-RUN-CC13 EEA2 m utant in 
which aa 636 - 708 were deleted. Immunofluore­
scence microscopy revealed a diffuse cyto­
plasmic labeling consistent with a cytosolic 
localization (Figure 5B) showing that the FYVE 
dom ain of EEA2 is required for its binding to 
membranes. FYVE domains bind with moderate 
to high affinity to PI(3)P, a phosphatidylinositol 
derivative required for m em brane association of 
EEA1. We therefore next assessed whether PI(3)P 
might be im portant for m em brane binding of 
EEA2. HeLa cells transiently transfected with full 
length EEA2 were incubated for 15 m in at 37°C 
with 50 nM wortmannin. As shown in Figure 
5C, the presence of the PI3-kinase inhibitor dra­
matically changed the distribution of EEA2 and 
EEA1 (not shown) from m em branes to the cyto-
T  Figure 5. The FYVE domain is required for membrane 
binding of EEA2
HeLa cells were transiently transfected with VSV-G-tagged EEA2 
(A) or N-RUN-CC13 mutant lacking the FYVE domain (B). A 
15 min incubation of cells expressing VSV-G-tagged EEA2 with 
50 nM wortmannin at 37°C resulted in relocation of EEA2 to the 
cytoplasm (C), which was not found in cells receiving the sol­
vent only (not shown). Cells were fixed 18-24 hr after transfec­
tion. Detection was done with mouse anti-VSV-G-tag antibody 
and Alexa488-rabbit anti-mouse IgG.
^ Figure 6. EEA2 is associated with early endosomes
HeLa cells were transiently transfected with VSV-G-tagged EEA2 
(A-L), fixed and subjected to confocal immunofluorescence 
microscopy. EEA2 was labeled with a monoclonal antibody 
against the VSV-G tag and counterstained with Alexa488-labeled 
goat anti-mouse IgG (A,D) or Cy3-labeled goat anti-mouse IgG 
(G,J). EEA1 was detected with a rabbit antibody and Cy3-labeled 
goat anti-rabbit (B).TGN46 detection was with a sheep antibody 
and Alexa488-goat anti-sheep (H), while lgp120 was detected 
with a rabbit antibody against its cytoplasmic tail and stained 
with Alexa488-goat anti-rabbit IgG (K). To label the entire TfR 
pathway, cells were incubated for 30 min at 37°C with 25 ^g/mi 
Alexa594-Tf (D,E,F). Merged images are shown in panels C, F, I, L. 
A colour version of this image is available on page 133.
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plasm. The results of this morphological assay, 
thus show that EEA2 is a peripheral m em brane 
protein whose m em brane association is depen­
dent on a FYVE dom ain and perturbed by a PI3- 
kinase inhibitor.
EEA2 is associated with early endosomes
Since the cytoplasmic structures containing VSV- 
G-tagged EEA2 could be endocytic organelles, 
we perform ed double label immunofluorescence 
microscopy with established marker proteins. In 
HeLa cells transfected with VSV-G-tagged EEA2, 
we found partial colocalization between EEA2 
(Figure 6A) and EEA1 (Figure 6B) as evidenced 
by the merged images in Figure 6C. Because 
EEA1 is restricted to sorting endosomes (202), 
and since some of the structures contained only 
EEA1 while others were positive for EEA2, we 
also com pared the localization of EEA2 to other 
com partm ents of the transferrin receptor (TfR) 
pathway. For this purpose Alexa594-Tf was inter­
nalized for 30 m in in  HeLa cells expressing 
VSV-G-tagged EEA2. Most if not all of the endo­
somes that were decorated with the anti-VSV-G- 
tag antibody (Figure 6D) contained Alexa594-Tf, 
whereas a portion of Alexa594-Tf endosomes 
(Figure 6E) did not contain EEA2 as evidenced 
by the merged images (Figure 6F). To investigate 
w hether EEA2 was present in the trans-Golgi 
network, we double labeled EEA2 transfected 
cells (Figure 6G) with an antibody against the 
trans-Golgi network marker TGN46 (Figure 6H). 
As shown in the merged image (Figure 6I), EEA2 
and TGN46 did not colocalize. Although some 
FYVE dom ain proteins such as Fablp (210) and 
PIKfyve (211) distribute to late endocytic com ­
partm ents, this is not what we found for EEA2. 
Double labeling experiments of EEA2 (Figure 6J) 
and lgp120 (Figure 6K), a protein associated with
late endosomes/lysosomes, showed that they 
have mutually exclusive localizations (Figure 6L). 
Taken together, these data indicate that the 
m em branous structures to which EEA2 binds are 
EEs.
EEA2 regulates transport through early 
endosomes
The extensive colocalization between EEA2 and 
Tf in EEs and the absence of EEA2 on the plasma 
membrane, suggested that it might function in 
a distal transport step of the TfR pathway. We 
therefore examined the effect of EEA2 on transit 
of endocytosed Tf through EEs. HeLa cells were 
transiently transfected with wild-type EEA2, or 
the CC13-FYVE EEA2 m utant lacking the N-ter- 
m inal aa 1-290, including the RUN dom ain (see 
Figure 9A). Alexa594-Tf was internalized for 30 
m in at 16°C to accumulate the probe in EEs (212). 
Cells were then washed and chased at 37°C in 
the presence of Desferal to prevent re-internal­
ization of recycled tracer. As shown in Figure 7E”, 
CC13-FYVE EEA2 caused extensive swelling of 
EEs and inhibited entry of Alexa594-Tf in  EEs 
at 16°C as com pared to cells expressing wild 
type EEA2 (Figure 7A”) and the non-transfected 
cells in  Figure 7E”. During the first 10 m in of 
chase the tracer reached the swollen EEs in 
cells transfected with CC13-FYVE EEA2, but exit 
of Alexa594-Tf from these structures was com ­
pletely blocked during a 40 m in chase (Figure 
7F”-H”). In contrast, in non-transfected cells 
or wild-type EEA2 transfectants, most if not all 
Alexa594-Tf was chased out of the cells after 
40 min. Thus CC13-FYVE EEA2 appeared to act 
as an inhibitory m utant delaying entry into and 
inhibiting recycling from EEs.
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Figure 7. EEA2 regulates Tf transport through early endosomes
HeLa cells were transfected with VSV-G-tagged EEA2 (A-D) or the VSV-G-tagged CC13-FYVE EEA2 mutant (E-H). Cells were labeled 
with mouse anti-VSV-G-tag followed by Alexa488-goat anti-mouse IgG (A-H). Alexa594-Tf was taken up for 30 min at 16°C, washed, 
and chased at 37°C for 0 min (A, E'), 10 min (B, F'), 20 min (C, G'), and 40 min (D, H') in the presence of 50 mM Desferal. The cor­
responding merged images are shown in A''-H''. A colour version of this image is available on page 134.
EEA2 directly interacts with the GTP-bound 
forms of rab4 and rab5
The phenotypic effects of the CC13-FYVE m utant 
on TfR kinetics suggested a cooperative role of 
EEA2 and the monomeric GTPases rab5 and 
rab4. Rab5 and rab4 are known to control vesicu­
lar transport to EEs and recycling from this com ­
partm ent, respectively (213, 214). We therefore 
investigated whether EEA2 directly interacted 
with the two rab proteins using a GST pull-down 
assay (200). Bacterially expressed GSTrab4 and 
GSTrab5 were bound to GSH beads and each 
charged with either GTPyS or GDP, and incu­
bated with 35S-labeled VSV-G-tagged EEA2, pro­
duced in  an in vitro transcription-translation 
reaction. As shown in Figure 8A, EEA2 directly, 
and preferentially bound to the active forms (> 20 
times the GDP-form) of rab4 and rab5, while 
rab5 appeared to bind 2-3 times less EEA2 than 
rab4. The interaction was specific since EEA2 did 
not bind to rab11 or GST.
If EEA2 binds to rab4 and rab5 in vivo, it should 
colocalize at least in  part with rab4 and rab5. To 
investigate this, we co-transfected cells with VSV- 
G-EEA2 and rab4 or GFP-rab5 and analyzed their
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Figure 8 . EEA2 directly binds to the GTP-forms of rab4 and rab5
GSTrab4, GSTrab5, G STrab ll were loaded with GTPgS or GDP 
and incubated overnight with 35S-labeled VSV-G-tagged EEA2. 
Beads were washed 3 times and proteins were eluted with 
25 mM reduced glutathione. Eluates were resolved on 10% 
SDS-PAA gels and analyzed by phosphorimaging (A). HeLa cells 
expressing VSV-G-EEA2 and rab4 (B-D),or VSV-G-EEA2 and EGFP- 
rab5 (E-G) were labeled with a monoclonal antibody against 
the VSV-G tag and counterstained with either Alexa488-goat 
anti-mouse IgG (B) or Alexa594-goat anti-mouse (E). Rab4 was 
labeled with a rabbit antibody and stained with Cy3-goat anti­
rabbit IgG (C), while rab5 was detected by EGFP fluorescence 
(F). Merged images are shown in panels D, G, and colocalization 
is indicated by arrowheads. A colour version of panels B-G is 
available on page 134.
distributions by confocal fluorescence m icros­
copy. As shown in  Figure 8D, we found a nearly 
com plete colocalization of EEA2 and rab4 on 
EEs tha t appeared to be som ew hat swollen with 
respect to those seen in Figure 6 (panels C and  F). 
EEA2 also colocalized w ith GFP-rab5 as shown 
in  Figure 8G. Rab5, in  contrast to rab4, however, 
less extensively colocalized w ith EEA2 as m ight 
be expected from the partial colocalization of 
EEA1 and EEA2 (Figure 6A-C) and the reported 
codistribution of rab5 and  EEA1 (202). This sug­
gested that EEA2 m ight bind both  rab5 and rab4 
in vivo, which is supported  by the ability of
EEA2 and the two GTPases to cause m orphologi­
cal alterations to EEs (Figure 8D, G), tha t are sim ­
ilar to those seen after overexpression of rab4 
and rab5 and rabaptin  effectors (215, 216). Thus 
EEA2 no t only co-localized w ith rab4 and rab5, 
bu t also directly interacted  w ith the active forms 
of both  proteins.
Given that rab4 and rab5 bound  to EEA2, we next 
investigated w hether their binding sites m ap to 
the sam e or distinct dom ains on  EEA2. To this 
aim  we generated a series of VSV-G-tagged EEA2 
deletion m utants (Figure 9A) and tested their 
ability to bind to guanine nucleotide-loaded 
GSTrab5 or GSTrab4 in  the GST pull-dow n assay. 
As shown in Figure 9B, deletion of CC3 abol­
ished binding to both  rab4 and rab5. Trunca­
tions that retained the ability to b ind rab5 or 
rab4, did so in  a GTP-dependent m anner. None 
of the EEA2 truncations bound  to GDP-charged 
rab4 and  rab5 (not shown). These results strongly 
suggested that am ino acids com prising CC3 are 
required and  sufficient for GTP-dependent b ind ­
ing of rab4 and  rab5.
EEA2 is associated with a large cytosolic 
protein complex
Recent evidence shows tha t rab proteins act 
through the local assem bly of highly specific 
effector complexes that contain  a m yriad of p ro ­
teins, of which som e have b een  identified so far. 
For instance at least 26 cytosolic proteins could 
be isolated on  a rab5GTP colum n, including 
rabenosyn-5, EEA1, and rabaptin5 (217). Having 
found tha t EEA2 directly binds to rab4 and rab5, 
we were interested to know w hether endoge­
nous EEA2 was present as a m onom er or w ithin 
a p rotein  com plex in  the cytoplasm. To this aim 
we fractionated a HeLa S100 extract by gel filtra-
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Figure 9 . Rab4 and rab5 bind 
to the CC3 dom ain o f EEA2
Schematic structure of EEA2 
truncation mutants. See legend 
to Figure 2B for domain nomen­
clature (A).GSTrab4 and GSTrab5 
were loaded with GTPyS. Bind­
ing and analysis of 35S-labeled 
VSV-G-tagged EEA2 (fl) and 
truncations N-RUN-CC13 (1), 
LZ1-CC13-FYVE (2), CC13-FYVE 
(3), LZ1-CC13 (4), N-RUN-CC12 
(5), N-RUN-CC1 (6), N-RUN (7), 
LZ1-CC12 (8) and LZ1-CC1 (9) 
was done as described in the 
Materials and methods section 
(B).
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Figure 10. Cytosolic EEA2 is associated w ith  a large protein com plex
A HeLa S100 extract was fractionated by Superdex 200 HR 10/30 gel filtration chromatography as described in Materials and meth­
ods. The position of marker proteins is indicated above the elution profile. Column fractions were analyzed by western blotting with 
antibodies against EEA2, EEA1, rab5, rab4 and rabaptin5. The positions of the various proteins are indicated with arrows.
tion on  a Superdex 200 HR colum n. The m ajor­
ity of EEA2 eluted in  fractions corresponding to 
a m olecular weight > 670 kDa (Figure 10). Upon 
overexposure of the w estern blot, we detected 
trace am ounts of EEA2 in the fractions corre­
sponding to its m onom eric state (not shown). 
The EEA2 com plex (or complexes) are devoid of 
nucleic acids since we did n o t find RNA or DNA 
in im m unoprecipitations of 32P-orthophosphate- 
labeled cells using SN569 antibody against-EEA2 
(not shown). We also analyzed the colum n frac­
tions for the presence of EEA1, the m ajority of 
which eluted in  fractions 3 - 7, showing no over­
lap w ith EEA2. Rabaptin5, an  effector of rab4 and
rab5 eluted in fractions betw een the EEA2 and 
EEA1 peaks, while rab5 and rab4 eluted from 
the colum n after the 44 kDa marker. These data 
dem onstrate that the vast m ajority of cytosolic 
EEA2 is associated w ith a relatively large protein 
complex, tha t is distinct from complexes con­
taining other rab5 effectors.
Discussion
We here describe the identification of EEA2, a 
novel 80 kDa pro tein  colocalizing w ith endo- 
cytosed transferrin, rab4 and albeit to a lesser
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extent w ith EEA1, and  rab5 on EEs. We isolated 
EEA2 from HeLa cells w ith the high affinity SW5 
m onoclonal antibody against La. Since SW5 spe­
cifically binds to hum an  La (93), we were sur­
prised  to find that EEA2 directly b ound  to SW5, 
independently  of La. The m olecular basis for the 
interaction  betw een SW5 and EEA2 is no t yet 
clear, possibly EEA2 contains a similar confor­
m ational epitope as is recognized by SW5 in the 
RNP dom ain  of La (93). EEA2 is a hydrophilic 
pro tein  containing three coiled-coil domains, 
two leucine zipper motifs, a RUN dom ain, and 
a FYVE-finger dom ain. The prim ary structure of 
EEA2 displays som e hom ology to EEA1, partic­
ularly in  the FYVE-finger dom ain. EEA2, how­
ever, is quite distinct from EEA1. First, EEA2 
contains an N -term inal RUN dom ain, and has 
a significantly lower coiled-coil conten t than 
EEA1. Second, rab4 and rab5 b ind  to the same 
dom ain  of EEA2, a property  that is n o t shared by 
EEA1 (or any of the other rab4 and rab5 effec­
tors). These features suggest that EEA2 is an 
effector of rab5 and rab4, and  relies on the pres­
ence of a FYVE-domain to localize to EEs.
During the preparation  of this m anuscrip t Cor- 
m ont et al. reported  the identification of rabip4, 
a m urine rab4 effector (218). Sequence com ­
parison of EEA2 and rabip4 revealed extensive 
homology, suggesting that rabip4 is the m urine 
orthologue of EEA2. However, the rabip4 cDNA 
is probably no t complete, as it lacks a sequence 
encoding the N -term inal 108 am ino acids of 
EEA2, whereas the rem ainder of the p ro tein  dis­
plays m ore than  90% identity. Since the 5’ end 
of rabip4 cDNA was generated w ith 5’ RACE 
(218), it is likely that the high G /C -content of the 
sequence in  this region im peded the synthesis 
of longer cDNA molecules. Moreover, the m ouse
dbEST database contains an  entry  (AI425458) 
that is highly hom ologous to the 5’ end of EEA2. 
This strongly suggests tha t the clone that was 
used to generate sequence entry  AI425458 con­
tains the m issing p art of the rabip4 cDNA. Since 
the N -term inal 108 aa of EEA2 do no t constitute 
known protein  motifs, it is no t im m ediately obvi­
ous w hether the truncation  affects the functional 
properties of the protein. We do note however, 
that this p art of the protein  is im m ediately adja­
cent to the RUN dom ain, a conserved elem ent 
found in  m any proteins tha t are known to func­
tionally associate with GTPases of the rab and 
rap subfam ilies (206). Importantly, EEA2 binds 
to both  rab4 and rab5, and  is involved in  trans­
port steps that are regulated by rab5 and  rab4, 
w hereas rabip4 does no t interact w ith rab5 
(218).
Analysis of the EEA2 N-RUN-CC13 deletion 
m u tan t showed that the FYVE-finger dom ain 
plays an essential role in the binding of EEA2 
to early endosom al m em branes. Low concen­
trations of w ortm annin  selectively inhibit PI3- 
kinase and resulted in the redistribution of EEA2 
from EEs to the cytoplasm, suggesting that PI(3)P 
is required for the early endosom al association 
of EEA2. Currently it is n o t known w hether other 
proteins are involved in  the association of EEA2 
w ith EEs, as is the case for rabenosyn-5 (200) and 
EEA1 (199). Endosom e association of these rab5 
effectors involves binding to rab5-GTP, which 
interacts w ith a region com prising the FYVE 
dom ain  and flanking am ino acids (219). Align­
ing this region of EEA1 w ith EEA2, revealed a 
hom ologous elem ent im m ediately upstream  (aa 
562-647) of the FYVE-domain in  EEA2 w ith 31% 
identity  and 42% similarity. Interestingly, this 
part of EEA2 is 89% identical to the rab4 b ind ­
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ing dom ain  of rabip4 (218), and  contains the 
rab4 and  rab5 binding dom ain  in  CC3 (Figure 8). 
Because N-RUN-CC13 EEA2 (Figure 5) is local­
ized in  the cytoplasm, it is clear that binding 
of EEA2 to rab4 an d /o r rab5 is no t sufficient 
for the association w ith EEs. Since PI(3)P is not 
exclusively localized to EEs, bu t also occurs in 
late endocytic com partm ents as well as in the 
nucleus (192), we inferred that rab4 an d /o r rab5 
binding and the FYVE dom ain  are required for 
endosom al recru itm ent of EEA2.
The in vitro binding studies showed tha t rab5 
and  rab4 in  their GTP-bound form  directly in ter­
act w ith EEA2. The interaction  with the two 
GTPases was specific since rab11, which is also 
functionally associated w ith com partm ents of 
the TfR pathway, did no t b ind to EEA2. These 
interactions suggest that EEA2 m ay coordinate 
rab4, and rab5 function on  EEs, bu t no t on recy­
cling endosom es where rab11 is localized (220, 
221). This idea is supported  by several of our 
findings. First, EEA2 is associated w ith EEs that 
contain  rab4 and rab5. Second, the CC13-FYVE 
EEA2 m u tan t acts as an inhibitor of Tf entry into 
EEs, a step tha t is typically controlled by rab5. 
Third, CC13-FYVE EEA2 generated enlarged EEs, 
a phenotype also arising from the expression 
of rab5 and  its effector proteins. Fourth, CC13- 
FYVE EEA2 inhibits the exit or recycling of Tf 
from  EEs, an event that is regulated by rab4.
W hat w ould be the purpose of a p rotein  that 
binds two endosom al GTPases? Previous stud­
ies have shown that rab5, rab4, and rab11 con­
taining endosom es are reached in this order by 
endocytosed Tf (222). Triple label fluorescence 
m icroscopy of Zerial’s group confirm ed these 
biochem ical data (202), and  also showed that
pairs of these sequentially acting rab proteins 
had distinct and partially overlapping d istribu­
tions. It is thought that rab proteins m ay form 
dom ains in  the lateral plane of a m em brane by 
recruiting effectors and other interacting m ole­
cules to control a specific m em brane transport 
event (201). Extrapolation of this hypothesis sug­
gests that the m orphological and biochem ical 
heterogeneity  of early endocytic organelles can 
be m aterialized in  term s of dom ains that are 
form ed by rab5, rab4, and rab11 (202). The spa­
tial coordination of rab5-dependent entry  and 
rab4-m ediated  exit of Tf can then  simply be 
brought about by connecting the rab5 and  rab4 
dom ains via effector m olecules that have the 
ability to b ind  both  rab5 and  rab4. Although rab5 
and rab4 b ind to the sam e dom ain  of EEA2, it is 
im m aterial in  this m odel w hether rab5 and rab4 
b ind sim ultaneously or com petitively to CC3 of 
EEA2. In both  scenarios the increased local con­
centration  of EEA2 on early endosom al m em ­
branes caused by recru itm ent to either rab5 or 
rab4 will enhance the probability of an in ter­
action with the dom ain  form ed by the other 
GTPase. Since EEA2 binds rab4 and rab5 and 
likely depends for its association w ith EEs on a 
FYVE dom ain  - PI(3)P interaction, it qualifies as 
a bona fide  effector p ro tein  to connect the rab5- 
and rab4-dom ains on EE.
Cytosolic EEA2 is associated w ith a large 
(> 670 kDa) p ro tein  complex which does not 
contain  EEA1 and  rabaptin5, suggesting that it 
is distinct from  the previously identified rab5 
effector complex consisting of EEA1-rabaptin5- 
rabex5-syntaxin13 (201). Although we have not 
yet identified o ther com ponents of the complex, 
the m odular structure of EEA2 affords associa­
tion w ith m ultiple proteins via its leucine zippers
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an d /o r coiled-coil dom ains, which are estab­
lished pro tein-protein  interaction  dom ains (223, 
224). Cytosolic rab4 and rab5 did no t co-frac- 
tionate w ith the complex, possibly because they 
are p resen t in  the cytosol in  the GDP-bound 
form  (225, 226) that does no t b ind  to effector 
proteins. Alternatively, the EEA2 association 
w ith the GTPases m ight be transient and deter­
m ined by cycles of GTP-hydrolysis and GDP 
exchange reactions tha t preclude their co-frac­
tionation. Similarly, the m ultim eric rab5 endo- 
som al docking/fusion com plex (201) did not 
contain  rab5. Possibly, the cytosolic EEA2 com ­
plex m ight serve as a pre-com plex that is acti­
vated upon  binding to rab4/rab5 on EEs.
Materials and methods
Antibodies
The mAbs SW5 and SW3 against hum an La (93) and 
the rabbit antibodies against lgp120 (227), and rab4 
(228) have been described. The mouse mAb against 
the VSV-G-tag was purchased from Roche (Almere, 
The Netherlands), the sheep antibody against TGN46 
was from Serotec (Oxford, UK) and the goat antibody 
against rabaptin5 was from Santa Cruz Biotechnology 
(Santa Cruz, CA). The rabbit antibody against EEA1 
and mouse monoclonal against rab5 were generously 
provided by Michael Clague (Physiological Laboratory, 
Liverpool) and Angela Wandinger-Ness (Department 
of Pathology, University of New Mexico, Albuquerque 
NM). Antibodies against EEA2 were generated by 
immunizing rabbits with KLH-conjugated peptides 
corresponding to aa 93-107, and 302-316, respectively. 
Peroxidase-labeled secondary antibodies were from 
Dako Immunoglobulins (Glostrup, Denmark). Fluore­
scently labeled antibodies and Tf were from Molecular 
Probes (Leiden, The Netherlands).
Cell culture and transfection
HEp-2 cells and HeLa cells were maintained in DMEM 
containing 10% heat-inactivated fetal calf serum, 
penicillin and streptomycin. HeLa cells were trans­
fected using Fugene6 (Roche, Almere, The Netherlands) 
according to the manufacturer’s protocol. Cells were 
used for experiments 18-24 h after transfection.
Cell extracts
S100 extracts were prepared from HeLa cells purchased 
from Computer Cell Culture Center (Mons, Belgium). 
Briefly, cells were washed twice in isotonic buffer 
(10 mM Tris-HCl pH 7.9, 140 mM KCl, 1.5 mM MgCl2, 
1 mM EDTA, 1 mM DTE, 20% glycerol), resuspended 
in 2 volumes of buffer A (25 mM Tris-HCl pH 7.4, 
50 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTE, 
20% glycerol) and disrupted by dounce homogeniza- 
tion. Nuclei were removed by centrifugation (3,000 x g,
5 min) and the supernatant was first centrifuged for 
20 m in at 20,000 x g, followed by centrifugation at 
100,000 x g for 1 h.
Isolation and cloning o f EEA2
Protein A-agarose beads were coated with SW5, or 
rabbit anti-mouse control antibody, by overnight rota­
tion at 4°C in IPP500 (10 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 0.05% NP-40). HeLa S100 extract (1409 cells) was 
diluted in IPP100 (10 mM Tris-HCl pH 8.0, 100 mM NaCl, 
0.05% NP-40) and incubated with SW5-coated protein 
A-agarose beads for 2 h at 4°C. After extensive washing, 
proteins were eluted in IPP1000 (10 mM Tris-HCl pH 8.0, 
1000 mM NaCl, 0.05% NP-40; 30 min, 4°C), followed 
by acetone precipitation and solubilization in SDS- 
sample buffer. Proteins were resolved by 12% SDS- 
PAGE and stained with Coomassie Brilliant Blue. Bands 
of interest were excised, destained, and subsequently 
digested with trypsin and processed for Q-TOF-mass 
spectrometry (94). Peptide sequences were used to 
identify ESTs, which were used to assemble a contig
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comprising -88% of full-length EEA2. Screening of 
the hum an genome database with this contig led to 
the identification of a sequence that potentially corre­
sponded to the N-terminal part of EEA2. This sequence 
was recently corroborated by the database deposition 
of a new EST (accession num ber BE745186), fully cor­
responding to the sequence derived from the genomic 
library. The complete N-terminal part (aa 1-87) was 
cloned from HeLa genomic DNA by PCR using the 
Advantage-GC cDNA PCR kit (Clontech, Leusden, 
The Netherlands). The remaining part of the coding 
sequence (aa 87-708) was isolated by PCR from a hum an 
placental cDNA library, and fused to the N-terminal part 
encoding aa 1-87 to generate a full length EEA2 cDNA 
(Genbank accession num ber AF312367). The predicted 
protein sequence was analyzed using COILS (http:// 
www.ch.embnet.org/software/coils_form.html), SMART (http:// 
smart.embl-heidelberg.de) and PSORT (http://psort.nibb.ac.jp) 
(205, 229, 230).
Expression constructs
Constructs encoding N-terminally or C-terminallyVSV- 
G-tagged EEA2 fusion proteins, were generated in PCR 
reactions and cloned into pCI-neo (Promega, Leiden, 
The Netherlands). The N-RUN (aa 1-290), N-RUN-CC1 
(aa 1-378), N-RUN-CC12 (aa 1-514), LZ1-CC1 
(aa 205-378), LZ1-CC12 (aa 205-514), LZ1-CC13 
(205-636), LZ1-CC13-FYVE (205-708), N-RUN-CC13 
(aa 1-636), CC13-FYVE (aa 291-708) EEA2 mutants 
were created by PCR and ligated into VSV-G-tag con­
taining pCI-neo. Rab4-pcDNA3 (231) and rab4-pGEX2T 
(228) have been described. Rab11 (232) was cloned in 
the BamHI site of pGEX5X-3 (Pharmacia, Roosendaal, 
The Netherlands) and rab5 (216) in the BcoRI site of 
pGEX1XT and of pEGFP-C2 (Clontech, Leusden, The 
Netherlands).
Subcellular fractionation
HEp-2 cells were trypsinized, washed with ice-cold PBS 
and resuspended in 10 mM Tris-HCl pH 7.4, 10 mM 
NaCl, 3 mM MgCl2 and incubated on ice for 10 min. 
Cells were dounced using a type B pestle and homo- 
genates were centrifuged at 600 x g to pellet nuclei. The 
postnuclear supernatant was centrifuged at 10,000 x g 
to pellet mitochondria. Finally the postmitochondrial 
supernatant was centrifuged at 100,000 x g to generate 
m em brane and cytosol fractions. Pellets were solubi­
lized in the same buffer supplemented with 1% SDS. 
Mitochondria and m em brane fractions were resus­
pended in 20% of the volume of the cytosol and nuclear 
fractions.
Immunoblotting
Western blots containing HeLa S100 extracts, lysates 
from transfected HEp-2 cells, and column fractions 
were prepared, blocked in wash buffer (5% non-fat 
dried milk, 0.1% NP-40, PBS) for 1 h at room tem pera­
ture, and incubated with antibodies against VSV-G tag 
(1:500), EEA2 (1:500), rabaptin5 (1:500), rab4 (1:2000), 
and rab5 (1:1000) for 1 h at room temperature. Bound 
antibodies were visualised by HRP-conjugated second­
ary antibodies followed by chemiluminescence.
Gel filtration
A HeLa S100 extract prepared from 5-107 cells was 
loaded on a Superdex 200 HR 10/30 column (Pharma- 
cia, Roosendaal, The Netherlands), calibrated with thy- 
roglobulin (670 kDa), bovine gamma globulin (158 kDa) 
and chicken ovalbumin (44 kDa). Chromatography was 
performed at a flow-rate of 0.5 m l/m in in 25 mM Tris- 
HCl pH 7.5, 50 mM KCl, 1 mM DTE, 1 mM PMSF
In vitro transcription-translation and GTPase 
binding assay
35S-methionine-labeled EEA2 was synthesized from 
VSV-G-EEA2-pCI-neo using the TNT T7 Quick Cou-
EEA2 ,  a nove l  ear ly  e n d o s o m a l  p r ote i n  81
pled Reticulocyte Lysate System (Promega, Leiden, The 
Netherlands). For immunoprecipitation, protein A-aga- 
rose beads were coated with SW5 and incubated with 
the in vitro translated proteins in IPP300 (10 mM Tris- 
HCl pH 8.0, 300 mM NaCl, 0.05% NP-40) for 1 h at 4°C. 
After extensive washing, bound protein was eluted in 
SDS-sample buffer, separated by SDS-PAGE and visu­
alized by fluorography.
GST, GSTrab4, GSTrab5, and GSTrab11 were expressed 
in E. coli and retrieved on glutathione beads, and the 
am ount of bound protein was estimated from Coo- 
massie Brilliant Blue stained SDS-PAA gels using a 
series of BSA dilutions as standards. Fusion protein 
was charged with GTPyS or GDP as described (217) 
and incubated at 4°C with 35S-labeled EEA2 or m utants 
thereof produced by in vitro transcription-translation. 
Beads were washed 3 times at 4°C with 50 mM HEPES 
pH 8.0, 150 mM NaCl, 5 mM ß-mercaptoethanol, 0.05% 
Tween-20, 1 mM GTPyS or GDP. Bound material was 
eluted with 25 mM reduced glutathione, resolved by 
SDS-PAGE on 10% SDS-PAA gels and analyzed by phos­
phorimaging on a STORM 860. For the analysis of EEA2 
mutants, equal amounts of radiolabeled in vitro trans­
lated proteins were used as input.
Internalization and recycling o f Alexa-labeled Tf
HeLa cells grown on 10 mm round coverslips were incu­
bated for 30 min in serum-free DMEM. For steady state 
internalization experiments, cells were washed once 
with uptake medium  (DMEM, 20 mM HEPES pH 7.4, 
0.5% BSA) and incubated for 30 min with 25 |xg/ml 
Alexa594-Tf at 37°C. The cells were next fixed with 
3% paraformaldehyde for 15 m in at 37°C, followed 
by 30 min of 3% paraformaldehyde at room tem pera­
ture. For pulse chase experiments, cells were washed 
with uptake medium  and incubated with 25 |xg/ml
Alexa594-Tf for 30 m in at 16°C. After one wash with 
DMEM, 20 mM HEPES pH 7.4, 0.5% BSA, the cells 
were re-incubated at 37°C with prewarmed medium 
(DMEM, 20 mM HEPES pH 7.4, 0.5% BSA, 50 pM 
Desferal) for different periods of time and then fixed 
with 2.5% paraformaldehyde. Fixed cells were subse­
quently subjected to immunofluorescence microscopy 
as described below.
Confocal immunofluorescence microscopy
Cells were grown for 24 hrs on 10 mm round cover­
slips, fixed with 3% paraformaldehyde for 45 min and 
quenched with 50 mM NH4Cl in PBS for 5 min. The 
cells were permeabilized for 60 m in in 0.1% saponin,
0.5% bovine serum albumin in PBS (blocking buffer). 
Incubations with prim ary antibodies in blocking buffer 
were done for 45 min. The coverslips were washed three 
times in blocking buffer and then incubated for 30 min 
with appropriate combinations of fluorescently labeled 
secondary antibodies diluted in blocking buffer. Cov­
erslips were m ounted in Mowiol and inspected with a 
63x planapo objective on a Leitz DMIRB fluorescence 
microscope (Voorburg, The Netherlands) interfaced 
with a Leica TCS4D confocal laser microscope (Heidel­
berg, Germany).
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Co-immunoprecipitation studies with SW5, a frequently used and specific mouse monoclonal antibody directed against the human La autoantigen, led to the iden­tification of a functionally unrelated 80-kDa protein, designated early endosome 
antigen 2. EEA2 appeared to be directly targeted by mAb SW5. Since an RNA- 
binding domain, a structural element of La containing the SW5-epitope, was not 
discernable in the primary structure of EEA2, the SW5-epitope on EEA2 was deter­
mined. Coiled-coil region 3 of EEA2 appeared to contain the epitope recognized 
by SW5. The SW5 epitope regions of La and EEA2 share a limited sequence homo­
logy and probably share a higher degree of structural similarity at the tertiary level. 
Most likely, the most critical determinants for recognition by SW5 reside in ele­
ments adopting alpha-helical conformations. These data indicate that the applica­
tion of specific mAbs to purify and characterize (functionally) interacting proteins 
can be severely obscured by the cross-reactivity of mAbs with structurally, but not 
functionally, similar proteins.
Introduction
The hum an  La (SS-B) protein  is an RNA-binding 
phosphoprotein  that is frequently targeted by 
autoantibodies occurring in sera from patients 
w ith diseases like systemic lupus erythem ato­
sus and  Sjögren’s syndrom e (142, 143). This 
abundan t p rotein  has been  identified in  m any 
eukaryotic organism s including Saccharomyces 
cerevisiae, Drosophila melanogaster and Xeno­
pus laevis (144-146). La has been  im plicated in 
RNA polym erase III transcription  and internal 
initiation  of translation (147, 148, 150). The best 
docum ented  function  of La is the binding to 
and  stabilization of newly synthesized RNA poly­
m erase III transcripts and therefore La has been 
proposed to act as an  RNA chaperone ((31) and 
references therein). La binds to its target RNAs 
via three RNP motifs (also known as RNA rec­
ognition motifs), designated RNP-1, RNP-2 and
RNP-3 (31). Structural data obtained w ith other 
RNP m otif containing RNA-binding proteins, 
as for instance nucleolin, revealed that the 
RNP m otif adopts a globular dom ain  w ith a 
ß -a - ß - ß - a - ß  topology (233). The four ß strands 
form  a ß sheet, constituting a potential RNA- 
interaction surface, while the two a  helices are 
positioned on the opposing side of the ß sheet. 
The m ouse anti-La m onoclonal antibody (mAb) 
SW5 recognizes a conform ational epitope in  the 
RNP-2 m otif of La (93). Recently, co-im m unopre- 
cipitation studies w ith SW5 led to the identifica­
tion of a novel 80-kDa protein, designated early 
endosom e antigen 2 (EEA2). EEA2 is a m em ber 
of the FYVE-finger dom ain  protein  family and is 
localized to early endosom es, where it functions 
as a putative bifunctional effector of the small 
GTPases rab5 and rab4 (Chapter 5). The lack of a
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discernable RNP m otif in EEA2 raised the ques­
tion which region of EEA2 is responsible for the 
recognition by SW5. In this study we investigated 
the recognition of EEA2 by SW5 and  show that 
the cross-reactive epitope is located in  coiled- 
coil region 3 of EEA2.
Results
SW5 precipitates EEA2 from a HeLa S100 extract
To identify proteins interacting w ith La we per­
form ed preparative im m unoprecipitations from 
HeLa S100 extracts w ith the mAb SW5. Co-pre­
cipitated p roteins were eluted from SW5-coated 
pro tein  A-agarose beads w ith 1 M NaCl and were 
fractionated by 12% SDS-PAGE. Several proteins 
were specifically isolated from the extract in 
addition to the expected La and  Ro60 proteins 
and  one of these was identified as EEA2 (Chap­
ter 5). To investigate w hether EEA2 also co- 
im m unoprecipitated  from HeLa S100 w ith a 
related anti-La mAb, SW3, we probed  western 
blots of SW5- and SW 3-im m unoprecipitates with 
the rabbit antiserum  SN569, raised against EEA2. 
As shown in Figure 1A, EEA2 was clearly detected 
in  the SW5 precipitate (lane 4), bu t no t in  the 
SW3 precipitate (lane 3). This indicates that EEA2 
is specifically co-im m unoprecipitated  by SW5, 
and  no t by the related mAb SW3. Incubating the 
sam e blot with a rabbit antiserum  raised against 
the h um an  La protein  showed that, as expected, 
the La pro tein  was precipitated  by both  SW3 and 
SW5 (Fig. 1B, lanes 3 and 4).
SW5 cross-reacts with recombinant GST-EEA2 
protein on immunoblots
The efficient co-im m unoprecipitation of EEA2 
by SW5 can be due to either an interaction
EEA2
La
Figure 1. The hum an anti La monoclonal antibody SW5 co­
precip itates EEA2 from  a HeLa S100 extract
(A) SW5, but not SW3, precipitates EEA2 from a HeLa S100 
extract. Protein A-agarose beads coated with the anti-La mAbs 
SW3 or SW5, or beads alone, were incubated with HeLa S100 
extract. Bound proteins were eluted and EEA2 in the eluate was 
detected by immunoblotting using the anti-EEA2 rabbit serum 
SN569. Lane 1, HeLa S100 extract (2% of the amount used in the 
immunoprecipitations); lane 2, beads alone; lane 3, material pre­
cipitated by SW3; lane 4, material precipitated by SW5. (B) Both 
SW3 and SW5 precipitate La from a HeLa S100 extract. Reprob­
ing of the western blot from Figure 1A with an anti-La rabbit 
serum. Lane 1, HeLa extract; lane 2, beads alone; lane 3, material 
precipitated by SW3; lane 4, material precipitated by SW5.
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Figure 2 . SW5 reacts w ith  recom binant GST-EEA2 on immu- 
noblots
A HeLa S100 extract (H) and recombinant GST-EEA2 protein (R) 
were separated using 10%-SDS-PAGE, transferred to nitrocel­
lulose membranes, and the blots were incubated with rabbit 
serum SN569 (anti-EEA2; lanes 1 and 2), mouse mAb SW5 (lanes 
3, 4 and 7) and mouse mAb SW3 (lanes 5 and 6). Bound antibod­
ies were visualized by peroxidase-conjugated secondary anti­
bodies. Arrows indicate the positions of GST-EEA2, EEA2 and La, 
respectively.
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betw een EEA2 and La or to direct recognition 
of EEA2 by SW5. To investigate this, we probed 
w estern blots containing a bacterially expressed 
fusion p ro tein  of EEA2 and GST or a HeLa S100 
extract w ith the anti-EEA2 rabbit serum  SN569 
(Figure 2, lanes 1 and  2), the anti-La mAb SW5 
(Figure 2, lanes 3 and 4) or the anti-La mAb 
SW3 (Figure 2, lanes 5 and 6). SW5 reacted 
w ith recom binant GST-EEA2 on im m unoblots 
(Figure 2, lane 4), in  contrast to SW3, w hich did 
no t react with GST-EEA2 (Figure 2, lane 6). It 
should be no ted  that SW3 is suited for imm u- 
noblotting, as indicated by the efficient detec­
tion of La in  the lane containing the HeLa S100 
proteins (Figure 2, lane 5). As expected, the anti- 
EEA2 serum , which was used as a positive con­
trol for this protein, was reactive w ith both  the 
recom binant and  the HeLa EEA2 pro tein  (Lanes 
1 and 2). Moreover, overexposure of an  im m uno­
blot of a HeLa S100 cell extract probed  with SW5 
showed that SW5 also displays reactivity w ith a 
polypeptide co-m igrating w ith EEA2 (Figure 2, 
lane 7). These results dem onstrate that mAb SW5 
directly interacts w ith EEA2 on  w estern blots. 
This strongly suggests that the im m unopreci-
1 2 3 4 5 6
B
rp rl a
1 2 3 4 5 6
pitation  of EEA2 from  HeLa extracts was due to 
direct targeting of EEA2 by SW5.
SW5 recognizes a structurally related epitope 
in La and EEA2
The results of the im m unoprecipitation  and 
w estern blotting experim ents described above 
strongly suggest tha t SW5 is also reactive w ith the 
folded EEA2 protein  in solution. To confirm  this, 
we subjected in vitro translated, 35S-labeled EEA2 
to im m unoprecipitation  w ith SW5. As shown 
in Figure 3A, lane 2, SW5 indeed im m unopre- 
cipitated EEA2 independen t of the presence 
of the La protein. Similar im m unoprecipitation  
experim ents tha t were done in  the presence 
of increasing am ounts of bacterially expressed 
recom binant hum an  La p ro tein  indicated that 
La com petes for the binding of EEA2 to SW5 
(Figure 3A, lanes 3 - 5). This result indicates that 
EEA2 shares antigenic determ inants w ith La, 
w hich are recognized by mAb SW5. As expected, 
under these conditions recom binant La also 
com peted for the binding of in vitro translated 
La (Figure 3B, lanes 3 - 5).
Figure 3 . Recom binant La com petes w ith  in vitro  translated 
EEA2 for binding to SW5
Protein A-agarose beads coated with the anti-La mAb SW5 were 
incubated with increasing concentrations (0, 0.1, 1 and 10 
recLa) of recombinant La, followed by incubation with in vitro 
translated 35S-methionine-labeled EEA2 (A) or in vitro translated 
35S-methionine-labeled La (B). Subsequently, the beads were 
extensively washed, followed by solubilization of the precipi­
tated protein and analysis by 10%-SDS-PAGE and autoradiogra­
phy. Lane 1, in vitro translated protein (5% of the amount used 
in the precipitations); lane 2, SW5 immunoprecipitation; lanes 
3-5, SW5 immunoprecipitation in the presence of 0.1, 1 and 10 
^g recLa, respectively); lane 6, control precipitation with beads 
alone and 35S-methionine-labeled EEA2 (panel A) or 35S-methio- 
nine-labeled La (panel B).
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SW5 recognizes an epitope in coiled-coil 
region 3 of EEA2
Since SW5 cross-reacted w ith recom binant EEA2 
pro tein  both  on w estern blots and  in solution, we 
were interested  to delineate the region of EEA2
responsible for the recognition by SW5. To inves­
tigate this, we constructed a series of deletion 
m utants of EEA2 (Figure 4A). These m utants, 
as well as wild-type EEA2, were produced  by in 
vitro transcription-translation  (Figure 4B, lanes
Figure 4 . SW5, but not SW 3, b inds to 
in vitro  translated EEA2 v ia  coiled- 
coil region 3
(A) Schematic structure of EEA2 and 
EEA2 mutants. The RUN domain, the 
coiled-coil domains (CC1, CC2 and CC3), 
the FYVE-finger domain and the leu­
cine zipper regions (LZ1 and LZ2) are 
indicated. (B) Immunoprecipitations of 
in vitro translated EEA2 and deletion 
mutants of EEA2. Protein A-agarose 
beads coated with the anti-La mAbs 
SW3 or SW5 were incubated with in 
vitro translated 35S-methionine-labeled 
EEA2 and mutants thereof, and preci­
pitated proteins were analyzed by gel 
electrophoresis and autoradiography. 
Lanes 1-8, in vitro translated proteins 
(5% of the amount used in the pre­
cipitations); lanes 9-16, proteins pre­
cipitated by SW5; lanes 18-25, proteins 
precipitated by SW3; lanes 17 and 26, 
control precipitations with beads alone 
and wild-type 35S-methionine-labeled 
EEA2.
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1 - 8) and  subjected to im m unoprecipitation 
with either SW5 (figure 4B, lanes 9 - 16) or SW3 
(Figure 4B, lanes 18 - 25). All in vitro translated 
EEA2 m utants were reactive w ith the anti-EEA2 
rabbit serum  in im m unoprecipitation  analyses, 
suggesting efficient (re)folding of these proteins 
(data no t shown). The results dem onstrated  
that all m utants of EEA2 lacking coiled-coil 
region 3, nam ely N-LZ1, N-LZ1-CC1, LZ1-CC12 
and  LZ1-CC1, were no t or only very inefficiently 
precipitated  by SW5 (Figure 4B, lanes 10, 13, 
15 and 16), indicating that coiled-coil region 3 
plays an  im portan t role in  the recognition of 
EEA2 by SW5. SW3 did no t detectably precipi­
tate 35S-labeled EEA2 nor its m utants (Figure 4B, 
lanes 18 - 25), in agreem ent w ith the lack of rec­
ognition of EEA2 by SW3. The results of these 
deletion m u tan t analyses are sum m arized in 
Figure 5B.
Coiled-coil region 3 of EEA2 and RNP-2 of La 
share a moderate sequence homology
To investigate the two SW5 epitopes in  m ore 
detail, we com pared the prim ary sequences of 
the RNP-2 m otif of the La p ro tein  and CC3 of 
EEA2 using the CLUSTAL W algorithm  (Figure 5C; 
(113)). The CLUSTAL W alignm ent was per­
form ed using am ino acids 524 to 636 (coiled-coil 
region 3, CC3) of EEA2 and am ino acids 112 to 
183 (RNP-2) of hum an  La. The sequences share 
an  identity  of 18 percent and a similarity of 28 
percent.
Discussion
In this report we describe the recognition of 
EEA2 by the anti-La mAb SW5. The cross-reac­
tivity of SW5 w ith both  recom binant EEA2 in 
im m unoblotting  and  35S-labeled EEA2 in  imm u-
Figure 5 . Com parison o f the SW5 epitopes o f La and EEA2
(A) Schematic structure of human La. The RNP motifs are indi­
cated by RNP-1, RNP-2 and RNP-3, and the nuclear localization 
signal is indicated by NLS. The region recognized by SW5 is indi­
cated. The predicted secondary structure of the region contain­
ing the SW5 epitope (RNP-2) is depicted in the lower scheme. 
The arrow marks the position of glutamate-132, which plays an 
important role in the recognition of La by SW5. Beta strands 
are indicated by ß1, ß2, ß3 and ß4, alpha helices by a1 and a2.
(B) Schematic structure of human EEA2. The RUN domain, the 
coiled-coil domains (CC1, CC2 and CC3), the FYVE-finger domain 
and the leucine zipper regions (LZ1 and LZ2) are indicated. The 
region recognized by SW5 is indicated. (C) Sequence compari­
son of coiled-coil region 3 of EEA2 and RNP-2 motif of La. The 
glutamate at position 132 in the La protein is indicated by an 
asterisk.
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noprecipitation  assays indicated that SW5 recog­
nizes an  epitope on  EEA2. Our previous studies 
have shown that SW5 specifically interacts with 
a structural epitope located w ithin the RNP-2 
m otif of La (93). Surprisingly, such a structural 
elem ent does no t seem  to occur in EEA2. Never­
theless, the recom binant La protein  was shown 
to com pete for the binding of EEA2 by SW5. 
Analysis of a series of deletion m utants of EEA2 
revealed that the epitope recognized by SW5 is 
located in coiled-coil region 3 (CC3) of EEA2. 
A sequence com parison of the CC3 region of 
EEA2 and the SW5 epitope region of La (RNP-2), 
showed that both  regions share som e am ino acid 
sequence homology. A clue for the basis of the 
cross-reactivity of SW5 cam e from the obser­
vation that SW3 did no t cross-react w ith EEA2. 
Both SW3 and SW5 recognize an epitope w ithin 
the RNP-2 m otif of La, bu t their epitopes are 
clearly distinct. The recognition by SW5 is criti­
cally dependent on  a glutam ate residue at posi­
tion 132 (indicated by an arrow in  Figure 5A), 
whereas the recognition by SW3 is no t influ­
enced by the substitution  of this residue. In 
addition, SW5 has been  shown to co-precipitate 
m ost, if no t all, La associated RNAs from a cell 
extract, whereas SW3 co-precipitates only a spe­
cific subset of La RNPs (93). These data indicate 
that SW5 and  SW3 recognize structurally differ­
en t epitopes in  the RNP-2 m otif of La. The SW3 
epitope is p robably at least in part form ed by the 
ß sheet (the putative RNA interaction  site of RNP 
motifs; (234, 235)) of the RNP-2 motif, since the 
binding of m any RNAs to La seem s to interfere 
w ith the accessibility of the SW3 epitope (93). 
The SW5-epitope of La, on  the o ther hand, is 
probably located on  the opposite side of the ß 
sheet (with respect to the RNA interaction sur­
face), w here the two alpha-helices of the RNP-2
m otif are located, which is consistent with the co­
precipitation of La associated RNAs (93). W hen 
the sequence of the RNP-2 m otif of La is m od­
eled on the existing structures for RNP motifs, 
the position  of glutamate-132 is found at the 
C-term inal border of the a1-helix (Figure 5A). 
The whole SW5-epitope on EEA2 (CC3 region, 
Figure 5B) m ost likely adopts an  a-helical struc­
ture (223). These data strongly suggest that 
the key residues of the SW5 epitope reside in 
a-helices, p resen t in  both  La and  EEA2. W hat do 
our findings tell us about the reactivity of SW5 
w ith other cellular proteins containing coiled- 
coil regions? The fact that SW5 is only reactive 
w ith the CC3 region of EEA2, bu t no t w ith CC1 
or CC2, suggests that the reactivity of SW5 with 
coiled-coil structures is no t a general phen o ­
m enon.
The hum an  La p ro tein  is a well-known au to ­
antigen and autoantibodies against this protein 
are com m only found in  sera of patients suf­
fering from  systemic lupus erythem atosus and 
Sjögren’s syndrom e (236). The observed cross­
reactivity of the anti-La mAb SW5 prom pted  us 
to investigate w hether hum an  anti-La au toan­
tibodies are also cross-reactive w ith EEA2. Fifty 
hum an  sera including 25 sera w ith anti-La reac­
tivity were tested for reactivity with recom binant 
EEA2. The results showed that none of the fifty 
sera tested reacted with recom binant EEA2 (data 
no t shown). From these data we concluded that 
EEA2 is no t autoantigenic, and that anti-La au to ­
antibodies do no t cross-react w ith EEA2. 
Cross-reactivity of antibodies is no t uncom m on. 
For example, antibodies im m unoadsorbed to 
lam inin have been  reported  to cross-react with 
the hum an  La pro tein  (237, 238). In this case 
the lam inin/La epitope consisted of a linear epi­
tope, p resent in  both  proteins (239). On the
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other hand, cross-reactivity due to epitopes that 
share higher order similarities is m uch less docu­
m ented  in the literature. Several reports have 
described the cross-reactivity of the anti-Sm 
mAb Y12, w hich recognizes the Sm proteins B, 
B’, N, D1, D3 and  E proteins (168, 240, 241), with 
the functionally unrelated  ribosom al pro tein  S10 
(242). Detailed analyses revealed that Y12 rec­
ognizes a conform ational epitope w ithin both 
the target Sm -proteins and  the S10 protein  (242). 
Similar to w hat we describe here for the SW5 epi­
tope, the Y12 epitope spontaneously  renatured  
on  w estern blots after SDS-PAGE (242).
As illustrated in this report by the cross-reac­
tivity of SW5, the application of specific mAbs 
to purify and characterize proteins interacting 
with the p rotein  targeted by the antibody can be 
severely obscured by the cross-reaction of the 
antibody w ith structurally, bu t no t functionally, 
related proteins. As a consequence data obtained 
by studies in which such antibodies are applied, 
e.g. for im m unodepletion  or im m unopurifica- 
tion, should be interpreted  w ith great care.
Materials and methods
Antibodies
The monoclonal antibodies against the hum an La/SS-B 
autoantigen (SW5 and SW3) have been previously 
described (93, 243). Polyclonal antisera against EEA2 
were generated by immunizing rabbits with KLH-con- 
jugated peptides corresponding to amino acids (aa) 
93-107, and 302-316, respectively. Polyclonal antisera 
against La have been described (244). Peroxidase- 
conjugated swine anti-rabbit and horseradish perox­
idase-conjugated rabbit anti-mouse were from Dako 
Immunoglobulins (Glostrup, Denmark).
Cell extracts
HeLa S100 extracts for western blot analyses and im m u­
noprecipitation analyses were prepared using cells pur­
chased from Computer Cell Culture Center (Mons, 
Belgium). Briefly, HeLa cells were washed twice in iso­
tonic buffer (10 mM Tris-HCl, pH 7.9, 140 mM KCl,
1.5 mM MgCl2, 1 mM EDTA, 1 mM DTE, 20% glycerol), 
resuspended in 2 pellet volumes of buffer A (25 mM 
Tris-HCl, pH 7.4, 50 mM KCl, 1.5 mM MgCl2, 1 mM 
EDTA, 1 mM DTE, 20% glycerol) and disrupted by 
dounce homogenization. Nuclei were separated by 
centrifugation (3,000 x g, 5 min) and the supernatant 
was first centrifuged for 20 min at 20,000 x g, followed 
by centrifugation at 100,000 x g for 1 h.
Constructs and recombinant protein expression
For in vitro transcription/translation an N-terminally 
VSV-G-tagged La protein construct was used (59). 
Recombinant hum an La was expressed and purified 
as described previously (41). An N-terminally VSV- 
G-tagged hum an EEA2 construct has been described 
(Chapter 5). M utants of EEA2 were generated using a 
PCR-based approach by amplifying the desired regions 
of EEA2 using gene-specific primers and the full-length 
EEA2 cDNA as template. The following m utants were 
made: N-RUN (aa 1 to 290), CC13-FYVE (aa 291 to 
708), N-RUN-CC13 (aa 1 to 636), N-RUN-CC1 (aa 1 
to 378), LZ1-CC13 (aa 205 to 636), LZ1-CC12 (aa 205 
to 514) and LZ1-CC1 (aa 205 to 378). The integrity 
of all constructs was confirmed by DNA sequencing. 
A GST-EEA2 fusion-protein construct was generated 
by inserting the full-length EEA2 cDNA in-frame to a 
GST-encoding sequence from the pGEX-4 vector (Phar- 
macia, Roosendaal, The Netherlands). GST-EEA2 was 
expressed and purified according to protocols sup­
plied by the manufacturer (Pharmacia, Roosendaal, 
The Netherlands).
SW5 c r os s - r eac ts  w i t h  EEA2 91
Immunoprecipitation
Protein A-agarose beads (10 |xl packed beads) were 
coated with anti-La mAbs SW3 or SW5 (500 |xl of culture 
supernatant; mAb concentration approx. 20 |xg/ml) by 
overnight incubation at 4°C in IPP500 (10 mM Tris-HCl, 
pH 8.0, 500 mM NaCl, 0.05% NP-40). A HeLa S100 
extract (from 5-106 cells) diluted in IPP100 (10 mM Tris- 
HCl, pH 8.0, 100 mM NaCl, 0.05% NP-40) was mixed 
with either the SW5-coated protein A-agarose beads, or 
SW3-coated beads, or beads alone, and rotated for 2 h 
at 4°C. After extensive washing, co-precipitated pro­
teins were solubilized in SDS-sample buffer, separated 
by 12%-SDS-PAGE, followed by transfer to nitrocellu­
lose and immunoblotting.
Immunoblotting
Western blots containing either HeLa S100 extracts or 
recombinant EEA2 were prepared, blocked in blotting 
buffer (5% non-fat dried milk, 0.1% NP-40, PBS) for 1 h 
at room temperature, and incubated with either m ono­
clonal antibodies SW5 or SW3 diluted 1:100 in wash 
buffer or anti-EEA2 rabbit serum SN569 diluted 1:500 
in blotting buffer for 1 h at room temperature. After 
washing with blotting buffer, bound antibodies were 
detected by incubation with horseradish peroxidase- 
conjugated rabbit anti-mouse IgG (for SW3 and SW5) 
or horseradish peroxidase-conjugated swine anti-rab­
bit IgG (for SN569), followed by chemiluminescence.
In vitro translation and immunoprecipitation
In vitro translated 35S-methionine-labeled wild-type 
EEA2 or La protein were synthesized using the TNT 
T7 Quick Coupled Reticulocyte Lysate System (Pro- 
mega, Leiden, The Netherlands), using the VSV-G- 
tagged versions of EEA2 and La in the pCI-neo vector 
as templates. For immunoprecipitation analysis, pro­
tein A-agarose beads were coated with SW5 or SW3 
as described above. 35S-methionine-labeled EEA2 or La 
proteins were incubated with the mAb-coated beads in 
IPP300 (10 mM Tris-HCl, pH 8.0, 300 mM NaCl, 0.05% 
NP-40) for 1 h at 4°C. After extensive washing, bound 
protein was eluted in SDS-sample buffer, separated 
by SDS-PAGE and visualized by autoradiography. For 
competition assays, the mAb-coated beads were pre­
incubated with increasing am ounts of recom binant La 
(0, 0.1, 1 and 10 |xg recLa) prior to the incubation with 
35S-methionine-labeled EEA2 or La proteins.
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S ince the discovery of the Ro RNPs in 1981 (7, 8) major efforts have been made to characterize these RNA-protein complexes in organisms ranging from humans to Caenorhabditis elegans. Although these efforts resulted in a large body of experi­
mental data (see reviews (35, 96)), as yet no biochemical function could be assigned 
to these complexes. The aim of the studies described in this thesis was to identify 
novel protein subunits of the human Ro RNPs, or proteins interacting with Ro RNPs, 
which might contribute to the elucidation of the function(s) of these enigmatic par­
ticles. Because the core proteins of Ro RNPs are expected to play an important role 
in such interactions, we analyzed the Ro60 protein in more detail. In this chapter the 
results presented in this thesis will be discussed.
Analysis of the human Ro60 
protein
A detailed analysis of the post-translational 
m odifications of the Ro60 p ro tein  purified from 
HeLa cells (Chapter 2) resulted in  the identifica­
tion of serine-265 as a phosphorylated  residue. 
We showed tha t phosphorylation of serine-265 
by a yet unknow n protein  kinase leads to a 
reduced accum ulation  of Ro60 in  the nucleus. 
The analysis of the phosphorylation state of Ro60 
during several types of cell-stress (heat stress, 
irradiation w ith UV and apoptosis) and  during 
the cell cycle did no t reveal detectable changes 
(unpublished results). Hence, the significance of 
this finding is currently unknown, although sev­
eral possibilities can be envisioned. Simons et 
al. showed that Ro60 is involved in  the nuclear 
export process of hY1 RNA m olecules in  X. laevis 
oocytes (71). It thus is possible that phosphory­
lation  of serine-265 m odulates this export p ro­
cess. Alternatively, the phosphorylation state of
serine-265 m ay m odulate pro tein-protein  in ter­
actions as has been  observed for m any other 
proteins. For instance, phosphorylation of the 
SR protein  ASF/SF2 affects the interaction  with 
several p rotein  partners including the U1-70K 
pro tein  (106). Recently, the association of Ro60 
w ith the cytoplasmic phosphoprotein  pp75 has 
been  described (91). It w ould be interesting 
to investigate w hether phosphorylation of 
serine-265 m odulates this interaction. In addi­
tion, the phosphorylation m ight induce subtle 
changes in  the RNA-binding capacity of Ro60, 
although we did no t detect significant differences 
in  hY RNA binding by m utation  of serine-265. In 
conclusion, it is evident tha t Ro60 interacts with 
various cellular proteins and  RNAs, and  in  p rin ­
ciple all these interactions m ight be m odulated 
by phosphorylation of serine-265.
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Immunoaffinity purification of Ro60- and 
La-associated proteins from a HeLa cell 
extract
The search for novel Ro RNP-associated proteins 
was driven by two reasons: first, the identifica­
tion of additional Ro RNP-proteins could shed 
light on  the elusive function(s) of these particles; 
and  second, the discrepancy betw een the cal­
culated m olecular m ass of the Ro RNPs (based 
upon  the known com ponents) and  the observed 
m olecular m ass (estim ated to be betw een 150 
and  600 kDa; Chapter 3 and (34, 42, 58)) ind i­
cated that such additional proteins m ust exist. 
Using a variety of approaches including yeast 
two- and three-hybrid assays and in vitro recon­
stitution  of Ro RNPs, several groups have iden­
tified a num ber of putative Ro RNP-associated 
proteins (58, 59, 67, 68, 91). Of these proteins, 
only the association of heterogeneous nuclear 
ribonucleoprotein  I (hnRNP I) with hY1 and  hY3 
RNPs has been  proven conclusively (59). The 
availability of m onoclonal antibodies against 
Ro60 (mAb 2G10) and La (mAb SW5), suited 
for im m unoprecipitation  of Ro RNP complexes 
from HeLa cell extracts (92, 93), p rom pted  us 
to use these antibodies for im m unoaffinity puri­
fications as an alternative approach to identify 
novel Ro RNP-associated proteins. Putative Ro 
RNP-associated proteins (i.e. proteins co-puri­
fied w ith both  Ro60 and La, the two core proteins 
of the hum an  Ro RNPs (8, 29, 34)) were excised 
from the gel and subjected to m ass spectrom etry 
to determ ine their identity. An overview of the 
results obtained by this approach is given in 
Figure 1 and Table 1.
Since the anti-Ro60 im m unoprecipitate (Figure 1, 
lane 3) reproducibly contained sm aller am ounts 
of protein  than  the anti-La im m unoprecipitate 
(Figure 1, lane 4), we focussed on the latter in our
initial attem pts to identify Ro RNP-associated 
proteins. Due to the presence of PEST regions 
in  the La protein, La is susceptible to proteolytic 
cleavage. This cleavage often results in  degrada­
tion products of 23, 29 and 43 kDa (36, 245, 246). 
The presence of the degradation products (of 
29 kDa and 43 kDa) in  the anti-La im m unopre­
cipitate could possibly interfere with the detec­
tion of co-precipitated proteins w ith a similar 
m olecular mass. Therefore, we chose to inves-
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Figure 1. O verv iew  of p roteins co-purified w ith  Ro60 and La 
from  a HeLa cell extract
Protein A-agarose beads coated with anti-Ro60 mAb 2G10 
(anti-Ro60) and anti-La mAb SW5 (anti-La) via a rabbit anti­
mouse IgG bridge, were incubated with a HeLa S100 extract 
(from 1109 cells) and after washing of the beads co-precipitated 
material was eluted by 1 M NaCl and analyzed by SDS-PAGE. 
Proteins were visualized by Coomassie Brilliant Blue staining. 
Lane 1,molecular weight markers (kDa); lane 2, control precipita­
tion (rabbit anti-mouse IgG); lane 3, 2G10 immunoprecipitation; 
lane 4, SW5 immunoprecipitation. Arrows indicate the positions 
of hnRNP U, nucleolin, DDX15, EEA2, Ro60 and La and asterisks 
mark immunoglobulin heavy and light chains.
hnRNP U 
■«—-  nucleolin 
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'  EEA2 
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tigate only proteins migrating above the Ro60 
protein  (60 kDa). In the anti-La im m unopre- 
cipitate the following proteins were identified: 
hnRNP U (molecular weight of ~115 kDa), 
nucleolin (~100 kDa), DDX15 (~92 kDa) and 
EEA2 (~80 kDa). W hereas the band  identified 
as nucleolin was also visible in the anti-Ro60 
im m unoprecipitate, all the other bands used for 
p rotein  identification (hnRNP U, DDX15, EEA2) 
were only visible in  the anti-La im m unopre­
cipitate. In subsequent attem pts we chose to 
use tw o-dim ensional isoelectric focussing/SDS- 
PAGE instead of one-dim ensional SDS-PAGE to 
fractionate the anti-Ro60 im m unoprecipitates. 
This im proved the detection of co-precipitated 
proteins considerably. The use of this m ethod 
yielded the identification of three proteins in 
the anti-Ro60 im m unoprecipitate (not depicted 
in  Figure 1), nam ely RoBPI (~60 kDa), hnRNP I 
(~60 kDa) and pro tein  L-isoaspartyl m ethyltrans- 
ferase (PIMT; ~25 kDa). All data are sum m arized 
in  Table 1, and a short discussion of these find­
ings is given below.
Nucleolin, hnRNP I and RoBPI
We identified nucleolin as a novel pro tein  associ­
ated  w ith hY1 and  hY3 RNPs (described in  C hap­
ter 3). A sem i-quantitative analysis indicated that 
about fifty percent of hY1 and  hY3 RNPs in HeLa
cells contain nucleolin. Although the m ajority of 
nucleolin  is localized to the nucleolus, a signifi­
cant fraction of it is cytoplasmic (for reviews see 
(120, 121)). Conversely, the hY1 and hY3 RNPs 
alm ost exclusively reside in  the cytoplasm  (18, 
30, 40, 73). Thus, probably only a m inority  of 
nucleolin  seems to be associated w ith the hY1 
and hY3 RNPs.
In vitro RNA-binding assays showed that the 
internal pyrim idine-rich Loop 2 of hY1 RNA is 
needed  for the association of nucleolin. Previ­
ous work by Fabini and co-workers revealed that 
hnRNP I and K interact w ith the sam e region of 
the hY1 RNA m olecule (58, 59). This suggests that 
nucleolin, hnRNP I and hnRNP K either b ind to 
Loop 2 in  close proxim ity to each o ther on  the 
sam e hY1 RNA molecule, or that their binding 
to the central pyrim idine-rich region is m utually 
exclusive. A third possibility is that com bina­
tions of the three proteins associate w ith this 
region on  hY1 RNA via nucleolin, because it has 
no t been investigated if hnRNP I and hnRNP K 
directly contact Loop 2 (59). The latter possibil­
ity is no t very likely because both  hnRNP I and 
K have b een  shown to posses RNA-binding acti­
vity (60-62). Alternatively, nucleolin m ay recruit 
other proteins to the hY1 and hY3 particles. In 
this respect it is im portan t to note tha t nucleolin 
is known to associate w ith a variety of proteins
Protein name MW (kDa) a-Ro60 a-La Remarks
PIMT 25 + nd a-specific binding to 2G10?
hnRNPI 60 + nd associates with hY1 and hY3 RNPs (59)
RoBPI 60 + nd associates with hY5 RNPs (68)
EEA2 80 nd + directly recognized by SW5
DDX15 92 nd + protein-protein interaction with La
nucleolin 100 + + associates with hY1 and hY3 RNPs
hnRNPU 115 nd + putative protein-protein interaction with La
Table 1. Sum m ary o f proteins co-purified w ith  Ro60 and La from  a HeLa cell extract.
+: detected in immunoprecipitate; MW: molecular weight in kDa; nd: not determined.
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including several ribosom al proteins (119) and 
transcription  factors (247, 248). The two proteins 
w ith m olecular weights of 68 kDa and 80 kDa, 
identified by Fabini et al. m ay represent such 
proteins since they also need  Loop 2 for their 
association w ith the hY1 RNA molecule (58, 59). 
In conclusion, we hypothesize tha t nucleolin 
plays a role in  the biogenesis of (a subset of) 
hY1 and  hY3 RNPs, facilitating the association 
of other proteins w ith these complexes (see Bio­
genesis of the Ro RNPs and  Figure 2).
Using the sam e im m unoaffinity purification 
approach as described above, hnRNP I and 
RoBPI were identified as proteins associated with 
Ro60 from  a HeLa cell extract (our unpublished 
results). These data corroborate the observations 
of other researchers indicating that these p ro ­
teins are associated w ith subsets of the hum an 
Ro RNPs (59, 68). Moreover, the purification of 
hnRNP I and RoBPI substantiates the suitability 
of our m ethod  to find novel Ro RNP-associated 
proteins.
DDX15
A pro tein  with an  apparent m olecular m ass of 
92 kDa, detectable in  the anti-La im m unopre­
cipitate, bu t absent in  b oth  the anti-Ro60 preci­
p itate and  the control precipitate (Figure 1) was 
identified as DDX15 (described in  Chapter 4). 
The association of DDX15 w ith La was shown to 
be due to a direct pro tein-protein  interaction, 
thus independen t of RNA. The low efficiency 
of the co-precipitation of DDX15 with La sug­
gests tha t only a fraction of the total pool 
of La and DDX15 interact in  the cell. Rabbit 
antisera raised against DDX15 failed to precipi­
tate hY RNAs from a HeLa extract, whereas seve­
ral U snRNAs were co-precipitated, suggesting
that DDX15 does no t associate w ith hum an  Ro 
RNPs.
DDX15 belongs to the superfam ily of DExD/ 
H-box RNA helicases (167). The putative RNA 
helicases, also called ‘unw indases’, function in 
a variety of cellular processes involving RNA, 
including ribosom e biogenesis, pre-mRNA edit­
ing and splicing, RNA export and RNA degrada­
tion (for reviews see (137, 138, 170)). Although 
several RNA helicases of the DExD/H-box family 
have been  shown to possess RNA helicase acti­
vity (249-251), it is currently unknow n if also 
DDX15 is capable of unw inding RNA duplexes, 
and w hether this unw inding is ATP dependent. 
Initial a ttem pts to investigate this function were 
ham pered  by the failure to express DDX15 as 
a GST-fusion protein  in Escherichia coli (our 
unpublished results). La has been  shown to 
be capable of unw inding DNA-RNA hybrids 
and double-stranded RNA in an ATP-dependent 
m anner (153-155), although recently the double­
stranded RNA-unwinding activity of La has been 
questioned (156). It is tem pting to speculate that 
DDX15 contributes to this La-associated heli- 
case activity, bu t this is no t very likely since in 
the studies m entioned  above either recom binant 
La, or La purified to hom ogeneity was used.
The surprising presence of DDX15 in nucleoli 
in addition to nuclear speckles (described in 
Chapter 4) suggests that DDX15 functions in 
additional processes besides pre-mRNA splicing 
(139-141). Since also part of the La p ro tein  has 
been  shown to reside in the nucleolus (96), 
we speculate that in the nucleolus La recruits 
DDX15 to RNA polym erase III transcripts, e.g. 
U6 RNA, 5S rRNA and SRP RNA, where DDX15 
m ight be required for the further processing of 
these RNAs in the early phases of their b iogen­
esis. Proof of this hypothesis m ight be obtained
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by studies in  yeast (Saccharomyces cerevisiae) 
strains defective in Lh1p (the yeast ortholog of 
La) and  Prp43 (the yeast ortholog of DDX15) 
expression.
EEA2
The characterization of the novel 80-kDa p ro­
tein  early endosom e-associated antigen 2 (EEA2) 
w hich was specifically precipitated by the anti-La 
mAb SW5 (Figure 1, Lane 4), showed that this 
p rotein  represented a novel m em ber of the family 
of FYVE-finger dom ain  proteins (Chapter 5). Sur­
prisingly, EEA2 did no t associate w ith La bu t was 
directly recognized by the anti-La m onoclonal 
antibody SW5. Subsequent analysis of the recog­
nition of EEA2 by SW5 revealed an SW5-cross- 
reactive epitope in  coiled-coil region 3 of EEA2 
(Chapter 6).
EEA2 is a hydrophilic protein  containing three 
coiled-coil dom ains, two leucine zipper motifs, 
a RUN dom ain, and  a FYVE-finger dom ain. The 
prim ary structure of EEA2 displays some hom o­
logy to EEA1 (207), particularly in  the FYVE-fin- 
ger dom ain. In vitro binding studies showed that 
rab5 and rab4, b u t no t rab11, in their GTP-bound 
form  directly interact w ith EEA2. These in ter­
actions suggest that EEA2 m ay coordinate rab4 
and rab5 function on early endosom es, bu t no t 
on  recycling endosom es w here rab11 is local­
ized (213, 220, 221, 252). Indeed, expression of a 
dom inant negative EEA2 m u tan t reduced in ter­
nalization, and recycling of transferrin from  early 
endosom es, suggesting that it m ay be function­
ally linked to the sm all GTPases rab4 and rab5. 
Recent data indicate tha t rab4 and rab5 can bind 
sim ultaneously to EEA2 in vitro (unpublished 
results), suggesting that EEA2 is a bifunctional 
rab effector. In addition to EEA2 several other 
divalent effectors binding to both  rab4 and rab5
are known, including rabaptin-5, rababtin-5b, 
rabex-5 and  rabenosyn-5 (215, 253, 254). 
Previous studies have shown tha t rab5, rab4, and 
rab11 containing endosom es are reached in this 
order by endocytosed transferrin  (222). Sönnich- 
sen  et al. confirm ed these data, and also showed 
that pairs of these sequentially acting rab p ro ­
teins had distinct though partially overlapping 
distributions (202). It is thought tha t rab proteins 
m ay form  dom ains in the lateral plane of a m em ­
brane by recruiting effectors and other interact­
ing m olecules to control a specific m em brane 
transport event (201). The sequential transport 
of cargo (e.g. transferrin) through early endo­
som al dom ains selectively occupied by rab p ro ­
teins implies that m echanism s m ust exist to 
coordinate these events. Our data suggest that 
EEA2 (possibly in  the context of the large cyto­
solic complex we identified) m ight regulate the 
functional link betw een rab5 and  rab4 domains, 
and thus the transition  of cargo betw een them. 
Various questions still need  to be answered, e.g. 
w hich proteins are associated w ith the cytosolic 
complex associated with EEA2 and  w hat is the 
exact role of EEA2 in the transferrin pathway.
hnRNPU
H eterogeneous nuclear ribonucleoprotein U 
(hnRNP U) migrating at approxim ately 115 kDa 
was identified in  the anti-La im m unoprecipi­
tate, whereas it was no t detectable in both  the 
anti-Ro60 im m unoprecipitate and  the control 
precipitate (Figure 1). In agreem ent w ith this, 
specific antisera against hnRNP U failed to co­
precipitate hY RNAs from a HeLa extract, sug­
gesting that hnRNP U does no t associate with 
h um an  Ro RNPs (unpublished results).
HnRNP U is also known as Scaffold A ttachm ent 
Factor A (SAF-A) since it is known to b ind scaf­
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fold a ttachm ent region DNA sequences, thereby 
playing a role in the higher order organization 
of chrom atin (255). In addition to binding to 
DNA, hnRNP U has b een  shown to be capable of 
binding RNA via its RGG box (256). By forming 
hnRNP particles w ith nascen t RNA polym erase
II transcripts in the nucleoplasm  it functions in 
pre-mRNA processing (64, 65).
We did no t extensively pursue the putative in ter­
action betw een La and hnRNP U. However, 
prelim inary experim ents suggest tha t La and 
hnRNP U interact directly in vitro (our u np ub ­
lished results). Despite the fact that b oth  La and 
hnRNP U have been  described to play a role in 
the life cycle of vesicular stom atitis virus (165, 
257), the possible functional im plications of this 
interaction in uninfected cells are no t clear and 
p rom pt further exploration.
PIMT
Protein L-isoaspartyl m ethyltransferase (PIMT; 
EC 2.1.1.77) was identified in  the anti-Ro60 
im m unoprecipitate, in  addition to hnRNP I and 
RoBPI (see above). PIMT is a highly conserved 
cytosolic enzyme tha t catalyzes the methyles- 
terification of unusual D-aspartyl and L-aspartyl 
residues in  proteins (258). Expression of VSV- 
G-tagged versions of hum an  PIMT, followed 
by im m unoprecipitation  analysis of the VSV-G- 
tagged p roteins and the isolation and analysis of 
the co-precipitated RNAs, did no t reveal detect­
able am ounts of Y RNAs. Moreover, we failed 
to dem onstrate the co-precipitation of Ro60 by 
PIMT from HeLa cell extracts using polyclonal 
anti-PIMT antibodies (our unpublished results). 
It has been  described that antibodies becom e 
deam idated during prolonged storage, thereby 
becom ing a target for PIMT (259). Therefore it is 
possible that PIMT bound  directly to the 2G10
mAb during the im m unoaffinity procedure and 
hence was co-purified w ith Ro60. Thus, the co­
precipitation of PIMT with Ro60 is probably n o n ­
specific and should be disregarded.
In conclusion, the im m unoaffinity purification 
m ethod  used in  our studies yielded several Ro 
RNP-associated proteins (nucleolin, hnRNP I and 
RoBPI), two La-associated proteins (DDX15 and 
hnRNP U), one protein  directly recognized by the 
anti-La mAb SW5 (EEA2) and one non-specifi- 
cally co-precipitated pro tein  (PIMT). Thus, this 
approach represents a good alternative for other 
m ethods (e.g. the yeast three-hybrid system) p re­
viously em ployed by other researchers to search 
for Ro RNP-associated proteins (58, 67, 91).
Biogenesis of the Ro RNPs
The identification of nucleolin as a p ro tein  sub­
unit of hY1 and hY3 RNPs led us to suggest a 
role for this p ro tein  in  the biogenesis of (subsets 
of) the Ro RNPs (Chapter 3 and Figure 2). Based 
upon  all available data the following m odel for 
Ro RNP biogenesis can be envisaged. During or 
shortly after transcription  of the hY RNAs by 
RNA polym erase III in  the nucleoplasm , the hY 
RNAs are bound  by La, the binding of which 
efficiently retains the hY RNA m olecules in the 
nucleus (71, 73). By in situ hybridization experi­
m ents M atera and co-workers have previously 
detected  the hY1, hY3 and hY5 RNAs, bu t no t hY4 
RNA, in  the perinucleolar com partm ent (PNC) 
(25). The newly transcribed La-associated hY1 
and hY3 RNAs m ay first move to and  accum ulate 
in  the PNCs. In the PNCs the La-hY1 and  La-hY3 
RNPs possibly associate w ith hnRNP I, which 
recently has been  reported  to interact w ith hY1
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CaR ?
NUCLEUS CYTOPLASM
Figure 2 . Hypothetical model for the assem bly and nuclear export o f the hY1 RNP
It should be noted that this assembly pathway is hypothetical and currently it is unknown if, for instance hnRNP I is present in the 
same hY1 RNP as nucleolin. The stages during the assembly process where e.g. Ro52, calreticulin, a 65-kDa protein, a 80-kDa protein 
and hnRNP K possibly associate with the complex are not known. Furthermore, it is unknown if nucleolin and hnRNP I remain associ­
ated with the hY1 RNP in the cytoplasm following nuclear export. CaR, calreticulin; K, hnRNP K; I, hnRNP I, NPC, nuclear pore complex; 
Nuc, nucleolin; PNC, perinucleolar compartment; ST2BF, stem 2 binding factor.
and  hY3 RNPs (59) and w hich has been  detected 
in  the PNCs as well (25). Alternatively, hnRNP I 
m ay be involved in  the transport of hY1 and  hY3 
RNA to the PNCs. The presence of these RNAs 
in  the PNCs, which are tightly associated with 
the nucleoli, m ay allow the interaction  of nucle­
olar nucleolin w ith these RNAs. This m ight be 
a signal for further transport, w hich m ay p ro­
ceed either through the nucleoli or directly to 
the nuclear envelope. During the intranuclear 
m igration the p ro tein  m oiety of the hY RNPs 
m ay becom e even m ore complex due to the 
association of o ther proteins, like RoBPI and 
hnRNP K (59, 68) (Figure 2). Nuclear export fur­
ther requires the association of Ro60 and Stem 2 
binding factor (ST2BF), which both  associate
w ith the m ost conserved parts of the Y RNAs 
(66, 71). It is unclear at which stage during the 
nuclear transport process the latter factors asso­
ciate w ith the RNAs. M ost likely, this is a rel­
atively late event given that both  proteins are 
involved in nuclear export and that Ro60 is nei­
ther detectable in PNCs nor in  nucleoli. In view 
of the nucleocytoplasm ic shuttling behavior of 
nucleolin  (122) it is tem pting to speculate that 
nucleolin  rem ains associated w ith hY1 and  hY3 
RNPs during their nuclear export. Prior to export 
to the cytoplasm  the La protein  is either released 
from the Y RNPs or m odified in  such a way that 
its nuclear reten tion  function  is tu rned  off (71, 
73). In the cytoplasm  nucleolin m ay dissociate 
from these RNAs and re tu rn  to the nucleolus.
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Although hY5 RNA was also detectable in the 
PNCs, the lack of association of both  hnRNP I 
and  nucleolin w ith hY5 RNPs implies tha t a sim i­
lar transport m odel as outlined above for hY1 
and  hY3 RNA does no t apply to hY5 RNA. Indeed, 
recent data indicate that hY5 RNPs, associated 
w ith RoBPI (68), rem ain  in  the nucleus (74). The 
biogenesis pathw ay of hY4 RNPs is currently 
even m ore elusive, although hY4 RNPs are likely 
to accum ulate also in  the cytoplasm  (18, 30, 40, 
73).
Recent data indicate that o ther RNA polym erase
III transcripts including U6 small nuclear RNA 
(127) and the RNA com ponent of RNase P (128) 
pass through the nucleolus during the early 
phases of their life cycles. Of particular interest 
in this respect is the fact that also the RNA 
com ponent of the signal recognition particle 
(SRP) (129, 130) is transiently associated w ith the 
nucleolus. Like the hY RNAs, SRP RNA is an RNA 
polym erase III p roduct and does no t undergo 
post-transcriptional m odifications (8, 10, 131). It 
thus seem s feasible that subsets of the Ro RNPs 
pass through the PNC and nucleolus on their 
way to the cytoplasm  where they can carry out 
their function(s).
Possible functions of the Ro 
RNPs
Data obtained by us and  other researchers on 
the com position of the hum an  Ro RNPs ind i­
cate that several subpopulations of these parti­
cles exist (Chapter 3 and  (34, 42, 58, 59, 68, 72). 
As a result of this heterogeneity  these subpop­
ulations m ay have different cellular functions. 
The cytoplasmic accum ulation of hY1, hY3 and 
hY4 RNPs suggests that these particles function
in the cytoplasm  (18, 30, 40, 73). Conversely, the 
hY5 RNPs containing RoBPI are predom inantly  
localized to the nucleus, and thus probably have 
a nuclear function (68, 74). RoBPI is identical 
to the hum an  pre-mRNA splicing-factor PUF60 
(69) and to a repressor of activated RNA poly­
m erase II transcription  (70). In agreem ent with 
this, RoBPI localized to granular nuclear struc­
tures rem iniscent of speckles (68). Previous data 
showed that also part of the Ro60 pro tein  co­
localized w ith nuclear speckles (260). However, 
the functional significance of these findings is 
still unknown.
As m entioned  above, the hY1, hY3 and hY4 RNPs 
probably have cytoplasmic functions. Indirect 
evidence that these particles have im portan t 
functions com es from  the observation that the 
hY RNAs are specifically degraded early during 
apoptosis (261). During apoptosis various m ole­
cules (protein, DNA and RNA) functioning in  key 
processes like pre-mRNA splicing, pro tein  syn­
thesis and DNA duplication are modified, hence 
m aking the cell death  process irreversible (262, 
263).
So w hat m ight be the function  of the Ro RNPs in 
the cytoplasm? The individual functions of the 
core Ro RNP proteins Ro60 and La have been 
discussed in  Chapter 1 of this thesis. Therefore 
only the possible functions of these proteins 
in  the context of Ro RNPs will be discussed 
here. Recently, X. laevis Ro60 was shown to be 
an essential cofactor for the interaction  of La 
and cellular nucleic acid binding p ro tein  (CNBP) 
w ith the 5’-untranslated  region (UTR) of the L4 
ribosom al p ro tein  mRNA (80, 264, 265). In addi­
tion to Ro60, a yet unidentified RNA m olecule (Y 
RNA?) appeared to be essential for the binding 
of La and CNBP to the 5’-UTR (80). Based upon
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these data the authors suggested that the cyto­
plasm ic Ro RNPs m ay play a role in  the coordi­
nation  of the expression of ribosom al proteins 
encoded by 5’-term inal oligopyrimidine (TOP)- 
containing mRNAs (266), as for example the L4 
mRNA. However, a role of the Y RNAs in this p ro­
cess is still unproven and  m ore clarity m ay be 
obtained by the identification of the RNA spe­
cies acting as a cofactor in  this translational reg­
ulatory process.
A nother indication for the function of the Ro 
RNPs com es from  the recent identification of 
the ortholog of Ro60, Rsr, in  the radiation-resis­
tan t eubacterium  Deinococcus radiodurans (81). 
D. radiodurans cells lacking Rsr are m ore sen­
sitive to UV irradiation than  are wild-type cells. 
During recovery from UV irradiation, the levels 
of Rsr increase, consistent w ith a role in repairing 
radiation  damage. Moreover, during the recovery 
phase, Rsr associates w ith several sm all RNAs, 
and  at least one of these RNAs resem bles the hY3 
RNA molecule. Although the m olecular m echa­
nism  by which these Ro RNP-like particles act 
in the survival of irradiated D. radiodurans cells 
rem ains to be elucidated, the authors suggest 
that Ro RNPs m ight have a similar function in 
eukaryotic cells (81).
Support for such a Ro RNP function in  the 
response to cellular dam age com es from stu­
dies with the C. elegans Ro60 ortholog ROP-1 
(82). Labbé and co-workers observed that ROP-1 
knock-out strains contain significantly decreased 
levels of the ceY RNA and  do no t readily form 
dauer larvae under conditions that induce dauer 
form ation in  wild-type strains (83, 100). The 
dauer pathw ay is a specialized stress-resistant 
stage of C. elegans in case of unfavorable envi­
ronm ental conditions. They therefore suggest
that the Ro RNP in C. elegans is functioning in 
this stress-response m echanism .
Com bining all available data it is tem pting to 
speculate that the cytoplasmic Ro RNPs have 
a regulatory role in the initiation of translation 
of certain mRNA molecules, the expression of 
w hich is only required under abnorm al (stress) 
circum stances (e.g. after exposure to UV irradi­
ation). Support for this hypothesis com es from 
several observations. Firstly, all proteins cur­
rently known to associate with the cytoplasmic 
Ro RNPs (Ro60, La, hnRNP I and nucleolin) 
have been im plicated in translational processes 
(63-65, 80, 120, 264). Secondly, it has been  sug­
gested that a Y RNA m olecule plays a role in  the 
translational regulation of L4 mRNA (80). A pos­
sible role for Y RNA in this process m ight be the 
recognition of certain  mRNA sequences or the 
induction  of structural changes in  the 5’-UTRs 
of these mRNAs in cooperation w ith the proteins 
associated w ith the Y RNA molecule. This may 
lead to a transition  from a translationally inac­
tive to a translationally active mRNA conform a­
tion.
Concluding remarks and 
future prospects of Ro RNP 
research
The studies described in this thesis have iden­
tified nucleolin as a novel protein  subunit of 
hY1 and  hY3 RNPs, DDX15 as a novel La-asso­
ciated p ro tein  and EEA2 as a novel FYVE-finger 
dom ain  protein. We hypothesized that nucleo­
lin is involved in  the biogenesis an d /o r traffick­
ing of hY1 and hY3 RNPs to the cytoplasm. A 
rem aining challenge in this respect is to prove 
if the subsets of Ro RNPs containing nucleolin
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indeed traverse the perinucleolar com partm ent 
and the nucleolus during their trafficking to the 
cytoplasm. One way of tackling this question is 
to use fluorescently labeled hY RNAs in  m icro­
injection studies. RNAs can be m icroinjected in 
either the nucleus or the cytoplasm  of living cul­
tured  cells, and  their m ovem ent can be followed 
in  tim e by fluorescence microscopy. This may 
yield inform ation about the routes followed by 
these RNAs on their way to the cytoplasm. This 
technique has been  successfully applied to study 
the biogenesis of the cytoplasmic ribonucleo­
pro tein  com plex called the signal recognition 
particle (129, 267).
Despite the growing set of data on functional 
aspects of the Ro RNPs obtained in  several orga­
nism s their actual functions are still elusive. A 
m ajor challenge will be the elucidation of these 
functions, as well as the identification of the 
subsets of Ro RNPs fulfilling them . The imm u- 
noaffinity purification m ethod  described in  this 
thesis will be of use in this respect, since the 
identification of novel Ro RNP-associated p ro ­
teins m ight give a h in t about the function of 
these particles. For future purifications using this 
approach it is advisable to focus on  the anti-Ro60 
im m unoprecipitate since about 50-70% of the 
Ro60 m olecules are associated with Y RNAs (40), 
whereas only a sm all percentage (< 2 %) of the La 
m olecules are associated w ith the Y RNAs. Thus 
selecting for Ro60-associated proteins enhances 
the chance to identify a Ro RNP-associated p ro ­
tein  in com parison w ith the selection for La- 
associated proteins. In addition, the efficiency 
of the anti-Ro60 co-im m unoprecipitation  m ight 
be increased by using extracts of stressed cells 
(e.g. UV-irradiated cells), which m ay result in  the 
enhanced  and functionally relevant association 
of proteins w ith the Ro RNPs. Alternatively, the
recently developed tandem  affinity purification 
(TAP) m ethod  can be used (268). This involves 
TAP-tagging the protein  of interest (Ro60), stably 
expressing this p rotein  in  eukaryotic cells (e.g. 
HeLa suspension culture) and  purification of the 
tagged protein  and associated factors (Ro RNPs) 
under native conditions. The purification com ­
bines a first high-affinity purification, m ild 
elution using a site-specific protease, and a 
second affinity purification to obtain the target 
complexes (269). Com bined with the powerful 
m ethod  of m ass spectrom etry analysis of the co­
precipitated  proteins this approach could yield 
additional valuable inform ation on the com ­
position of the Ro RNPs. The suitability of the 
TAP-method was recently dem onstrated  by the 
analysis of the U6 snRNA-associated Lsm p ro ­
tein  complex (270) and  a proteom ic analysis of 
approxim ately 250 distinct p rotein  complexes 
(271).
In order to investigate the putative regulatory 
role of the Ro RNPs in  translation of certain 
mRNAs (e.g. the 5’TOP-mRNAs) an  in vitro trans­
lation system, preferably generated from  hum an 
cells, m ight be helpful. The cell lysate used in 
this system  could be specifically depleted  of the 
Ro RNPs using the m onoclonal anti-Ro60 an ti­
body and and the effects on the translation of 
certain  mRNAs in this system could be studied. 
In principle, this approach allows the analysis 
of the translation of any type of mRNA, includ­
ing 5’TOP and  IRES-containing mRNAs. Alterna­
tively, the synthesis of proteins in  hum an  cells 
lacking Ro60, which m ight be achieved by the 
recently developed RNA interference technique 
for m am m alian  cells (272), could be examined. 
In com bination  w ith pulse-labeling experim ents 
the latter approach m ight also allow the deter­
m ination  of the influence of UV-irradiation on
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the synthesis of proteins in cells containing or 
lacking Ro60.
In the near future the application of the various 
m ethods (e.g. im m unopurification, Ro RNP 
depletion and  the generation of knock-out cells/ 
organisms) will hopefully provide m ore insight 
into the functions of the Ro RNPs.
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Summary
Ro ribonucleoprotein particles (Ro RNPs) belong 
to the family of the small cytoplasmic RNA-pro- 
tein  complexes. In hum an  cells the RNA com po­
nen t of a Ro RNP consists of one of the four hY 
RNAs designated hY1, hY3, hY4 and  hY5. These 
RNAs are associated w ith the Ro60 pro tein  and 
the La protein. Furtherm ore, hnRNP I has been 
shown to be associated w ith hY1 and hY3 RNPs 
and  RoBPI has been  reported  to associate with 
hY5 RNPs. In addition, the association of Ro52, 
calreticulin and  hnRNP K w ith (subsets of) the 
Ro RNPs has been  suggested bu t is still uncer­
tain. Despite the large body of experim ental 
data collected in  the last decade, as yet no b io­
chem ical function could be assigned to these 
complexes. The aim  of the studies described in 
this thesis was to identify novel proteins that 
are capable to associate (temporarily) w ith the 
hum an  Ro RNPs. Such data m ight contribute to 
the elucidation of the function(s) of these enig­
m atic particles. Because the core proteins of Ro 
RNPs are expected to play an  im portan t role 
in  such interactions, we also analyzed the Ro60 
protein  in  m ore detail.
In C hapter 1 an  overview of the current knowl­
edge on  the structure and putative function 
of the Ro RNPs is presented. Furtherm ore, the 
im m unoaffinity purification m ethod  employed 
in  Chapters 3 to 5 to purify novel Ro RNP-associ- 
ated p roteins is introduced.
C hapter 2 describes the analysis of the phos­
phorylation of the h um an  Ro60 pro tein  using 
nanoelectrospray m ass spectrom etry to m ap the 
phosphorylation site(s). This study showed that 
Ro60 is weakly phosphorylated in  vivo, and iden­
tifies serine-265 as the m ajor phosphorylation 
site. Furtherm ore, (de)phosphorylation of ser­
ine-265 did no t affect the incorporation  of Ro60 
into Ro RNPs bu t influenced the subcellular dis­
tribution  of Ro60 in  hum an  and m onkey cells.
In C hapter 3 the im m unoaffinity purification 
m ethod  described in Chapter 1 was used to 
purify novel Ro RNP-associated proteins. This 
resulted in the identification of nucleolin as a 
novel specific p ro tein  subunit of the hY1 and hY3 
RNPs, bu t no t of the hY4 and hY5 RNPs. Using 
an  in vitro hY RNA-binding assay we established 
that the internal pyrim idine-rich loop of hY1 
and hY3 RNA is essential for the association of 
nucleolin. This RNA-protein interaction  is criti­
cally dependent on  the presence of all four RNP 
motifs of nucleolin, whereas the RGG-box did 
no t appear to be im portant.
In C hapter 4 the identification of a novel p ro tein­
pro tein  interaction  betw een La and  a m em ber 
of the DEAH-box RNA helicase family, DDX15, 
is described. The La-binding dom ain  of DDX15 
was m apped  to a region overlapping the DEAH- 
box. Furtherm ore, DDX15 was shown to localize 
to both  nucleoli and nuclear speckles in  hum an 
cells.
C hapter 5 describes the identification of a novel 
FYVE-domain protein, nam ed  early endosom e 
antigen 2 (EEA2), by virtue of its direct interac­
tion w ith the anti-La mAb SW5. We have shown 
that EEA2 functionally interacts w ith the small 
GTPases rab4 and rab5 and is involved in  the 
internalization  and  recycling of transferrin from 
early endosom es. The unexpected interaction
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of SW5 with EEA2 was analyzed in  m ore detail 
(C hapter 6). The cross-reactive epitope was 
shown to be located in coiled-coil region 3 of 
EEA2.
Finally, in  C hapter 7 the research described in 
this thesis is discussed and future prospects of 
Ro RNP investigations are presented.
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Samenvatting
Ro ribonucleoproteïne partikels (Ro RNP’s) beho­
ren tot de familie van kleine cytoplasm atische 
RNA-eiwitcomplexen. In hum ane cellen bestaat 
de RNA-component van een Ro RNP uit één 
van de in  totaal vier hY RNA’s, aangegeven m et 
hY1, hY3, hY4 en hY5. Deze RNA’s associëren m et 
het Ro60 eiwit en het La eiwit. Ook is de asso­
ciatie van hnRNP I m et hY1 en hY3 RNP’s aan ­
getoond. Bovendien is recent gesuggereerd dat 
RoBPI specifiek associeert m et hY5 RNP’s. Daar­
entegen is de associatie van Ro52, calreticuline 
en  hnRNP K m et (subsets van) de Ro RNPs 
weliswaar gesuggereerd m aar nog n ie t eendui­
dig bewezen. Ondanks de grote hoeveelheid 
aan experim entele data is er m om enteel nog 
geen biologische functie toegeschreven aan de 
Ro RNP’s. Het doel van de studies beschreven 
in dit proefschrift was om  nieuwe eiwitten die 
(tijdelijk) kunnen  associëren m et de hum ane Ro 
RNP’s te identificeren. De identificatie van deze 
eiwitten zou kunnen  bijdragen aan het ophel­
deren  van de functie(s) van de Ro RNP’s. Van de 
centrale eiwitten van de Ro RNP’s w ordt gesug­
gereerd dat deze een belangrijke rol kunnen 
spelen bij RNA-eiwit en eiwit-eiwit interacties 
b innen  het Ro RNP partikel. Vandaar dat ook het 
Ro60 eiwit gedetailleerd is bestudeerd.
In H oofdstuk 1 w ordt een overzicht van de 
recente kennis over de structuur en functie van 
de Ro RNP’s gepresenteerd. Ook w ordt de bij de 
in  dit proefschrift gebruikte im m uno-affiniteits 
zuiveringsm ethode geïntroduceerd.
H oofdstuk 2 beschrijft de analyse van de fos- 
forylering van het hum ane Ro60 eiwit m et 
behulp van ‘nanoelectrospray’ m assaspectrom -
etrie. Deze studie toont aan  dat Ro60 zwak 
gefosforyleerd is in  vivo, en  dat serine-265 
de belangrijkste fosforyleringsplaats is. Boven­
dien blijkt dat (de)fosforylering van serine-265 
de associatie van Ro60 m et de Ro RNP’s n iet 
beïnvloedt. D aarentegen beïnvloedt de 
(de)fosforylering van serine-265 wel de subcel­
lulaire localisatie van Ro60 in zowel h um ane als 
apencellen.
In H oofdstuk 3 is de in Hoofdstuk 1 beschreven 
im m uno-affiniteits zuiveringsm ethode gebruikt 
om  nieuwe Ro RNP-geassocieerde eiw itten te 
isoleren. Toepassing van deze m ethode result­
eerde in de identificatie van nucleoline als een 
nieuwe specifieke eiw itcom ponent van de hY1 
en hY3 RNP’s, m aar n ie t van de hY4 en hY5 
RNP’s. Via een in vitro RNA bindingtest hebben 
we aangetoond dat de in terne pyrimidine-rijke 
lus van het hY1 en hY3 RNA essentieel is voor de 
associatie m et nucleoline. De vier RNP m otieven 
van nucleoline zijn, in tegenstelling to t de RGG- 
box, essentieel voor deze associatie.
In H oofdstuk 4 w ordt de identificatie van een 
nieuwe eiwit-eiwit interactie tussen La en een lid 
van de DEAH-box RNA helicase familie, DDX15, 
beschreven. Het gebied van DDX15 w aar La b indt 
is onderdeel van h et geconserveerde DEAH-box 
dom ein. DDX15 accum uleert in  zowel nucleoli 
als kernspikkels (nuclear speckles) in hum ane 
cellen.
De identificatie van een nieuw  FYVE-domein 
eiwit, genaam d early endosom e antigen 2 (EEA2) 
w ordt beschreven in  H oofdstuk 5. De isolatie 
van EEA2 bleek een gevolg te zijn van een directe
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binding aan het anti-La m onoclonale antili- 
chaam  SW5. We beschrijven dat EEA2 een  func­
tionele interactie aangaat m et de kleine GTPases 
rab4 en rab5, en betrokken is bij de internali­
sering en recycling van transferrine door vroege 
endosom en. De onverw achte interactie tussen 
SW5 en  EEA2 is verder onderzocht in H oofd­
stuk  6. Het kruis-reactieve epitoop is gelegen in 
coiled-coil regio 3 van EEA2.
In H oofdstuk 7 w orden de in dit proefschrift 
gepresenteerde data als geheel bediscussieerd. 
Bovendien w ordt een aantal suggesties gedaan 
voor toekom stig onderzoek aan  de Ro RNP’s.
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